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 Thesis Abstract 
Background 
Eating Disorder research has highlighted the role of neuropsychological functioning, 
informing the treatment of Anorexia Nervosa.  There is ambiguity in the data relating 
to cognitive impairment in Bulimia Nervosa, with the latest review providing 
inconclusive results.  Executive function impairments in the area of set shifting and 
inhibition reported in BN are proposed to relate to traits of compulsivity and 
impulsivity.  Other psychological disorders have also demonstrated executive 
function impairments.  Among anxiety disorders, only PTSD and OCD have strong 
evidence of executive function deficits while a number of studies point towards 
executive function deficits in depression.  This thesis aims to investigate the 
specificity of cognitive impairments seen in a group of female outpatients with 
bulimia nervosa, using a clinical comparison group of anxious and/or depressed 
female outpatients. 
Methods 
A systematic review was conducted to address a gap in the anxiety disorder literature 
and assess the neuropsychological profile of panic disorder.  In order to address the 
main study aims, a comparison between a group of patients with BN and an anxious 
depressed group was conducted on neuropsychological measures of the Trail Making 
Test, Wisconsin Card Sorting Test, Hayling and Brixton tasks, Stroop and Verbal 
Fluency.  In addition, psychological symptoms were assessed using SCL-90-R, Yale-
Brown Obsessive Compulsive Scale and the Self-liking Self Competence scale.  
Social problems solving skills were assessed as a potential real world effect of 
executive function difficulties associated with eating disorders.  The relationships 
between psychological and neuropsychological variables were investigated.  
Results 
The systematic review concluded that there was limited evidence of specific 
impairment in short term memory in panic disorder. The empirical study indicated no 
group differences on the above neuropsychological measures.  Groups also did not 




relationships were found between psychological symptoms and neuropsychological 
measures.  Few individual participants were found to be impaired on 
neuropsychological measures in either group. However, those impaired in the BN 
group were exclusively impaired on the non-perseverative errors and categories 
completed variables of the WCST, which is thought to be related to impulsivity.   
Conclusion 
These findings suggest that the neuropsychological profile of bulimia is broadly 
similar to that of an anxious and/or depressed clinical group on measures of set 
shifting and inhibition.  Although there was evidence of a deficit in inhibition among 





Chapter 1: Introduction 
 
1.2 Introduction to Thesis 
This thesis focuses on the neuropsychological profile of Bulimia Nervosa (BN).  
Neuropsychological impairment in psychological disorders is a popular field of 
research as links between cognitive impairments central to a disorder and its 
symptoms can serve to identify predictors of the course of the illness (Keefe, 1995) 
and treatment outcomes (Porter et al., 2007).  Knowledge about the specific 
cognitive profile of a disorder can also contribute to the development of disorder 
specific cognitive models and therapies (Dudley et al., 2011) 
The aim of this thesis is to contribute to the body of research investigating the 
neuropsychological profile of BN by considering the specificity of the cognitive 
impairments reported in the literature.  It is hoped that research into 
neuropsychological deficits in BN could increase our understanding of the disorder 
and inform treatment as it has in anorexia nervosa (AN) and schizophrenia (Kurtz et 
al., 2001; Tchanturia et al., 2008). The potentially confounding influences of 
comorbid anxiety disorders and depression in BN have been highlighted in recent 
reviews as a neglected area of research (Van den Eynde et al., 2011; Zakzanis et al., 
2010).  Therefore the current study incorporates a comparison group of anxious 
and/or depressed outpatients. 
This chapter will provide an overview of the structure of this thesis submission.  
1.3 Overview of Chapters 
1.3.1 Chapter 2 – Systematic Review 
Chapter 2 is a systematic review of the neuropsychological profile of panic disorder.  
This disorder has been selected, as a very recent review had comprehensively 
covered the neuropsychological profile of BN (Van den Eynde et al., 2011).  
Common comorbidities of BN such as OCD (Martinez-Gonzalez & Piqueras-
Rodriguez, 2008), PTSD (Polak et al., 2012), social anxiety (O'Toole & Pedersen, 
2011) and depression (Castaneda et al., 2008) have also been recently reviewed.  No 
specific review was available on GAD, specific phobia or panic disorder when the 




disorder review provided the opportunity to make a useful contribution to the 
literature and it allowed for a review of the appropriate size for thesis requirements.  
1.3.2 Chapter 3 – Bridging Chapter 
Chapter 3 provides a brief summary of the research and the aims of the thesis.  It 
contains bridging information, which will introduce themes and literature that could 
not be included in the journal article introduction. 
Information relating to Aims 1 and 2 are presented and discussed in the journal 
article (Chapter 4) and information relating to Aim 3 will be introduced in Chapter 3 
and analysed and discussed as ‘additional’ data in Chapters 6 and 7.  
1.3.3 Chapter 4 – Journal Article 
Chapter 4 is a journal article reporting on the comparison between a group of females 
in psychological treatment for bulimia and a group of females in psychological 
treatment for anxiety and/or depression on neuropsychological measures of set 
shifting and inhibition.   
This article explores whether the neuropsychological profile of BN involves patterns 
of performance that are specific to BN or shared by other psychiatric disorders.  
Similarly to BN, conflicting results have been published in the literature relating to 
possible neuropsychological deficits in people with anxiety disorders and depression, 
as described further in Chapter 4.    
1.3.4 Chapter 5 – Methods 
The journal article is followed by a comprehensive Methods Chapter including 
extended description of the measures used in the study and details relating to 
recruitment of participants. 
1.3.5 Chapter 6 – Additional Results 
The data presented in Chapter 4 are further analysed and data related to two 
additional neuropsychological measures (D-KEFS Verbal Fluency and the Brixton 
task) and two additional psychological measures (Self-liking/Self competence scale 
(SLSC) and the Social Problem Solving Inventory (SPSI)) are presented.  Further 
introductory information related to the SLSC and SPSI is provided within the 




1.3.6 Chapter 7 – Additional Discussion 






Chapter 2: Systematic Review 
(Written for the Journal of Affective Disorders, see author guidelines in Appendix 1. 
7,319 words including tables) 
Abstract 
Background: There is a growing body of literature investigating the 
neuropsychological profile of Panic Disorder (PD), some of which suggests 
potential cognitive dysfunction.  This paper systematically reviews the existing 
literature on neuropsychological performance in PD. 
Method: PsychINFO, Embase, Medline and PsychArticles databases were 
searched to identify articles reporting on neuropsychological function in PD 
published in English during the time period 1980 to March 2012.  14 studies were 
identified. 
Results: There was limited support for impairment in short term memory among 
individuals with PD, although this was not found across all studies.  Overall, the 
reviewed studies did not support the presence of impairment in other areas of 
cognitive functioning, including executive function, long term memory, 
visuospatial or perceptual abilities and working memory.  
Limitations: Studies containing samples of less than 15 participants per group 
were excluded from this review.  A limited amount of research has been 
published on this topic and small sample sizes (under 25 per group) have been 
used by many studies.  Therefore, the current review is based on a small number 
of studies with limited statistical power. 
Conclusions: There is limited evidence of specific neuropsychological 
impairments in participants with PD. Impairments in short term memory have 
been noted in some of the literature, which warrants further investigation to 
establish its relevance to clinical practice.  Larger sample sizes and appropriate 






Panic disorder (PD) is a disabling mental health problem characterised by 
unexpected, recurrent panic attacks, fear about the implications of attacks and 
modifications of behaviour as a result of the attacks (American Psychiatric 
Association, 2000).  PD can occur with or without agoraphobia and is associated 
with high levels of psychiatric comorbidity and severe role impairment (Baillie & 
Rapee, 2005; Kessler et al., 2006).   
A growing interest in the neurobiology of anxiety disorders in recent years has led to 
increasing research into neuropsychological deficits associated with them (Millan et 
al., 2012).  Neuropsychological deficits are of interest, as they may be the basis for 
some key symptoms of PD and have implications for treatment, as has been seen in 
schizophrenia and anorexia (Cavedini et al., 2006; Tabarés-Seisdedos et al., 2008).  
The cognitive (Clark, 1986; Beck and Clark, 1997) and learning (Bouton et al., 2001) 
theoretical models of panic, support a role for biased information-processing of 
threat-related stimuli in the formation and maintenance of the disorder.  This 
suggests that neuropsychological deficits in areas of information processing may 
underlie some symptoms of panic disorder.  A large body of evidence suggests that 
patients with PD tend to selectively and automatically direct their attention towards 
threat-related stimuli (Ehlers et al., 1988; Clark et al., 1997; Lundh et al., 1999; 
Teachman et al., 2007 ).  A difficulty shifting focus away from perceived threats 
could be related to difficulty with cognitive set shifting.  Such difficulties have been 
reported in some neuropsychological studies of individuals with Panic Disorder (e.g. 
Airaksinen et al., 2005 ).  Memory difficulties may also contribute to the biased 
appraisal of threat if examples of overcoming potentially threatening situations are 
not available in memory.  Recent research suggests that memories of panic attacks 
may have the same qualities as traumatic memories, being poorly processed and 
involving re-experiencing which may keep them predominant in memory (Hagenaars 
et al., 2009 ).  If underlying neuropsychological difficulties were found consistently 
in patients with PD, this would support the modification of common therapeutic 
interventions, such as CBT, or the incorporation of specific interventions to improve 
memory or set shifting ability, such as those that have been used successfully with 





Neuropsychological deficits may also act as measurable symptoms of underlying 
neurobiological dysfunction.  Several studies have found structural brain 
abnormalities in patients with anxiety disorders, including patients with PD (Mataix-
Cols & van den Heuvel, 2006; Phan et al., 2009; Szeszko et al., 2005; van den 
Heuvel et al., 2005).  Patterns of impairments in executive function have been 
reported in a number of recent reviews of neuropsychological performance in OCD 
(Martinez-Gonzalez & Piqueras-Rodriguez, 2008; Menzies et al., 2008; Olley et al., 
2007).  Executive function deficits have also been implicated in Post Traumatic 
Stress Disorder (PTSD). Anxiety disorders such as social anxiety disorder (SAD) and 
PD have been less well researched.   
In PD, some imaging studies have indicated abnormalities in specific brain regions 
compared to controls, including different metabolic activity in the hippocampal and 
parahippocampal areas (Bisaga et al., 1998) and abnormalities in the temporal lobe 
structures (Vythilingam et al., 2000).  However, Reiman and colleagues have noted 
similar regional blood flow patterns in panic disordered patients as in healthy 
controls with anticipatory anxiety, which calls into question whether abnormalities 
seen relate to structural differences or transient effects of anxiety (Reiman, 
Fusselman, et al., 1989; Reiman, Raichle, et al., 1989).  Brain abnormalities such as 
these may lead to learning and memory deficits, if present in panic disordered 
individuals. 
Individual studies have found associations between PD and a number of 
neuropsychological deficits, including executive function and episodic memory 
deficits (Airaksinen et al., 2005). However, many conflicting results have been 
produced, with some studies supporting memory deficits in PD (Asmundson et al., 
1994; Lucas et al., 1991) and others reporting no memory problems of any kind 
(Gladsjo et al., 1998).  No review was found of neuropsychological performance in 
PD.  This paper aims to provide a systematic review of neuropsychological 





2.2.1 Search Strategy 
Relevant studies published between January 1980 and March 2012 were identified by 
systematic searches of the PsycInfo, Embase, PsycArticles and Medline databases.  
Articles reporting neuropsychological performance of all anxiety disorder groups 
were initially identified, as a preliminary search of the literature indicated that PD 
groups were often used as comparison groups in studies that focused on other anxiety 
disorders, such as OCD (e.g. Purcell et al., 1998).  Keywords for the search were 
“neurocognition”, “attention”, “executive function”, “leaning”, “memory”, 
“inhibition” AND “neuropsychological tests” AND “anxiety”, “OCD”, “PTSD”.  
Terms were adapted and ‘exploded’ in keeping with subject headings for each 
database (see Appendix 2 for full search term list for each database).  The reference 
lists of ten papers identified as appropriate after inclusion and exclusion criteria were 
applied, were checked for relevant studies, resulting in 3 additional papers.  A ‘cited 
by’ search was conducted using Web of Science (1899-present) resulting in 2 
additional papers.  This resulted in 15 papers meeting study criteria.  Subsequently 
two studies were discovered to be reporting on the same data (Lautenbacher et al., 
2002; Spernal et al., 2003).  The paper containing the most data was retained in the 
review, resulting in a total of 14 papers (Lautenbacher et al., 2002). 
2.2.2 Inclusion and exclusion criteria 
Studies were included if they reported on: (1) adults (18-65 years) (2) diagnosed with 
current PD according to DSM or ICD criteria (3) a comparison group of healthy 
controls (HC) (4) had ≥ 15 participants in each group and (5) were published in 
English.  A relevant Spanish paper was found during the search but could not be 
included as it was only available in the Spanish language (Castillo et al., 2010).  
Studies on the effect of psychotropic medication or a treatment intervention were 
excluded.  Investigations of cognitive performance in the presence of anxiety 
provoking words or stimuli were excluded.  Studies of neuropsychological 
performance during brain imaging or brain activity recording were also excluded.  











Figure 2.1 Flowchart showing search results, and the number of included and 
excluded studies. 
2.2.3 Data Extraction 
Data were extracted from each paper by the first author, according to a structured 
pro-forma covering key study characteristics.  Data were extracted and compiled into 
Table 2.1. 
Full text articles assessed for eligibility 
N=59 
Studies retained from 
search  
 n = 10 
Suitable papers 
from references 
n = 3 
Excluded as duplicates n = 12 
No panic group n=19 
No healthy control group n=2 
Panic patients but mixed patient 
group reported in results n = 6 
Cognitive function in the presence 
of emotional stimuli n = 6 
Less than 15 per group n = 2 
Imaging study n = 1 
Intervention n = 1 
Papers obtained 
using ‘cited by’ 
search  
 n = 2 
Studies included in 
qualitative synthesis 
n = 14 
Screen 1 by titles and abstracts, n=420 
Screen 2 by abstracts and full text, n =59 
4 Databases   n = 3431 




2.2.4 Assessment of methodological quality 
To rate the methodological quality of included studies, criteria were developed by the 
first author, drawing from the Cochrane Handbook for Systematic Review’s 
guidance on assessing risk of bias (Higgins & Altman, 2008) and the Centre for 
Reviews and Dissemination (CRD) guidance on conducting quality assessment 
(CRD, 2008).  A checklist of 8 quality criteria were identified a priori (Appendix 4).  
The ratings for the included studies are listed in Table 2.2.  For each criterion, 
included studies were assigned one of four outcome ratings: ‘well covered’ (2 
points); ‘adequately addressed’ (1 point); ‘poorly addressed’ or ‘not addressed’ (both 
0 points).  Two additional raters independently reviewed four studies each.  Exact 
agreement was reached on 88% and 84% of the ratings respectively.  A difference of 
one point occurred on 12.5% of the items and by 2 points on 1.5% items.  





Table 2.1 Key Study Characteristics 
Authors Sample size
a
 Groups matched on Key exclusion criteria Levels of anxiety compared 
between groups 
Medication 
Airaksinen et al. 
(2005) 
33 PD  (30 PD only and 




age, education No exclusions No comparisons No medications excluded 
Asmundson et al. 
(1994) 
18 PD   
16 HC  
gender, age, education Current major depression 
and Social phobia excluded  
BDI: PD > HC 
BAI: PD > HC    
1 PD taking p.r.n. 
benzodiazepines 
Boldrini et al. 
(2005) 
15 PD with Ag 
15 HC 
gender, age, education 
 handedness, intelligence 
All Axis I or II excluded   No comparisons Free from benzodiazepines 
(no time period) but SSRIs 
not excluded 
Cavedini et al. 
(2002) 




gender, age, education All Axis I or II excluded                           No comparisons All medication free for at 
least 2 weeks 
Deckersbach et al. 
(2011) 
20 PD  
20 HC 
gender, age, education  Depression, psychosis and 
bipolar disorder excluded  
STAI: PD > HC   
BDI: PD > HC 
All free from 
benzodiazepines for at 
least 4 weeks.  
One PD taking Sertraline 
Galderisi et al. 
(2008) 
28 PD (26 with Ag) 
32 HC  
gender, age,  education 
handedness 
MDD and other anxiety 
disorders excluded  
No comparisons  Medication free for 4 
weeks or drug naive 
Gladsjo et al. 
(1998) 
69 PD  
19 HC  
gender, age, education  
ethnicity,  handedness 
All Axis I or II excluded                           No comparisons Medication free for at least 
2 weeks  
Gordeev (2008) 93 PA 
36 HC  
education  No information BDI: PD > HC  
STAI: PD > HC 
Medication free for 2 
weeks 
Gorini et al. 
(2010) 
31 PD with Ag,  
31 HC  
gender,  age, education   Other primary diagnoses 
excluded 





Table 2.1 Key Study Characteristics Continued 
Authors Sample size
a
 Groups matched on Key exclusion criteria Levels of anxiety compared 
between groups 
Medication 
Kaplan et al. 
(2006) 
22 PD (11 PD only, 11 
PD + MDD)
c
,           
22 HC  
gender, age, education  Other anxiety or depressive 
disorder excluded  
MADRS: PD > HC  
Ham A: PD > HC  
All medication free (no time 
period given) 
Lautenbacher et al 
(2001) 
21 PD, (16 with Ag, 5 






Lifetime comorbidity of 
Axis 1 excluded 
No comparison  Medication free for 6 days  
Lucas et al. (1991) 25 PD  
 25 HC  
gender, age, education 
handedness  
Current mood disorder, or 
other anxiety disorder 
excluded 
BDI: PD > HC 
STAI: PD > HC 
Patients remained on 
medication 
Ludewig et al. 
(2003) 




gender, age  No information No comparisons  14 of 18 PDs on medication 
including SSRIs and TCA  






gender, age, education 
handedness, IQ 
Comorbid disorder 
excluded but anxiety or 
depression symptoms 
accepted         
Ham D: PD = HC 
Ham A: PD > HC 
19 PD on medication 
a PD group is mixed with and without agoraphobia with details unavailable unless otherwise specified, b Additional groups were included in the study which did not 
form part of this review, c MDD is episode secondary to PD, STAI= State Trait Anxiety Inventory, TCA = tricyclic antidepressant, SSRI = selective serotonin reuptake 
inhibitor 
Ag = agoraphobia, HamA = Hamilton Anxiety rating scales, HamD = Hamilton Depression rating scale, BDI= Beck Depression Inventory, BAI= Beck Anxiety 





Table 2.2 Quality Criteria applied to Reviewed studies 

















stats used Total 
Airaksinen et al. (2005) WC AA WC AA WC AA AA AA 11 
Asmundson et al. (1994) WC WC WC AA AA NA AA AA 10 
Boldrini et al. (2005) WC WC WC WC AA NA AA AA 11 
Cavedini et al. (2002) AA WC WC WC AA NA AA WC 11 
Deckersbach et al. 
(2011) 
AA WC WC WC AA NA AA AA 10 
Galderisi et al.(2008) WC WC WC AA WC NA AA AA 11 
Gladsjo et al. (1998) WC WC WC WC AA AA AA AA 12 
Gordeev (2008) PA PA AA AA WC NA AA WC 7 
Gorini et al.  (2010) PA WC AA AA WC NA AA AA 8 
Kaplan et al.  (2006) WC WC WC WC AA NA AA WC 12 
Lautenbacher et al. 
(2001) 
WC AA AA AA AA NA AA AA 
8 
Lucas et al. (1991) WC WC WC WC WC NA AA AA 12 
Ludewig et al. (2003) PA AA WC AA AA NA PA AA 6 
Purcell et al. (1998) WC WC WC WC WC AA AA WC 14 
i. Eligibility criteria are specified, ii. Comparison group is matched, iii. Diagnosis using appropriate criteria and measure, iv. Neuropsychological Measures are robust, 
v. Sample size adequate for all groups, vi. Levels of uptake are reported, vii. Results – appropriate outputs provided, viii. Appropriate Statistical techniques,  





2.3.1 Search results and characteristics of studies 
From the search, 14 papers were identified comparing a PD group with a HC group.  
The 14 studies involved 439 patients with PD in total and 510 HCs (see Table 2.1 for 
details).  The median sample size was 23.5 for PD patients (range 15 - 93) and 27.5 
for HCs (range 15 - 175).  
Three studies reported on the presence or absence of agoraphobia in their PD sample, 
but 11 did not.  Both Boldrini et al. (2005) and Gorini et al. (2010) reported all PD 
participants to have PD with agoraphobia.  Twenty six of the 28 PD participants in 
Galderisi et al.’s (2008) study had PD with agoraphobia. 
 
2.3.2 Findings of the review 
As many neuropsychological measures can be said to assess a number of cognitive 
functions, Lezak et al.’s (2004) categorisation of neuropsychological assessments has 
been broadly followed when tabulating and discussing the measures used in the 
reviewed studies.  However, the category of executive functioning was expanded 
from that of Lezak et al. (2004) in line with Burgess (2003) to incorporate tests of 
inhibition, coordinated dual tasks (e.g. the Trail Making Task) and verbal fluency.  In 
the context of the reviewed studies, such measures were used with the purpose of 
assessing executive functioning.  Measures used in the reviewed studies and their 
reported results are detailed in Tables 2.3 to 2.6. 
2.3.3 Memory 
2.3.3.1 Verbal Memory 
Short and long term verbal memory were investigated in eight studies using ten 
measures.  Of these, four found poor performance in a PD group compared to HC 
and four did not find group differences.   
Short term verbal memory was measured by five studies and impairment of PD 
patients compared to HC was reported in three studies.  Two studies indicating a 




(Airaksinen et al., 2005; Gordeev, 2008) and the other used the California Verbal 
Learning Test (CVLT; Asmundson et al., 1994; Delis et al., 1987).  The CVLT was 
used in two other studies, which did not report on performance of people with PD on 
short term memory scales (Deckersbach et al., 2011; Gladsjo et al., 1998).  No 
differences between PD and HC groups were reported by Lucas et al. (1991) or 
Deckersbach et al. (2011) in measures of immediate recall of stories or paired words, 
taken from the Wechsler Memory Scale (WMS; Wechsler, 1987).  Mixed results 
were reported in relation to cued short term memory, with deficits seen on a non-
standardised task (Airaksinen et al., 2005) but not on the cued recall subscale of the 
CVLT (Asmundson et al., 1994).  Overall, there was some support for impairment in 
short term memory when assessed by non-standardised measures but little support 
from standardised assessment. 
Delayed verbal memory was investigated by seven studies.  No differences were 
found between PD and HC groups on delayed verbal memory using the CVLT 
(Asmundson et al., 1994; Deckersbach et al., 2011; Gladsjo et al., 1998), the 
Auditory Verbal Learning Test (AVLT) (Galderisi et al., 2008), or the paired 
associates and logical memory subscales of the Wechsler Memory Scale (WMS) 
(Lucas et al., 1991). Using a selective reminding procedure (J. M. Fletcher, 1985), 
conflicting results were produced by two studies with Lucas et al. (1991) observing a 
deficit in long term verbal memory in a PD sample compared to HC while Boldrini et 




Table 2.3 Verbal memory in panic disorder compared to healthy controls 
Verbal Memory Test study/authors PD v HC 
CVLT 
  immediate free recall trial 5 Asmundson et al. (1994)  
immediate free recall trial 1 Asmundson et al. (1994) - 
short delay free recall Asmundson et al. (1994)  
total free recall Asmundson et al. (1994)  
 
Deckersbach et al. (2011) - 
 
Gladsjo et al. (1998) - 
short delay cued recall Asmundson et al. (1994) - 
retention Asmundson et al. (1994) - 
 
Deckersbach et al. (2011) - 
response inhibition Asmundson et al. (1994) - 
response discrimination Asmundson et al. (1994) - 
 
Deckersbach et al. (2011) - 
 
Gladsjo et al. (1998) - 
Word Lists 
  AVLT delayed recall Galderisi et al. (2008) - 
Warrington RMT Gladsjo et al. (1998) - 
words remembered short term Gordeev et al. (2008)  
words remembered  
 Free recall Airaksinen et al. (2005)  
Cued recall Airaksinen et al. (2005)  
Hebb Digit Recurring test - accuracy index Galderisi et al. (2008) - 
Buschke-Fuld Selective Reminding Test 
(SRT) 
  long term recall Boldrini et al. (2005) - 
long term storage Boldrini et al. (2005) - 
intrusions Boldrini et al. (2005) - 
delayed recall Boldrini et al. (2005) - 
Verbal Selective Reminding Test (SRT) 
  Long term storage Lucas et al. (1991)  
trials to criterion Lucas et al. (1991) - 
delayed recall Lucas et al. (1991)  
long term retrieval Lucas et al. (1991)  
Logical Memory (WMS) 
  Delayed recall Lucas et al. (1991) - 
immediate recall Deckersbach et al. (2011) - 
Paired associate learning (WMS) 
 
- 
Immediate recall Lucas et al. (1991) - 
Delayed recall Lucas et al. (1991) - 
Indicates significantly worse performance than HC 
indicates significantly better performance than HC 






2.3.3.2 Visual Memory 
Both short and long term visual memory in people with PD was investigated by eight 
studies using ten measures.  Three studies reported deficits in people with PD 
compared to HC, while five reported no significant differences between these groups.   
Short term visual memory was investigated in two studies, one using the Rey-
Osterrieth Complex Figure test (RCFT; Rey, 1941) immediate recall scale 
(Deckersbach et al., 2011) and one using a non-standardised task, in which an array 
of numbers was visually presented followed by immediate recall (Gordeev, 2008).  
Both these tasks were associated with an impaired performance in people with PD 
compared to HC.   
Seven studies reported on measures of long term visual memory, including measures 
of retention and recognition.  Three studies used the Benton Visual Retention test 
(BVRT) (BVRT; Benton, 1945) with two of these reporting significantly worse long 
term visual memory in people with PD relative to HC (Asmundson et al., 1994; 
Deckersbach et al., 2011; Lucas et al., 1991).  A selective reminding procedure (J. M. 
Fletcher, 1985) was used in two studies producing mixed results, as Lucas et al. 
(1991) reported poor performance in people with PD but this was not replicated by 
Gladsjo et al. (1998).   Visual recognition memory was investigated using 3 subtests 
of the computerised Cambridge Neuropsychological Test Automated Battery 
(CANTAB; Cambridge Cognition, Cambridge, UK) and the Warrington Recognition 
Memory test (Faces)(Warrington, 1984). No differences were reported between PD 
and HC groups on these visual recognition tasks (Gladsjo et al., 1998; Kaplan et al., 
2006; Purcell et al., 1998).  People with PD also performed similarly to HC on the 
RCFT percent recall (Boldrini et al., 2005; Deckersbach et al., 2011), the Continuous 
Visual Memory test (Gladsjo et al., 1998; Trahan & Larrabee, 1989) and delayed 
recall of the Visual Reproduction subscale of the WMS (Lucas et al., 1991).  These 
studies do not support a finding of difficulties in long term visual memory for people 
with PD. 
In summary there is some support for a short term memory deficit in people with PD 




tasks providing this support is unclear. There is little support for impairment in either 
verbal or visual long term memory. 
Table 2.4 Visual memory in panic disorder compared to healthy controls 
Visual Memory Test study/authors HC 
Benton Visual Retention Test 
   Form F (BVRT-F) Asmundson et al. (1994) - 
Errors Deckersbach et al. (2011)  
Errors Lucas et al. (1991)  
RCFT 
  immediate recall Deckersbach et al. (2011)  
percent recall Boldrini et al. (2005) - 
percent recall Deckersbach et al. (2011) - 
Visual Selective Reminding test (VSRT) 
  long term storage Gladsjo et al. (1998) - 
long term storage Lucas et al. (1991)  
total recalled Gladsjo et al. (1998) - 
long term retrieval Gladsjo et al. (1998) - 
long term retrieval Lucas et al. (1991)  
Delayed recall Lucas et al. (1991)  
Trials to criterion Lucas et al. (1991)  
   Warrington RMT Faces Gladsjo et al. (1998) - 
Continuous Visual Memory test (CVMT) 
  total recalled Gladsjo et al. (1998) - 
d-Prime Gladsjo et al. (1998) - 
   Numbers remembered, short term Gordeev et al. (2008)  
Visual Reproduction (WMS) - delayed recall Lucas et al. (1991)  
CANTAB 
  Spatial Recognition Memory Kaplan et al. (2006) - 
Spatial Recognition Memory Purcell et al. (1998) - 
pattern recognition memory  Kaplan et al. (2006) - 
pattern recognition memory  Purcell et al. (1998) - 
Delayed match to sample Kaplan et al. (2006) - 
Delayed match to sample Purcell et al. (1998) - 
 
Indicates significantly worse performance than HC 
indicates significantly better performance than HC 





2.3.4 Attention, perception and working memory 
2.3.4.1 Working Memory 
Working memory in people with PD was explored by seven studies using working 
memory span tasks. No difference between the performance of people with PD and 
HC were reported by four studies using the Digit Span (Wechsler, 1981) task.  Two 
studies using the CANTAB computerised Spatial Span and Spatial Working Memory 
tasks also found no differences.  Boldrini et al. (2005) and Galderisi et al. (2008) 
employed the Corsi Block Tapping Task (CBTT; Berch, 1998) to investigate 
working memory span, while Deckersbach et al. (2011) used the similar Spatial span 
task from the WMS (Wechsler, 1987).  Performance was reported as no different to 
HC on measures of span (Boldrini et al., 2005; Deckersbach et al., 2011), however 
on the supraspan subscale, Boldrini et al. (2005) reported a poor learning process in 
spatial working memory in people with PD compared to HC.  Galderisi and 
colleagues (2008) also administered the CBTT but only reported on the accuracy 
index, on which people with PD performed better than the HCs in their sample.  In 
summary, there is very little support for working memory impairment in PD. 
2.3.4.2 Attention 
Attention was investigated in seven studies using six different tests.  No impairments 
of people with PD were found compared to HC in any study (Airaksinen et al., 2005; 
Asmundson et al., 1994; Deckersbach et al., 2011; Galderisi et al., 2008; Gladsjo et 
al., 1998; Kaplan et al., 2006; Lucas et al., 1991). 
2.3.4.3 Perception 
Tests included in this section were classed primarily as tests of perception by Lezak 
et al. (2004) as they measure visual field perception, visual searching and facial 
recognition but also include selected and divided attention. 
Four studies investigated these abilities in PD using six tasks.  Poor performance was 
noted on three of these tasks.  Individuals with PD performed poorly compared to 
HC on the Munsterberg Test, described as a test of selective attention and on a 
Schulte tables task of sustained attention (Gordeev, 2008).  The Munsterberg test 
requires participants to find words in a random set of letters within a limited time.  




Some literature was found indicating that Schulte tables do not have well established 
psychometric properties (Ennok, 2010).  In contrast to Gordeev’s (2008) finding of 
poor selective attention, Lautenbacher et al. (2002) did not find overall group 
differences on selective attention using a computerised signal detection task.  
Divided attention was also explored by Lautenbacher et al. (2002) using a visual 
field neglect task in which individuals with PD demonstrated impaired performance 
relative to HC. Information on psychometric properties could not be found for 
Lautenbacher et al.’s (2002) measures.  Facial recognition in the absence of a 
memory condition was assessed using the Benton Facial Recognition test (short 
form)(Benton, 1983), where the participant must identify photographs of the target 
person taken from different angles.  Individuals with PD were as good at identifying 
faces as HCs (Boldrini et al., 2005).  No difference in ability was seen between the 
two groups on a digit cancellation test (Asmundson et al., 1994).  Overall, some 
support was found for impaired perceptual/attention abilities in people with PD but 
the reliability of the measures used was uncertain.  
2.3.5 Visuospatial Ability 
Visuospatial ability was investigated in PD by five studies using four measures.  
Three of these measures were standardised tasks - the Block Design task from the 
Wechsler Adult Intelligence Scale-Revised (WAIS-R), the copy task of the RCFT 
and the mental rotation task (Vandenberg & Kuse, 1978) and one a novel computer-
based task (Jacobs et al., 1997).  Two studies found no group differences in 
visuospatial ability using the RCFT copy score (Boldrini et al., 2005; Deckersbach et 
al., 2011). Poor visuospatial ability of people with PD was seen on the Block Design 
task by Asmundson et al. (1994) but was not replicated (Gladsjo et al., 1998). The 
ability to perform spatial rotations mentally was investigated by Deckersbach et al. 
(2011) using the mental rotation test.  The PD group performed as well as HCs on 
this test.  A virtual environment was used by Gorini et al. (2010) to investigate 
spatial orientation and learning in people with PD.  Their study used a virtual water 
maze analogue where participants had to find the hidden platform in a virtual 
environment, starting from a different position at each trial.  Learning the position of 
the platform over trials was impaired in the PD group compared to HCs, however 




performance was noted in both groups.  In summary, only one study provided 






Table 2.5 Working memory in panic disorder compared to healthy controls 
Cognitive function Test study/authors PD v HC 
Working Memory Digit span  Boldrini et al. (2005) - 
  
Deckersbach et al. (2011) - 
  
Gladsjo et al. (1998) - 
  
Lucas et al. (1991) - 
 
Corsi Block Tapping Task (CBT)  
  
 
span Boldrini et al. (2005) - 
 
supraspan Boldrini et al. (2005)  
 





spatial span forward Deckersbach et al. (2011) - 
 





Spatial Span Kaplan et al. (2006) - 
 
Spatial Span Purcell et al. (1998) - 
    Attention Mental control task (WMS-R) Deckersbach et al. (2011) - 
  
Lucas et al. (1991) - 
 
Continuous performance test Galderisi et al. (2008) - 
 
TMT A Airaksinen et al. (2005) - 
  
Asmundson et al. (1994) - 
  
Gladsjo et al. (1998) - 
 
Digit symbol (WAIS-R)  Galderisi et al. (2008) - 
  
Gladsjo et al. (1998) - 
 
Digit vigilance - time Gladsjo et al. (1998) - 
 





Rapid Visual Information Processing Kaplan et al. (2006) - 
    Perception 
   
 
Digit Cancellation Test (DCT) Asmundson et al. (1994) -  
 
Signal Detection (from Weiner-Test-System) Lautenbacher et al. (2001) - 
 
Munsterberg test Gordeev (2008)  
 
Schulte tables Gordeev (2008) 
 
 
Visual Field Neglect task (from TAP) Lautenbacher et al. (2001)  
 
Facial Recognition test (BFRT) short form Boldrini et al. (2005) - 
    Visuospatial  Block design (WAIS-R) Asmundson et al. (1994)  
ability 
 
Gladsjo et al. (1998) - 
 
Mental rotation test Deckersbach et al. (2011) - 
 
Spatial orientation and learning – 
virtual water maze analogue Gorini et al. (2010)  
 RCFT   
 Copy Boldrini et al. (2005) - 
 Copy Deckersbach et al. (2011) - 
Indicates significantly worse performance than HC 
indicates significantly better performance than HC 




2.3.6 Executive function 
Executive function was assessed by nine studies using nine measures.  Results were 
considered under the headings of set shifting, verbal fluency, decision making and 
planning and organising.  Significant group differences were reported only on two 
measures. 
2.3.6.1 Planning and Organising 
People with PD demonstrated impaired performance relative to HC on the 
organisation score of the RCFT (Deckersbach et al., 2011). Purcell et al. (1998) 
administered the Tower of London task (CANTAB; Cambridge Cognition, 
Cambridge, UK) and found comparable performance between the two groups. 
2.3.6.2 Set shifting 
The set shifting performance of people with PD in comparison to HC was examined 
by six studies using five tasks.  Individuals with PD performed as well as HC on the 
Wisconsin Card Sorting Task (WCST; Boldrini et al., 2005; Heaton et al., 1993).  
There were also no group differences found in both studies using the CANTAB 
intradimensional and extradimensional shifting task (Kaplan et al., 2006; Purcell et 
al., 1998).  Three studies reported on the Trail Making Task B (TMT B; R. M. Reitan 
& Davidson, 1974), with only one (Airaksinen et al., 2005) reporting slower times in 
people with PD compared to HC. 
2.3.6.3 Verbal Fluency 
Five studies investigated letter fluency abilities, finding individuals with PD 
produced as many words as HCs.  One of these also investigated category fluency 
(Benton, 1989; Gladsjo et al., 1998) and again found no group differences in number 
of words produced.  
2.3.6.4 Decision Making 
Decision Making ability was examined by Cavedini et al. (2002) using the Iowa 
Gambling Task (IGT; Bechara et al., 1994), by Kaplan et al. (2006) using the 
Cambridge Gambling task (Rogers et al., 1999) and by Ludewig et al. (2003) using a 
two-choice prediction task (Paulus, 1997).  Performance of the PD group was not 
significantly different to the control group for any task, although PD participants 




responding strategy even at low error rates in Ludewig et al.’s (2003) study.  Kaplan 
et al. (2006) reported that within their sample comorbid major depressive disorder 
(MDD) was associated with slow decision making. 
In summary, the evidence reviewed does not support an executive function deficit in 
PD. 
Table 2.6 Executive function in panic disorder compared to healthy controls 
Cognitive 
function Test study/authors PD v HC 
Set shifting TMT B Airaksinen et al. (2005)  
  
Asmundson et al. (1994) - 
  





categories Boldrini et al. (2005) - 
 
total errors Boldrini et al. (2005) - 
 
perseverative errors Boldrini et al. (2005) - 
 
non-p errors Boldrini et al. (2005) - 
 
perseverative responses Boldrini et al. (2005) - 
 









Total score Kaplan et al. (2006) - 
 
IDS trial score Purcell et al. (1998) - 
 
EDS trial score Purcell et al. (1998) - 
 
Spatial working memory Purcell et al. (1998) - 
    Planning 
and 
organising Tower of London Purcell et al. (1998) - 
 
RCFT organisation Deckersbach et al. (2011)  
    verbal 
fluency FAS in 60 sec 
Airaksinen et al. (2005) 
- 
 
FAS in 60 sec Boldrini et al. (2005) - 
 
letter fluency Gladsjo et al. (1998) - 
 
COWAT Deckersbach et al. (2011) - 
 
category fluency  Gladsjo et al. (1998) - 
    Decision 
making Iowa Gambling Task Cavedini et al. (2002) - 
 
Cambridge Gambling Task Kaplan et al. (2006) - 
 
Two-Choice Prediction Task 
(Paulus et al., 1997) Ludewig et al. (2003) - 
Indicates significantly worse performance than HC, indicates significantly better 




2.3.7 Summary of Neuropsychological findings 
The findings of the reviewed studies suggest limited support for a short term memory 
deficit in people with PD in both verbal and visual memory, with five out of seven 
studies indicating a difference in performance. There is little support for impairment 
in perceptual ability, as although three out of four studies found differences, the 
reliability and validity of the measures used was unclear. Only three of fourteen 
studies found differences in long term memory compared to HC, which did not 
support long term memory impairment in PD.  The findings reviewed did not 
indicate deficits in executive function, as only two of nine studies found group 
differences.  Similarly, working memory was impaired only in one of seven studies 
and attention was not impaired in any of the seven studies incorporating tests of 
attention.  Visuospatial abilities were impaired in two out of five studies, which does 
not suggest consistent impairment.   
2.3.8 Assessment of Methodological Quality 
Table 2.2 contains study ratings on the eight quality criteria selected.  This rating 
system provides an indication of the relative methodological strengths of the studies 
reviewed, although it does not allow for detailed comparison.   
Based on the chosen criteria, Purcell et al. (1998) was methodologically the strongest 
study, although the majority of studies were of average to high quality.  Studies that 
reported significant results for more than half of the measures they utilised, tended to 
be of lower quality, as defined by the quality criteria.  Four such studies (Airaksinen 
et al., 2005; Gorini et al., 2010; Lautenbacher et al., 2002; Lucas et al., 1991) failed 
to describe adjustment for the multiple comparisons they used. In addition, three of 
these studies (Airaksinen et al., 2005; Gorini et al., 2010; Lautenbacher et al., 2002) 
reported significant results on a measure for which no reliability or validity 
information was available. Gordeev (2008) used corrections for multiple 
comparisons and reported significant results for all the measures used, examining 
areas of perception and short term memory, however no reliability or validity data 
were available for any of these measures.  These studies provided some of the 





Studies which reported few significant differences associated with diagnosis of PD, 
tended to be of high quality as defined by the quality criteria.  These studies 
(Asmundson et al., 1994; Boldrini et al., 2005; Deckersbach et al., 2011; Galderisi et 
al., 2008) reported significant differences between PD and HC participants for fewer 
than half of the measures they investigated.  Although two (Asmundson et al., 1994; 
Galderisi et al., 2008) used one measure in their study that did not have reliability 
and validity data available, significant results were only reported on validated 
measures.  These studies contributed findings supporting difficulties in short term 
memory, working memory span and learning, visuospatial abilities and executive 
function. 
Four studies of high quality, as defined by the quality criteria, reported no significant 
differences between PD samples and HC (Cavedini et al., 2002; Gladsjo et al., 1998; 
Kaplan et al., 2006; Purcell et al., 1998).  Three described no differences in relation 
to long term memory and set shifting (Gladsjo et al., 1998; Kaplan et al., 2006; 
Purcell et al., 1998); two in relation to decision making (Cavedini et al., 2002; 
Kaplan et al., 2006) and two relating to other aspects of executive functioning 
(Gladsjo et al., 1998; Purcell et al., 1998).  One lower quality study also reported no 
significant findings on a decision making task for which no psychometric 
information was found (Ludewig et al., 2003).  Studies with high methodological 
quality tended towards findings of little or no differences between PD and HC 
groups. However, three of the four high quality studies with negative findings had 
small sample sizes, reducing their power to detect differences.   
Overall, within the studies reviewed, group matching, method of diagnosis and 
description of exclusion criteria were addressed adequately.  Presentation of results 
was generally adequate, but all studies failed to provide confidence intervals or effect 
sizes with their results.  Eight of the 14 studies reviewed reported sample sizes less 
than 25, indicating that they would have lacked the power to detect a large effect size 
with an alpha level of .05 in a 2-tailed comparison of two means (see Table 2.1).  No 
studies described statistical power. Uptake levels were poorly reported or not 
addressed in all but three studies (Airaksinen et al., 2005; Gladsjo et al., 1998; 




(Asmundson et al., 1994; Boldrini et al., 2005; Cavedini et al., 2002; Deckersbach et 
al., 2011; Galderisi et al., 2008; Gordeev, 2008; Kaplan et al., 2006; Purcell et al., 
1998).  As most studies included a number of measures and various post hoc tests, 
the absence of correction for multiple comparisons is a potential confound.  The lack 
of these corrections may have led to Type I errors in the four studies that did not 
address these corrections and reported significant results (Airaksinen et al., 2005; 
Gorini et al., 2010; Lautenbacher et al., 2002; Lucas et al., 1991). 
No studies reported on the reliability and validity of the measures used, therefore 
these properties were further investigated.  Most measures were described with 
psychometric properties in Lezak and colleagues’ (2004) detailed description of 
neuropsychological assessment and were described as valid and reliable for the 
groups in question.  However, six studies used a measure or measures not described 
in Lezak et al. (2004) and did not provide a reference to an appropriate source of 
reliability and validity data (Airaksinen et al., 2005; Asmundson et al., 1994; 
Galderisi et al., 2008; Gordeev, 2008; Gorini et al., 2010; Ludewig et al., 2003).  One 
study used a measure from a German test battery, which had no reliability or validity 
data in English (Lautenbacher et al., 2002).  An appropriate search for these data 
could not be performed in German due to translation difficulties. 
2.4 Discussion 
This systematic review examined the neuropsychological profile of individuals with 
panic disorder using the available literature.  With only 14 studies included in the 
review, it demonstrates the scarcity of research in the area.  The results obtained in 
these studies have mostly indicated an absence of difficulties in PD participants 
relative to HC, with no deficits being consistently reported across studies.   
There was some support in the reviewed studies for potential deficits in short term 
verbal and visual memory in people with PD compared to HC.  Results provided 
little support for impairment in any other area of neuropsychological function.  
A number of factors may have influenced the obtained results, including 




the presence of comorbid disorders and the medication status of participants.  These 
factors also affect the generalisability of the results. 
Quality criteria were applied to the studies reviewed, in order to further evaluate the 
reported findings.  Methodological strengths and weaknesses were highlighted.  Key 
issues arising from the assessment of methodological quality were risk of Type I 
error by failing to correct for multiple comparisons and use of measures without 
evident reliability or validity data for this population.  Considering only studies that 
did  not suffer from these methodological weaknesses the overall profile changes 
very little: limited support remained for visual and verbal short term memory 
difficulties in people with PD (Asmundson et al., 1994; Deckersbach et al., 2011) but 
the lack of consistency of results does not support a conclusion of impairment in this 
area.  No remaining studies supported verbal long term memory or perception 
deficits in people with PD, and only one of the five remaining studies reporting on 
visual long term memory provided support for deficits in that area (Deckersbach et 
al., 2011).  This removal of the less methodologically robust studies did not change 
the overall findings of no group differences on tasks of working memory, attention, 
visuospatial ability and executive functioning.   
As a number of Axis I and Axis II disorders have been associated with cognitive 
impairment (Trivedi, 2006), criteria allowing the inclusion of PD participants with 
comorbid disorders, may have impacted on the specificity of the findings.  Eight 
studies reported having no comorbid disorders, two allowed all comorbidities, two 
excluded only depression and two did not clearly state their exclusions.  Four out of 
five of those reporting no findings, excluded all comorbidities. The exclusion of 
comorbidities helps to isolate difficulties that are due to PD alone, without the 
influence of other psychological disorders.  However, this also limits the 
generalisability of results, as in a typical clinical group, comorbidities are common. 
Within the reviewed studies, patients without comorbidity tended to perform 
similarly to HCs (Cavedini et al., 2002; Gladsjo et al., 1998; Kaplan et al., 2006; 
Purcell et al., 1998). 
Half of the studies reviewed reported including participants on medication, although 




medication status of participants.  This is somewhat surprising as benzodiazepines 
(Deckersbach et al., 2011) and tricyclic antidepressants (Stein & Strickland, 1998) 
have been associated with additional cognitive impairment while SSRIs have not 
been consistently associated with impairment (Mataix-Cols et al., 2002). 
Ten of the fourteen studies matched groups on age, gender and education. Of the four 
poorly matched groups, three of these were among those who produced a high 
number of significant findings.  Poor group matching at the outset may have 
influenced results, as differences in age, gender and education have been shown to 
impact on neuropsychological test performance (Corral et al., 2006; Lowe et al., 
2003; Reitan & Wolfson, 1995). 
State anxiety at the time of testing was measured in eleven of fourteen studies.  Eight 
of these made comparisons between PD and HC groups.  In these studies, statistical 
tests suggested that PD groups were more anxious than HC at the time of testing.  
There was no pattern in the data relating to participant groups identified as being 
more anxious subsequently performing worse on tasks.  However, as higher levels of 
anxiety were consistent among PD patients where it was reported, it is likely that this 
was also the case in studies where comparisons were not made between PD and HC 
groups.  Literature suggests that state anxiety is unlikely to impact on test 
performance but it has suggested that those with lower IQ tend to be more anxious in 
advance of testing (Gass & Curiel, 2011). 
2.4.1 Limitations  
Only papers written in English were included in this review, limiting its scope. At 
least one potentially relevant study, not published in English, was excluded (Castillo 
et al., 2010).  Studies containing PD samples of less than 15 were excluded from the 
review.  This also reduced the number of studies reviewed, however the statistical 
power of such studies would have been low and findings, particularly negative 
findings, would have been difficult to interpret (Bezeau & Graves, 2001).  This 
review is based on a relatively small number of studies, however this is primarily due 
to the scarcity of literature rather than the exclusion of potentially relevant studies.  
The consistency of the findings across these studies allows for greater confidence in 




2.4.2 Recommendation/implication for future research 
These studies seem to suggest no consistent cognitive deficits in individuals with PD, 
which is in keeping with similar findings in populations with Social Phobia and 
Generalised Anxiety Disorder (Airaksinen et al., 2005; O'Toole & Pedersen, 2011).  
As such, neuropsychological functioning is unlikely to impact significantly on 
clinical practice in the treatment of PD.  An impairment in short term memory, if it 
were present in some PD patients, may impact on the psychoeducation phase of CBT 
treatment, as recommended by the National Institute of Health and Clinical 
Excellence (NICE, 2011).  The provision of written materials and other memory aids 
could potentially be helpful.  
Future research should consider using sample sizes appropriate to detecting medium 
to large effect sizes and reporting on the effect sizes obtained, in order to further 
illustrate the potential magnitude of any differences detected (Bezeau & Graves, 
2001).  Specific hypotheses focussing on the highlighted areas of potential 
impairment, particularly short term memory, with an effort to use the same or 
directly comparable measures to other studies, would contribute to the clarification 
of findings.  In addition, the specificity of any potential impairment requires further 
examination.  While PD has been compared to OCD on a number of occasions 
(Bannon et al., 2006), comparisons with disorders such as Social Phobia and GAD, 
which have demonstrated similar patterns of neuropsychological performance, may 
help to illustrate if there are any specific impairments related to PD. 
2.4.3 Conclusion 
This systematic review of the neuropsychological profile of Panic Disorder (PD) 
demonstrates that within the current literature there is little support for any 
neuropsychological impairment in PD.  Some support was found for an impairment 
in short term memory, which requires further investigation using larger sample sizes 
(25 or more) in order to detect large effect sizes (d=0.8) using the parameters of a 
power of 80% and a 0.05 two tailed significance level.  The use of appropriate 
clinical comparison groups to determine the specificity of any impairment found is 
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Chapter 3: Bridging Chapter 
 
As the introduction of the journal article is necessarily brief and focused on only the 
thesis aims covered in the article, additional introductory information is necessary to 
describe the areas covered by the additional data analysis conducted outside the 
scope of the journal article. 
3.1 The Cognitive Model of Bulimia Nervosa 
Fairburn et al.’s (2003) cognitive behavioural model of BN implicates a 
dysfunctional system for evaluating self worth as a central maintaining mechanism.  
They propose that sufferers evaluate themselves based on eating, shape and weight 
and on their ability to control them.  They further suggest that, in certain patients, 
one or more of four additional maintaining mechanisms operate.  These additional 
mechanisms are severe perfectionism, core low self esteem, mood intolerance and 
interpersonal difficulties.  Fairburn et al. (2003) broadened this model of BN into a 
transdiagnostic theory of eating disorders, emphasising the similarities between 
eating disorders.  They highlighted the fact that individuals will often move between 
diagnostic categories over time and suggested that the maintaining mechanisms 
proposed for BN are common to all eating disorders.  As key maintaining factors 
relate to maladaptive cognitive processes, neuropsychological research has 
investigated whether there are similar patterns of neuropsychological impairment in 
BN as have been observed in AN.  
Beyond the neuropsychological focus of the current study, additional data were 
collected relating to maintaining factors proposed for BN.  The primary maintaining 
mechanism of dysfunctional evaluation of eating, weight and shape, was measured 
by the Eating Disorder Examination, a semi structured interview described further in 
the Methods chapter.  Obsessive compulsive symptoms in BN, and their relation to 
neuropsychological performance were also addressed in the study.  Obsessive 
compulsive symptoms are common in BN and are linked to the construct of 
perfectionism (Egan et al., 2011; Tchanturia, Morris, et al., 2004).  Obsessive 
compulsive symptoms were measured using both the Yale-Brown Obsessive 




Checklist 90-Revised (SCL-90-R).  Core low self esteem was addressed using the 
Self Liking/Self Competence scale and aspects of interpersonal difficulties were 
addressed using the Social Problem Solving Inventory (SPSI) and the interpersonal 
sensitivity scale of the SCL-90-R.  The Self Liking/Self Competence scale and the 
Social Problem Solving Inventory are not included in the journal article and are 
introduced below. 
3.1.1 The Self liking/ Self Competence scale (Tafarodi & Swann, 2001) 
The Self liking/Self Competence scale was developed by Tafarodi and colleagues 
(Tafarodi & Milne, 2002; Tafarodi & Swann, 2001) based on theoretical research 
using factor analysis of Rosenberg’s (1965) self esteem scale.  The concept of self 
esteem used in Rosenberg’s scale, is a one-dimensional construct that taps into the 
‘self worth’ element of self esteem.  Tafarodi and Milne (2002) identified two 
separate dimensions of self-esteem, namely self liking and self competence.   Self 
liking taps into the ‘self worth’ element of self esteem, while self competence relates 
to an individual’s perception of their ability to deal with challenges. 
Low self esteem is considered to be a core element in eating disorder theory and 
treatment (Fairburn et al., 2003).  It has also been associated with anxiety and 
depression in community and eating disordered samples (Ackard et al., 2011; 
Rosenberg, 1962; Takagishi et al., 2011).  Self esteem, as measured by the Self 
Liking/Self Competence scale (Tafarodi & Swann, 2001) has been noted in the 
literature to be significantly lower in anorexic patient groups than in healthy controls 
(Paterson et al., 2007).  Self competence has been significantly associated with 
increased perfectionism and interpersonal distrust in anorexia nervosa (AN), and 
changes in self liking and self competence have been associated with changes in 
eating disordered behaviours in both AN and BN (Gordon et al., 2005; Surgenor et 
al., 2007).  This research suggests that self liking and self competence may be 
important factors in the development or maintenance of eating disorders. 
3.1.2 Social Problem Solving Inventory (SPSI) (D’Zurilla et al., 2002) 
Social problem solving has been proposed by D’Zurilla and Maydeu-Olivares (1995) 
to result from maladaptive cognitive processes and to be a risk factor for 




construct relating to adaptive orientation towards problems and the use of effective 
problem solving strategies.  The dimensions identified by the Social Problem Solving 
Inventory are Positive Problem Orientation, Negative Problem Orientation, Rational 
Problem Solving, Impulsivity/Carelessness style and Avoidance style.   
 
Although interpersonal difficulties are considered to be important in BN (Fairburn et 
al., 2003), and interpersonal therapy has been found to be as effective for BN as 
Cognitive-Behavioural Therapy in the long term (Agras et al., 2000), no research is 
available investigating social problem solving in BN.  However, the existing 
literature indicates that social problem solving is impaired in individuals with eating 
disorders (Paterson et al., 2011; Swanson et al., 2010). McFillin (2009) found that 
adolescents with an eating disorder demonstrated more hostile attributional biases 
and experienced a significantly greater intensity of negative emotions when 
presented with vignettes of social dilemmas than did healthy controls.  Svaldi et al. 
(2011) found that women with binge eating disorder produced less effective social 
problem solving strategies than healthy controls.  Using the SPSI, anorexic 
individuals have been found to show a significantly higher negative problem 
orientation than controls and to demonstrate impulsive and avoidant problem solving 
styles (Paterson et al., 2011; Swanson et al., 2010).   
 
Anxiety and depression symptoms have also been associated with poor problem 
solving in  non-clinical populations (Haaga et al., 1995; Haugh, 2006) and in clinical 
populations, such as the anxiety disorder group reported on by Abbass and 
Mohammad (2008).  This clinical group consisted of OCD, PTSD and panic disorder 
patients, who demonstrated higher negative problem orientation, 
impulsivity/carelessness style and avoidance style than healthy controls.  In a mixed 
clinical group with at least one Axis I disorder, patients were also found to use poor 
social problem solving relative to healthy controls (Bray et al., 2007).  Poor social 
problem solving has been found to correlate with both impulsivity (McMurran et al., 
2002) and perfectionism (Chang, 2002), and has been suggested to be associated 






Impulsivity is another feature of BN that has been investigated in the literature 
(Waxman, 2009).  This characteristic most commonly takes the form of binging 
behaviours, but bulimia is also associated with higher rates of shoplifting, substance 
abuse and self harm (Goldner et al., 2000; Hudson et al., 2007; Ruuska et al., 2005).    
Impulsive behaviours in BN may be a reflection of underlying cognitive deficits in 
inhibition (Engel et al., 2005; Kemps & Wilsdon, 2010; Kirisci et al., 2004; Rosval 
et al., 2006; Verdejo-García et al., 2006).  In relation to this, Robinson et al. (2009) 
have proposed a model of impulsivity in bulimia where the effect of trait impulsivity 
is moderated by cognitive inhibition skills.  They suggest that temperamental 
impulsivity is a risk factor for impulsive behaviour, but that temperamental 
impulsivity can be overcome by good cognitive inhibition.  They propose that 
training in cognitive control could be helpful to eating disordered individuals high in 
impulsive behaviours.  Levels of impulsivity may also have implications for 
recovery, with lower levels of impulsivity associated with better treatment outcomes 
in BN (Castellini et al., 2012). 
 
3.2 Composition of the Patient groups used in this study 
Selection criteria for the groups included in this study were chosen to allow a 
clinically representative sample of each disorder group.  The comparison group was 
selected on the basis of being in treatment for anxiety and/or depression in the Adult 
Psychological Therapies Service in Tayside, and scoring in the moderate to severe 
range on either of the anxiety or depression subscales of the Hospital Anxiety and 
Depression Scale (HADS; Zigmond & Snaith, 1983).   
The BN group included any patients in treatment for bulimia nervosa - both patients 
diagnosed with Bulimia Nervosa and also those diagnosed with Eating Disorder Not 
Otherwise Specified - Bulimic type (EDNOS-BN).  National Institute for Health and 
Clinical Excellence (NICE, 2004a) guidelines for the treatment of eating disorders 
recommend that treatment of EDNOS be conducted using the same model as the 
disorder it most closely resembles.  Therefore, patients with EDNOS-BN are 




criteria for bulimic groups used in other studies (Bara-Carril et al., 2004; Schmidt et 
al., 2006).  Different diagnostic systems were in use in the Tayside and Grampian 
Eating Disorder Services, therefore the ICD 10 diagnostic categories of BN and 
Atypical BN (excluding Binge Eating disorder) were applied (WHO, 2010).  These 
are comparable to the DSM-IV-TR diagnoses of BN and EDNOS-BN.   
The category of EDNOS exists in DSM-IV-TR to describe patients who do not meet 
all the criteria for BN or AN diagnoses, while ICD 10 includes categories of 
‘Atypical Anorexia’, ‘Atypical Bulimia’ and ‘Eating Disorder Unspecified’ for this 
purpose.  Recent studies have reported forty to sixty percent of those seeking 
treatment for eating disorders falling within the EDNOS category when using DSM-
IV-TR criteria, making them an important patient group in eating disorder research 
(Button et al., 2005; Fairburn et al., 2007; Ricca et al., 2001; Rockert et al., 2007).  
Differences between patients with BN and EDNOS-BN on measures of eating 
pathology and general psychopathology have been found to be non-significant 
(Garfinkel et al., 1995; Martin et al., 2000; Ricca et al., 2001; Tobin et al., 1997). 
3.2.1 Gender of Participants 
Both groups contained only female participants.  This was decided in order to be 
comparable to the majority of the current literature relating to BN (Alvarez-Moya et 
al., 2009; Brand et al., 2007; Kemps & Wilsdon, 2010; Rosval et al., 2006; Van den 
Eynde et al., 2012).  Male patients have been excluded from many recent eating 
disorder studies, due to the low numbers that present for treatment and the gender 
differences that have been found in the literature on eating disorders.  The literature 
suggests that significantly fewer males suffer from eating disorders than females 
(Hudson et al., 2007; Treasure et al., 2010).  In a large population study in the United 
States, a 0.5% lifetime prevalence of BN was reported among males compared to 
1.5% among females and a 12 month prevalence of 0.1% in males compared to 0.5% 
in females (Hudson et al., 2007).  In addition, proportions of males attending for 
treatment of bulimia, as represented in current literature, are of the order of 5-10% of 
consecutive referrals (Fairburn et al., 2007; Mehler et al., 2008; Zeeck et al., 2007).  
Differences between males and females with bulimia in relation to age of onset, 
premorbid obesity, homosexuality and concern with weight control have been 




differences (Carlat & Camargo Jr, 1991).  As the literature suggests that there may be 
differences between male and female patients with bulimia, and that few male 
patients are likely to be available for participation, it was decided to include only 
female patients. This also allows the study sample to be directly comparable to 
existing key papers that have used only female participants.   
3.3 Research Links of the current study 
Beyond the investigation of the specificity of cognitive impairment in BN, the data 
gathered in this study will be incorporated into the Tayside Eating Disorder Research 
Group’s ongoing research into the neuropsychological profile of eating disorders.  
Data from a group of healthy control participants was collected by the research 
group, administering the same neuropsychological measures used in the current 
study.  Therefore, data from an additional healthy control group was not collected as 
part of the current study.  The neuropsychological measures administered to 
participants, which were not a priori key measures of set shifting and inhibition, were 
included in the current study in order to facilitate comparison of this data with 
Research Group data already collected from AN groups and healthy controls. 
3.4 Summary  
As stated in the introduction, the aim of this thesis is to contribute to the body of 
research investigating the neuropsychological profile of bulimia by considering the 
specificity of the cognitive impairments reported in the literature.  The potentially 
confounding influences of comorbid anxiety disorders and depression in BN have 
been highlighted in recent reviews as a neglected area of research (Van den Eynde et 
al., 2011; Zakzanis et al., 2010).  Therefore, this study incorporates a comparison 
group of anxious and/or depressed outpatients. 
Current eating disorder theory emphasises the similarity between eating disorders 
and supports research investigating the presence of similar properties in BN as have 
been seen in AN.  It also proposes potential shared maintaining factors of severe 
perfectionism, low self esteem, mood intolerance and interpersonal difficulties.  
These potential maintaining factors of BN will also be explored by this thesis, 




3.4.1 Study Aims 
 
1. To investigate what differences are evident, if any, between the a BN 
group and a comparison group of anxious and/or depressed adult females 
on measures of general psychopathology, eating pathology, set shifting 
and cognitive inhibition.   
2. To investigate the relationships between general psychopathology, eating 
pathology, set shifting and inhibition within the groups.    
3. To investigate social problem solving and self esteem in BN, and any 





Chapter 4: Investigating the specificity of 
neuropsychological impairment in bulimic 
outpatients: a comparison with anxious and 
depressed outpatients.  
 
Following guidelines of Journal of the International Neuropsychological Society 
(Appendix 5)  
Abstract 
Background: Bulimia Nervosa (BN) has been associated with deficits in set shifting 
and inhibition but reported results are inconsistent.  Systematic reviews have 
highlighted the potentially confounding effects of comorbid disorders, and the 
specificity of deficits in BN has not been explicitly investigated  
Method: Twenty one female participants with BN were compared to 23 females, in 
treatment for anxiety and/or depression, on neuropsychological measures of set 
shifting and inhibition, including the Wisconsin Card Sorting Test, the Trail Making 
Test and the Stroop task.  Psychological symptoms were measured using the 
Symptom Checklist 90-R, the Yale Brown Obsessive Compulsive Scale and the 
Eating Disorder Examination. 
Results: No group differences were found on a priori selected neuropsychological 
measures or measures of anxiety, depression or obsessive-compulsive symptoms.  
The BN group reported significantly more eating disorder symptoms than the 
comparison group. 
Conclusions: These findings suggest that, in this sample, there is no evidence of a 
specific neuropsychological deficit in BN and suggest that deficits seen are shared 
with other disorders. 
4.1 Introduction  
Bulimia nervosa (BN) is characterised by binge eating accompanied by a sense of 
lack of control, the use of compensatory behaviours such as vomiting or excessive 
exercise, and self-evaluation unduly influenced by shape and weight (American 




about eating and purging, and strict adherence to personal rules, which have been 
associated with compulsive behaviour (Naylor et al., 2011).  Compulsive behaviours 
are defined by Robbins et al. (2012) as “actions inappropriate to the situation which 
persist”, or as “a maladaptive perseveration of behaviour” (p83). Compulsive 
behaviour and the related construct of perfectionism are common in BN, and are 
associated with impaired neuropsychological task performance on measures of set-
shifting (Egan et al., 2011; Tchanturia, Morris, et al., 2004).  Impulsivity is also a 
feature of BN.  This characteristic most commonly takes the form of binging 
behaviours, but BN is also associated with higher rates of shoplifting, substance 
abuse and self harm (Goldner et al., 2000; Hudson et al., 2007; Ruuska et al., 2005).  
A number of studies have linked impulsivity to cognitive disinhibition in BN patient 
groups and other disorders, suggesting a relationship between these variables (Kemps 
& Wilsdon, 2010; Kirisci et al., 2004; Rosval et al., 2006; Verdejo-García et al., 
2006).  Impulsive-compulsive behaviours often co-occur in BN and may be a 
reflection of underlying cognitive deficits in the areas of set-shifting and cognitive 
inhibition (Engel et al., 2005).   
These neuropsychological deficits have become an area of interest for research as 
they are hypothesised to be the basis for some key symptoms of BN. Fairburn et al. 
(2003) theorise that clinical perfectionism, which is associated with compulsive 
behaviour and poor set shifting, is a key maintaining factor for some individuals with 
BN (Tchanturia et al., 2004).  Where patients have a difficulty with set shifting, there 
can also be a difficulty engaging with CBT and using flexible thinking during the 
course of therapy.  Current research in AN suggests that intervention directed at set 
shifting, where it is a difficulty, improves CBT treatment outcomes (Tchanturia et 
al., 2007).  Observed impulsive binging and purging behaviour is theorised by 
Robinson et al. (2009) to relate to poor cognitive regulation of an underlying trait 
impulsivity.  They propose that specific training in cognitive control to reduce 
impulsivity could be helpful to BN patients as part of therapy.  Research 
demonstrating that lower impulsivity is associated with better treatment outcome 




The majority of neuropsychological research in eating disorders has focused on set-
shifting ability in anorexia nervosa (AN), finding specific cognitive deficits as 
compared to healthy controls (HC) (Roberts et al., 2007).  Comparisons have also 
been made between AN and other psychiatric groups such as obsessive compulsive 
disorder (OCD) (Murphy et al., 2004) and depression (Giel et al., In Press) to further 
clarify the specificity of these deficits.  An increasing amount of research is now 
focussing on the neuropsychological profile of BN (Van den Eynde et al., 2011).  As 
AN and BN are closely linked (Fairburn et al., 2003), set-shifting has also been a 
focus of research when investigating the neuropsychological profile of BN.  While 
cognitive impairments have been reported in BN, there is little agreement between 
studies.  Three recent systematic reviews on the topic have reached conflicting 
conclusions.  Zakzanis et al. (2010) concluded that the core impairment in BN was 
an impairment in inhibition without impairments in set shifting, while the opposite 
trend was reported by Roberts et al. (2007).  These reviews were limited in the 
number of studies they included, reviewing 14 and 4, respectively.  The most recent 
comprehensive review examined 34 studies, reporting that the area was under-
researched and that findings to date were inconclusive (Van den Eynde et al., 2011).   
 
In Van den Eynde et al.’s (2011) review, impairment in inhibition was seen in BN in 
only one of five studies that used the classic Stroop task (Kemps & Wilsdon, 2010).  
Similarly, no clear pattern of impairment of inhibition was seen in studies using the 
Go/NoGo task or Matching Familiar Figures Test (Claes et al., 2006; Kemps & 
Wilsdon, 2010; Rosval et al., 2006; Southgate et al., 2008).  One reviewed study 
used the Hayling sentence completion task as a measure of inhibition and found 
impairment in individuals with BN relative to controls (Kemps & Wilsdon, 2010).   
The Wisconsin Card Sorting Test (WCST) subscale of ‘number of non-perseverative 
errors’ has also been considered as a measure of inhibition.  Alvarez-Moya et al. 
(2009) noted that individuals with BN had difficulty maintaining the correct set on 
the WCST, scoring significantly worse than controls on ‘non-perseverative errors’.  
The WCST is usually used as a measure of set shifting ability, with ‘number of 
perseverative errors’ used as a key measure of compulsive responding behaviour.  




some studies, although an equal number of studies have found no significant 
differences (Alvarez-Moya et al., 2009; Brand et al., 2007).  Similarly, set shifting as 
measured by the Trail Making Task (TMT) has produced mixed results (Roberts et 
al., 2010; Tchanturia, Anderluh, et al., 2004).   
 
Cognitive impairment in inhibition and set shifting has been seen across a range of 
other disorders.  Studies on neuropsychological deficits in anxiety disorders have 
reported set shifting and inhibition impairment in Post Traumatic Stress Disorder 
(PTSD)  and Obsessive Compulsive disorder (OCD) (Kuelz et al., 2004; Polak et al., 
2012), but not in social anxiety, simple phobia, panic disorder or generalised anxiety 
disorder (Airaksinen et al., 2005; O'Toole & Pedersen, 2011; Chapter 2 of this 
thesis).  (Ferreri, et al., 2011)Depression has also been associated with 
neuropsychological impairments in inhibition and set shifting (Gohier et al., 2009; 
Porter et al., 2007; Xu et al., 2012).  However, much of the literature on depression 
has focused on the elderly, with deficits not consistently seen in young adult samples 
with mild to moderate depression (McClintock et al., 2010).  When anxiety and 
depression co-occur, some research has reported increased impairments (Basso et al., 
2007; Lyche et al., 2011), while others have reported that such clinical groups 
perform no differently to those with depression alone (Herrera-Guzman et al., 2009) 
or healthy controls (Graver & White, 2007).  In anxiety and depression, as in BN, 
reviews indicate potential deficits in areas of set shifting and inhibition but conclude 
that further research and clarification of neuropsychological findings is required 
(Castaneda et al., 2008; Ferreri et al., 2011).   
One possible confounder in assessments of neuropsychological performance is 
diagnostic comorbidity. Bulimia nervosa is frequently comorbid with both 
depression and anxiety disorders; up to 80% comorbidity is found with anxiety 
disorders and 60% comorbidity with Major Depressive Disorder (MDD) or 
dysthymia (Hudson et al., 2007).  Overall, the neuropsychological literature in 
relation to BN is somewhat equivocal and the large clinical overlap with other 
disorder groups that also display similar cognitive impairments calls into question the 




The reviews by both Van den Eynde et al. (2011) and Zakzanis et al. (2010) 
recommend that future research consider this overlap of diagnoses and symptoms 
when investigating the neuropsychological profile of BN.  It is currently unclear if 
reported cognitive impairments are specific to BN or whether they are shared across 
other psychiatric diagnoses, representing a transdiagnostic, rather than disorder-
specific feature.  Knowledge about the specificity of cognitive impairments is 
important, in order to facilitate the development of disorder specific cognitive 
models and therapies (Dudley et al., 2011).  
While one study has compared BN patients to OCD patients on neuropsychological 
measures (Murphy et al., 2004), no study to date has focused on further clarifying the 
specificity of reported cognitive impairments in BN through the use of a clinical 
group reflecting diagnoses that often co-occur with BN.  The current study compared 
a group of females in psychological treatment for anxiety and/or depression (AD 
group), who were free from comorbid eating disorder, to a BN group.  This study 
sought to investigate what differences, if any, exist between the two groups on 
measures of set shifting and inhibition.  Further exploratory analyses were conducted 
on the relationships between reported anxiety, depression, obsessive compulsive and 







The BN group consisted of 21 outpatients, 14 with BN and 7 with Eating Disorder 
Not Otherwise Specified-Bulimic Type (EDNOS-BN), recruited from eating disorder 
services of NHS Grampian (n=5) and NHS Tayside (n=16).  All patients meeting 
inclusion criteria and in treatment for BN with the NHS Tayside (29) were provided 
with study information by their clinicians.  Patients in Grampian meeting the 
inclusion criteria were posted study information by their clinician.  The number of 
patients contacted in Grampian was not available at the time of writing.  Patients 
with EDNOS were included if they had subthreshold bulimic symptoms and were 
therefore being treated as a bulimic patient as per National Institute for Health and 
Clinical Excellence (NICE) guidelines for the treatment of EDNOS (NICE, 2004a).  
EDNOS patients with primarily anorexic features and patients with Binge Eating 
Disorder were excluded.  Participants in the AD group were 23 outpatients in 
treatment for major depressive disorder (MDD) and/or an anxiety disorder in the 
Tayside Adult Psychological Therapies Service.  A breakdown of their diagnoses 
appears in Table 4.1. AD group participants were required to score 11 or more on 
either scale of the Hospital Anxiety and Depression Scale (HADS: Zigmond & 
Snaith, 1983). All participants were adult females recruited between November 2011 
and June 2012.  All diagnoses met Diagnostic and Statistical Manual, 4
th
 edition 
(DSM-IV;  American Psychiatric Association, 2000) criteria, as determined by the 




Table 4.1 Diagnoses of AD group 
Diagnosis Number of participants 
Anxiety 11 
GAD 3 
PD (with agoraphobia) 3 
Agoraphobia 1 
Specific Phobia 1 
OCD 2 
Health Anxiety 1 
MDD 3 
Mixed anxiety and depression 9 
MDD = Major Depressive Disorder, GAD = Generalised Anxiety Disorder,  
PD = Panic Disorder 
 
Patients were excluded if they were medically unstable, had a history of learning 
disability, substance abuse, developmental or neurological disorder, an uncorrected 
visual or motor impairment, or previous head injury involving loss of consciousness.  
In addition, AD group participants were excluded if they demonstrated significantly 
disordered eating (Eating Disorder Examination score ≥ 4).  The study was approved 
by NHS Tayside Research Ethics Committee and all participants gave written 
informed consent.   
The groups were matched on years of education, estimated premorbid IQ and Body 
Mass Index (BMI) (see Table 4.2).  However, bulimic patients were significantly 
younger than AD group patients (t(42)= 2.918; p <.008).  Mean age of disorder onset 
was also significantly lower in the BN group than in the AD group (U= 129, Z=-
2.65, p <.008).  Ninety percent of the BN group were right-handed compared to 74% 
of the AD group. This difference was not found to be significant using Fisher’s exact 
test (p=.432). Two BN participants reported having a previous diagnosis of anorexia.  
Forty eight percent of the BN participants and 65% of the AD participants were 
taking psychiatric medication, primarily antidepressants (5 SSRI, 3 serotonin-
norepinephrine uptake inhibitors (SNRI) and 1 tetracyclic antidepressant in the BN 
group, 9 SSRI and 3 tetracyclic antidepressants in the AD group).  Two BN 




Diazepam and one was taking Tramadol.  No medications had been changed within 





Table 4.2: Characteristics of groups 
Note. BMI= Body Mass Index, BN=Bulimia Nervosa, AD= Anxiety and/or Depression 
* p < 0.05 
**Bonferroni correction for 6 comparisons α=.008 
a: data available for only 42 patients (data missing for 2 BN participants) 
 BN group 
n=21 













t U p d r 
Clinical Characteristics            
   Age (yrs) 29.29 10.49  39.52 12.75  2.918  .006** -0.89  
   Education (yrs) 14.60   2.41  15.17 2.91  0.721  .475 -0.22  




 24.07 4.15 24.5 
(17.4-32.4) 
26.96 6.90 24.5  
(18.5-45.6) 
 178.5 .319  -0.16 
   Age of disorder onset 18.19 7.28 16 (7-38) 29.43 14.87 27 (11-62)  129 .007**  -0.40 
   Duration of disorder 10.17 7.45 9 (1-32) 9.19 11.85 3 (0.04-38)  170 .047*  -0.25 





Participants were administered a battery of standardised assessment measures 
relating to psychopathology and neuropsychological performance in the areas of set 
shifting and cognitive inhibition.   
4.2.2.1 Psychopathology Measures 
Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983) 
The HADS is a self-report measure containing two scales relating to anxiety and 
depression symptoms.  The HADS depression subscale has 90% sensitivity and 86% 
specificity for depression compared to the gold standard of a structured diagnostic 
interview (Zigmond & Snaith, 1983).  Good reliability for both scales has been well 
documented in adults.  A recent review by Bjelland et al. (2002) reported the 
reliability of the Anxiety subscale to vary from 0.68 to 0.93 (mean 0.83) and for the 
Depression subscale from 0.67 to 0.90 (mean 0.82).  The HADS was administered to 
AD group patients as part of routine clinical practice.  A score of 11 or more on 
either scale indicated moderate to severe symptoms.     
 
Eating Disorders Examination (EDE)Version 12 (Fairburn & Cooper, 1993) 
 The EDE is a semi-structured clinical interview, which measures eating disordered 
attitudes and behaviours.  It contains four subscales (Dietary Restraint, Eating 
Concern, Weight Concern and Shape Concern), and a global score.   All subscale 
mean scores and the global score range from 0-6.  Good internal consistency, 
(Beumont et al., 1993; Cooper et al., 1989) concurrent (Rosen et al., 1990) and 
discriminant (Cooper et al., 1989; Rosen et al., 1990; Wilson & Smith, 1989) 
validity, and inter-rater reliability (Black & Wilson, 1996; Cooper & Fairburn, 1987; 
Rosen et al., 1990; Wilson & Smith, 1989) have been demonstrated for the EDE in 
adults.   
 
Yale−Brown Obsessive Compulsive Scale−Symptom Check List (Y−BOCS−SC) 




The YBOCS consists of a 58 item symptom checklist and a 10 item severity scale.  
The symptom checklist covers a range of obsessions and compulsions, clustered by 
behavioural expression and thematic content.  Obsessions and compulsions are 
assessed over the 5 dimensions of time spent, interference in functioning, distress, 
efforts to resist and perceived control, creating a 10 item severity measure relating to 
the past 7 days.  The YBOCS can be administered in the form of interview or self-
report. Good agreement has been found between these for both the symptom 
checklist and severity ratings (Steketee et al., 1995). The current study used a self-
report version (Baer, 1991).   
 
Symptom Check List−90 Revised (SCL−90-R) (Derogatis, 1994; Derogatis et al., 
1973) 
The SCL−90-R is a 90−item self−report instrument for measuring general 
psychopathology for use with community, medical and psychiatric respondents. It 
comprises nine primary symptom dimensions; - Somatisation, Obsession-
Compulsion, Interpersonal Sensitivity, Depression, Anxiety, Hostility, Phobic 
Anxiety, Paranoid Ideation and Psychoticism - and  three global indices; the Global 
Severity Index (GSI), the Positive Syndrome Distress Index (PSDI) and the Positive 
Symptom Total (PST).  Good internal consistency of the primary symptom 
dimensions and global indices has been demonstrated across a number of 
populations. The SCL-90-R has been found to have good test-retest reliability across 
a range of patient groups and test-retest intervals (Derogatis, 2000).  The Depression 
and Anxiety subscales have the most evidence of convergent and discriminant 
validity (Bech et al., 1992; Derogatis, 2000; Koeter, 1992).  The Obsession-
Compulsion subscale has been shown to be internally consistent (Woody et al., 1995) 
but also demonstrates poor discriminant validity, therefore the YBOCS was taken as 
the primary measure of obsessive compulsive symptoms in this study (Kim et al., 
1992; Woody et al., 1995).   
  
4.2.2.2 Neuropsychological Measures 




The NART is a measure of premorbid intellectual ability. The participant is asked to 
read aloud 50 irregularly spelled words (e.g. cough).  The number of pronunciation 
errors is used to estimate the Wechsler Adult Intelligence Scale-Revised (WAIS-R; 
Wechsler, 1981) full scale IQ from standardised norms.  The NART’s validity as a 
measure of premorbid intelligence has been well documented (e.g. Crawford et al., 
2001). 
 
Delis−Kaplan Executive Function System (D-KEFS) (Delis et al., 2001) 
Two tests from the D-KEFS were used: 
Colour Word Inference Test (CWIT) − This is a measure of response inhibition and 
cognitive flexibility based on the Stroop procedure.  The CWIT has four conditions: 
colour naming (condition 1), word reading (condition 2), inhibition (colour word 
interference, condition 3) and set shifting (Inhibition Switch, condition 4).  In each 
condition, the outcome is the time taken to read 50 items and the number of errors 
made.   
 
Trail Making Test (TMT) − This is a measure of planning and cognitive flexibility 
based on the traditional TMT A and B.  The TMT has 5 conditions: visual scanning 
(condition 1), number sequencing (condition 2), letter sequencing (condition 3), 
number-letter switching (condition 4), and motor speed (condition 5).  The procedure 
for the first condition involves a timed visual search.  The remaining conditions 
involve drawing a line connecting the target items (numbers, letters or empty circles) 
as quickly as possible.  The switching task involves switching back and forth 
between connecting numbers and letters, completing the task as quickly as possible. 
In each condition, the outcome measures are time to complete task and number of 
errors.  Good to moderate test retest reliability and internal consistency are described 
in the technical manual for CWIT and TMT (Delis et al., 2001). 
 




The Hayling task evaluates initiation speed, by requiring participants to complete 15 
sentences as quickly as possible.  Part one requires sensible completion of the 
sentence while part two requires an unrelated word.  This is a measure of response 
suppression.  Outcome measures are the time taken to respond and total number of 
errors. Adequate inter-rater reliability and test-retest reliabilities have been reported 
for this task (Andres & Van der Linden, 2000; Burgess & Shallice, 1997).  
 
 
Wisconsin Card Sort Test (WCST) (Heaton et al., 1993) 
The WCST measures concept formation, set-shifting, and set maintenance. Four 
stimulus ‘key cards’ with symbols differing in colour, shape and number are placed 
in front of the participant, who is given a pack of 128 response cards and instructed 
to match each response card to one of the key cards.  The researcher only provides 
feedback of ‘correct’ or ‘incorrect’ for each trial.  After coupling 10 cards with the 
first criterion (colour), the subject is required to shift to the second criterion (shape) 
and then to the third (number).  The procedure is repeated twice or until all 128 cards 
have been used.  Good test-retest and inter-rater reliabilities have been reported in 
adults (Axelrod et al., 1992; Bowden et al., 1998; Heaton et al., 1993).  The official 
computer package was used to score this task. 
 
4.2.3 Measures selected as a priori key variables for set shifting and 
inhibition 
Seven specific variables were selected from the neuropsychological battery as a 
priori key measures.  The key variables chosen were those on which 
neuropsychological deficits have been previously reported in BN patients compared 
to HCs.  The 4 key variables selected to reflect set shifting performance were 
‘number of perseverative errors’ and ‘categories completed’ from the WCST 
(Roberts et al., 2010) and the completion time and number of errors in TMT 
condition 4 (Brand et al., 2007; Konstantakopoulos et al., 2011; Roberts et al., 2010; 
Tchanturia, Morris, et al., 2004). The 3 key variables selected to reflect cognitive 
inhibition were the WCST ‘number of non-perseverative errors’ (Alvarez-Moya et 




task part two (Kemps & Wilsdon, 2010).  Information on the additional outcome 
variables included in the above measures was provided in the form of secondary 
variables, as recommended by Van den Eynde et al.’s (2011) review. 
 
4.2.4 Procedure/Protocol 
Suitable patients were identified by their clinician and invited to participate. They 
were provided with study information and contacted by the first author no sooner 
than 24 hours after expressing interest in the study.  Demographic and historical 
information relating to participant characteristics was collected first using a 
questionnaire designed for the study, followed by administration of the EDE, the 
neuropsychological battery (in the order listed above) and the self report measures 
(in the order listed above).  Testing lasted approximately 1.5 to 2 hours.   
4.2.5 Data Analysis 
Data were analyzed using SPSS (version 15).  Means were calculated for all 
continuous variables and frequencies for categorical variables.  Means of the two 
groups were compared on assessment measures and demographic characteristics 
using t-tests, where data were normally distributed.  The non-parametric Mann 
Whitney U statistic was used to compare non-normal variables between groups.  
Appropriate effect sizes, Cohen’s d or r, were calculated for these comparisons.  
Associations between a priori key measures and psychopathological variables within 
groups were investigated using the non-parametric Kendall’s tau.  
4.2.5.1 Power for comparison of means 
The literature indicated expected effect sizes ranging from 0.78 to 1.2 for differences 
between BN and AD groups.  This suggested optimal samples sizes of 26 in order to 
detect large effect sizes (d=0.8, r=0.5) using the parameters of a power of 80% and a 
0.05 two tailed significance level.  Due to difficulties with recruiting this number of 
participants, the resulting sample sizes had the power to detect an effect size of 
d=0.88 with a power of 80% and a 0.05 two tailed significance level (calculated 






4.3.1 Group comparisons on psychological and neuropsychological 
measures 
Participants on medication did not perform significantly differently on key measures 
to those not taking medication using Mann Whitney U tests (all p>.05).  Descriptives 
and statistical group comparisons for psychological and neuropsychological variables 
are presented in Table 4.3 and Table 4.4 respectively.   
 
The BN group was not significantly different to the AD group in self reported 
obsessive compulsive symptoms as measured by the YBOCS, or on any of the 
symptom clusters measured by the SCL-90-R including anxiety and depression. The 
BN group scored significantly higher than the AD group on all scales of the EDE.   
On the a priori measures of set shifting and inhibition, the BN group did not perform 
significantly differently from the AD group (See Table 4.4).  As groups differed 
significantly on age, differences between the groups on age normed scaled scores 
were investigated on neuropsychological measures where such scaled scores were 
available.  There were also no significant differences using age normed scores (all p 





Table 4.3: Comparison of groups on psychological variables 
Note. SCL-90= Symptom Checklist-90-Revised, GSI= Global Severity Index, O-C = obsessive-compulsive scale, I-S = interpersonal sensitivity, YBOCS= Yale-
Brown Obsessive Compulsive Scale, EDE= Eating Disorder Examination (Version 12), Anx=Anxious. all analysis are two tailed, r =Z/√N 
a: n=20 in BN group  










  Cohen’s  
 Mean SD Median (range) Mean SD Median (range) t U p d r 
Psychological Measures            
   SCL-90 (GSI) 1.37 0.68  1.16 0.58  1.14  .262 0.34  
   O-C 18.00 8.80  13.26 6.57  2.04  .048 0.61  
   Depression 25.33 10.95  22.39 11.70  0.86  .395 0.26  
   Anxiety 11.33 8.41 9 (1-35) 12.57 8.61 14 (0-34)  216.5 .564  -0.09 
   Phobia 5.38 6.47 2.5 (0-21) 7.83 6.80 7 (0-22)  185.0 .185  -0.20 
   Somatisation 14.91 10.87 12.5 (1-41) 9.52 7.51 7 (0-23)  170.0 .094  -0.25 
   Hostility 5.19 3.37  4.22 3.36  0.96  .343 0.28  
   I-S 16.62 6.45  12.78 8.08  1.73  .091 0.53  
   YBOCS 
a
 13.75 7.35 14.5 (0-27) 9.96 7.96 9 (0-24)  159.0 .084  -0.27 
   EDE            
   Restraint 3.60 1.38 3.8 (0.3-6) 1.04 1.19 1.1(0.08-3.14)  42.5 .001*  -0.71 
   Eating concern 3.21 1.36 3.3 (0.6-5.2) 0.41 0.64 0 (0-2.2)  15.5 .001*  -0.81 
   Shape concern 4.59 1.04  1.61 0.92  10.11  .001* 3.04  
  Weight concern 4.10 1.22 4.1 (1.4-6) 1.37 1.17 0.8 (0-3.6)  29.5 .001*  -0.75 




Table 4.4: Comparison of groups on key Set Shifting and inhibition variables 
Set Shifting 
Bulimic group n=21 Anxious/Depressed group n=23    Cohen’s  
Mean SD Median (range) Mean SD Median (range) t U p d r 
WCST 
   Perseverative errors 10.71 6.37 10 (4-28) 14.04 11.96 8 (4-52)  211.5 .487  -0.11 
   Categories completed 5.19 1.66 6 (0-6) 4.91 1.83 6 (0-6)  217.0 .481  -0.11 
DKEFS            
  Trail Making test 
  Number/letter switch 69.21 22.41 
73.2 (20.1-
120.9) 76.12 26.31 
71.1 (41.5-
161.4)  228.0 .758  -0.05 
  Trail Making test   No. of errors 0.91 1.95 0 (0-8) 0.35 0.94 0 (0-4)  210.5 .331  -0.15 
Inhibition            
WCST 





DKEFS   
   Colour Word   Inhibition  47.06 10.67 46.1 (30.8-67.5) 52.05 14.31 49.4 (28.4-91.7) 1.30  .200 0.19  
Hayling Errors 1.05 1.99 1 (0-7) 2.35 4.10 1 (0-18)  193.0 .235  -0.18 
Secondary Measures            
WCST             
Number of trials to complete first 16.76 25.73 11 (10-129) 18.30 25.06 11 (10-129)  224 .654  -0.069 
% Conceptual level responses 68.05 23.54 76 (9-91) 67.35 21.57 77 (13-90)  223 .670  -0.066 
Failure to maintain set 0.43 0.60 0 (0-2) 0.91 1.56 0 (0-7)  206.5 .354  -0.140 









Trials administered 95.57 22.17 92 (70-128) 97.91 24.67 85 (70-128)  232.5 .836  -0.032 
Colour Word  








* p < .01,  **indicates significance at Bonferroni corrected alpha level of 0.05/7=.007 for à priori key variables,  




4.3.2 Relationship of Psychopathological Symptoms to Set Shifting 
and inhibition  
Relationships between neuropsychological performance and anxiety or depression 
symptoms, as measured by the SCL-90-R or obsessive compulsive symptoms as 
measured by the YBOCS were investigated using Kendall’s tau correlations within 
each group.  Correlations were performed between the seven a priori key variables, 
the three psychopathological measures and the subscales of the EDE (Table 4.5). 
 
A significance level of p < .01 was chosen, as a Bonferroni correction was 
considered too conservative for this analysis.  There was a significant relationship 
between the number of Hayling task errors and EDE Eating Concern in the BN 
group.  Within the AD group, the YBOCS correlated with WCST categories 
completed (0.46) and anxiety was correlated with TMT errors (-0.48) (Table 4.6).  
However, there were strong floor effects on the Hayling task and TMT errors and a 
ceiling effect in the WCST categories completed.  On visual inspection of the 
variables, within the AD group, the YBOCS correlation did not appear to be a true 





Table 4.5: Correlation of Set shifting and inhibition key measures with 
psychopathology measures in bulimic group 
 SCL-90 YBOCS EDE 
Anx Dep  Restraint Eating Shape Weight 
Set Shifting        
WCST  
   Perseverative errors .045 .130 .126 -.130 .069 -.177 -.104 
   Categories      
completed .164 -.104 -.040 -.089 -.118 -.022 -.059 
DKEFS        
  Trail Making test 
  Number/letter switch -.087 -.044 .133 -.277 -.043 -.053 -.329* 
  Trail Making test 
  Number of errors -.007 -.070 .225 .042 .213 -.110 -.166 
Inhibition        
WCST    
Non-perseverative 
errors .044 .118 .141 .020 .214 .019 .005 
DKEFS        
  Colour Word  
  Inhibition  .189 -.058 .149 -.194 .010 .029 -.149 
Hayling 
Errors -.247 -.400* -.006 -.406*   -.522** -.052 -.222 
Note. SCL-90= Symptom Checklist-90-Revised, YBOCS= Yale-Brown Obsessive Compulsive Scale, 
EDE= Eating Disorder Examination (Version 12). Anx = Anxiety subscale, Dep = Depression subscale,  
*p<.05, **p<.01, 
 
Table 4.6  Correlation of key set shifting and inhibition measures with 
psychopathology in the AD group 
 SCL-90 YBOCS EDE 
Anx Dep  Restraint Eating Shape Weight 
WCST  
   Perseverative errors -.016 .045 -.230 -.174 -.024 .045 -.168 
   Categories completed .127 .058 .462** .241 .232 .090 .242 
   Non-perseverative   
errors -.012 .127 -.382* -.287 -.114 -.012 -.257 
DKEFS        
  Trail Making test 
  Number/letter switch -.177 -.044 -.216 .122 -.009 .004 -.016 
  Trail Making test 
  Number of errors -.484** -.345* -.014 .385* -.229 -.263 .036 
  Colour Word  
  Inhibition  -.121 -.171 -.061 .017 -.148 -.012 -.090 
Hayling 
Errors -.072 -.080 .082 .054 -.104 -.040 -.151 
Note. SCL-90= Symptom Checklist-90-Revised, YBOCS= Yale-Brown Obsessive Compulsive Scale, 
EDE= Eating Disorder Examination (Version 12), Anx = Anxiety subscale, Dep = Depression subscale 





4.3.3 Post hoc exploratory analysis 
4.3.3.1 Association between psychopathological variables and 
neuropsychological performance using data from combined groups 
As no significant differences were found between groups on the a priori 
neuropsychological measures, the two groups were combined and Kendall’s tau 
correlations were used to investigate associations between psychopathological 
variables and neuropsychological performance in the entire sample (Table 4.7).  
Using the whole sample, significant correlations (p < .05) were seen between the 
YBOCS and WCST categories completed (0.25), and between SCL-90-R Anxiety 
and TMT errors (-.25).  For the same reasons as above, these relationships must be 
interpreted with caution due to the noted floor and ceiling effects.  Again, the 
YBOCS correlation did not appear to be a true relationship.  Graphs are provided in 
Appendix 6. 
Table 4.7: Correlation of key set shifting and inhibition measures with 
psychopathology in both groups combined 
 SCL-90 YBOCS 
Anx Dep  
WCST  
   Perseverative errors .030 .075 -.100 
   Categories 
completed .100 .002 .253* 
   Non-perseverative 
errors .020 .126 -.120 
DKEFS    
  Trail Making test 
  Number/letter 
switch -.176 -.103 -.036 
  Trail Making test 
  Number of errors -.247* -.170 .116 
  Colour Word  
  Inhibition  .001 -.132 -.006 
Hayling 
Errors -.134 -.211 .007 
Note. SCL-90= Symptom Checklist-90-Revised, YBOCS= Yale-Brown 
Obsessive Compulsive Scale, Anx = Anxiety subscale, Dep = Depression subscale 






Further analysis explored any possible predictive relationship between anxiety, 
depression and obsessive symptoms and neuropsychological performance, using 
multiple linear regression analysis.  A priori key variables were used as the 
dependent variables and the YBOCS and the SCL-90-R subscales of anxiety and 
depression were independent variables (Table 4.8).  Seven separate linear regression 
analyses were performed. 
 
Using 43 participants (one participant did not complete the YBOCS) this sample had 
the power to detect a large effect size using 3 predictors (power 0.8, α = .5) 
according to the calculations of Miles and Shevlin (2001).  Due to the non-normality 
of the data, some outliers were removed for regression analysis (detailed in Table 
4.8).  In order to control for interaction effects between predictors, all variables 
entered the regression analysis simultaneously.  Relationships between variables 
were investigated using Kendall’s tau correlations and examination of eigenvalues. 
The anxiety and depression subscales of the SCL-90-R were noted to correlate and to 
load primarily on the same small eigenvalue, indicating some collinearity.  No 
bivariate correlations exceeded 0.70 so no variables were excluded (Tabachnick & 
Fidell, 2001).  The assumption of normally distributed errors of the regression was 
violated for a number of the models, as determined from examination of graphs and a 
Kolmogorov-Smirnov test on the standardised residuals. This violation of 
assumptions suggests that the results of the regression analysis will generalise 
poorly.  
 
None of the models were significant (for all F values, p >.05), suggesting that in this 







Table 4.8: Adjusted Beta values for predictor variables in the regression 
analyses 
 





























SCL-90        
Anxiety -0.06 -0.154 -0.09 -0.311 -0.426  0.128 -0.222 
Depression 0.32 -0.091 0.197 -0.07 0.035 -0.356 -0.526*  
YBOCS -0.317  0.283  -0.343*  -0.018  0.254  -0.025  0.002  
AdjR2 0.086 0.021 -0.024 0.070 0.088 0.009 0.106 
F 2.283 1.295 0.666 2.046 2.315 1.124 2.615 
*p < .05, **p < .01, ***p < .001 
a  n=42, 1 outlier removed, 4 standard deviations from the mean 
b n=43 because data is missing for one BN participant on YBOCS 
c n=41, 2 outliers removed, each 3.2 standard deviations from the mean 
d n=43,   
e  n=42, 1 outlier removed, 4.62 standard deviations from the mean 
f  n=42, 1 outlier removed, 3.2 standard deviations from the mean 
g n=42, 1 outlier removed, 4.76 standard deviations from the mean  
h assumption of normality of errors violated 
 
4.3.4 Exploratory analysis of performance on secondary set shifting 
and inhibition variables 
4.3.4.1 Analysis of Secondary Variables 
The BN group were significantly slower on the CWIT condition 4 than the AD group 
with a large effect size of 0.84.  However, this was no longer significant after 






The present study was the first to use a clinical comparison group of people with 
anxiety and/or depression to investigate the specificity of neuropsychological 
impairments among patients with BN.  The a priori set shifting and inhibition 
variables were selected because they have been highlighted in the literature as 
demonstrating potential deficits in individuals with BN as compared to healthy 
controls (Alvarez-Moya et al., 2009; Brand et al., 2007; Roberts et al., 2010).  No 
statistically significant differences were found between the BN group and the AD 
group on these measures, indicating similar levels of neuropsychological ability in 
both groups.  While there was a significant relationship between anxiety and one 
neuropsychological measure, a regression analysis demonstrated that anxiety, 
depression and obsessive compulsive symptoms were not predictive of 
neuropsychological performance. 
Although no studies were found that conducted neuropsychological comparisons 
between a BN and AD group, over half of the AD group were diagnosed with 
depression and literature would suggest that a depressed group may perform worse 
on tasks of inhibition and set shifting than an eating disordered group.  Giel et al. (In 
Press) found that individuals with unipolar depression performed significantly worse 
than those with AN on set shifting, using the TMT and WCST perseverative errors, 
and on cognitive inhibition using the Parametric Go/NoGo task (PGNG; 
Langenecker et al., 2007).  As the performance of BN patients in the literature is 
reported as the same or better than AN patients (Lauer et al., 1999; Roberts et al., 
2010), it may have been expected that the BN group would also perform better than a 
depressed group.  However, in Giel et al.’s (In Press) study, only AN patients 
without comorbid depression were included, and as a result, the AN group reported 
significantly fewer depression symptoms than the unipolar depression group.  This 
was not the case in the current study where comorbid depression was not excluded in 
the BN group and similar levels of depression were reported in both groups.    It is 
possible that an AN group with no comorbid depression is a particular subgroup of 
AN, which is not comparable to the BN sample of mixed comorbidity used in the 




different levels of ability on neuropsychological tasks (Lauer et al., 1999; Roberts et 
al., 2010).   
The literature provides some indications that particular anxiety disorders, such as 
OCD and PTSD, may demonstrate greater impairment on inhibition and set shifting 
tasks than BN.  Murphy et al. (2004) reported that BN participants performed 
significantly better on the TMT than an OCD group.  However, while OCD is an 
anxiety disorder with replicated neuropsychological impairments (Martinez-
Gonzalez & Piqueras-Rodriguez, 2008) most participants in the AD group were 
diagnosed with GAD, specific phobia or panic disorder with or without comorbid 
depression. The literature would suggest that these anxiety disorders are less likely to 
have specific deficits in set shifting or inhibition than a group of OCD patients, and 
are therefore less likely to differ from a BN group (Airaksinen et al., 2005; Chapter 2 
of this thesis; McClintock et al., 2010; O'Toole & Pedersen, 2011). 
In the BN group, higher scores on the EDE eating concern scale were significantly 
associated with fewer errors on the Hayling task, suggesting that those higher in 
Eating Concern were better able to inhibit incorrect responses on this task.  However, 
this correlation was influenced by a floor effect and needs to be interpreted with 
caution.  Within the literature for BN, eating disordered symptoms have not been 
found to be associated with neuropsychological performance, on set shifting 
measures such as the TMT (Murphy et al., 2004) on a task of conditional associative 
learning (Murphy et al., 2004) or on a gambling task (Guillaume et al., 2010).  The 
finding, in this study, that most other neuropsychological measures were not 
correlated with ED symptoms is consistent with this literature.   
No associations were found between anxiety, depression and obsessive-compulsive 
symptoms and neuropsychological performance in the BN group, consistent with  the 
existing literature in BN, which has found no such associations using a cognitive 
flexibility test battery (Tchanturia, Anderluh, et al., 2004), the TMT (Murphy et al., 
2004), and a decision making task (Brand et al., 2007).   In the AD group and the 
combined groups, correlational analyses suggested some relationships between 
anxiety and TMT errors, and obsessive-compulsive symptoms and the WCST 




with caution due to the noted floor and ceiling effects.  These correlations are not 
consistent with reports in the literature that psychological distress and trait anxiety 
are unrelated to TMT performance in young adults suffering from anxiety disorders 
(Castaneda et al., 2011).  However, it should be noted that no significant associations 
were found on measures with more normally distributed data. 
A regression model using anxiety, depression and obsessive-compulsive symptoms, 
did not predict performance on any a priori measure when data from the two groups 
were combined.  This is consistent with the literature mentioned above, which has 
found no relationships between psychological symptoms and neuropsychological test 
performance in BN and anxiety groups.   In relation to patients with depression, 
McClintock et al.’s (2010) review reported that associations between 
neuropsychological performance and depression symptoms have been found but are 
not consistent across studies.   
4.4.1 Limitations 
There are limitations to the present study, which may restrict the generalisability of 
the findings.  The BN and AD groups in the current study were chosen on the basis 
of their primary diagnosis with no exclusion of comorbid major depression or 
anxiety disorder.  The BN group were a general clinical group, with participants who 
potentially had comorbid anxiety disorders and/or major depression, as is common in 
BN (Hudson et al., 2007).  However, there was no assessment of the BN participants 
for comorbid disorder.  Such assessment could have further contributed to the 
understanding of the data.   
 The power achieved within the study due to sample size, meant that only effect sizes 
above d=0.88 were detectable as significant in group comparisons.  A number of 
trends were observed in the data, which may have been found to be significant if the 
study had the statistical power to detect smaller effect sizes.  However, Bezeau and 
Graves (2001) concluded that clinical neuropsychology research commonly deals 





4.4.2 Implications and future directions  
The pattern of findings suggests that neuropsychological performance in BN is 
broadly the same as a clinical comparison group of anxious and/or depressed 
outpatients.   This implies that deficits seen in studies comparing BN to HC may 
reflect impairments that are shared with other disorders, rather than impairments that 
are specific to BN.  Future research may wish to document the comorbidities present 
in the BN sample or if possible include a BN group without comorbidities.  The 
inclusion of comparison groups for anxiety disorders and major depression 
separately, might help to further clarify how cognitive impairments may be shared 
among common psychological disorders, whether there are causal effects of 
particular comorbid disorders or if the neuropsychological performance patterns are 
epiphenomena of pathology.   The inclusion of a healthy control group would also be 
useful to examine how performance of clinical groups deviates from healthy 
performance.  At present, these findings suggest that the development of therapies 
based on a specific neuropsychological profile of BN is unnecessary. 
4.4.3 Conclusion 
This study examined set-shifting and cognitive inhibition performance in 21 bulimic 
patients and 23 matched clinical comparison patients in treatment for anxiety and/or 
depression.  The results indicated no significant differences between the two groups 
on a battery of neuropsychological tests focused on measures of set shifting and 
inhibition.  Further analysis indicated that shared anxiety, depression and obsessive-
compulsive symptoms were not predictive of neuropsychological test performance. 
These findings do not support the specificity of impairments in set shifting and 
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Chapter 5: Methodology 
 
The methodology outlined in this chapter is based on clinical guidelines and best 
research practice for eating disorder populations, self harm and those with diagnoses 
of anxiety or depression (NHS QIS, 2006; NICE, 2004a, 2004b, 2010, 2011). 
 
5.1 Design  
The current study incorporated a quantitative framework with a between groups cross 
sectional design.  Data were collected using formal neuropsychological testing, 
questionnaires and interview.  The study was designed to address methodological 
limitations recently highlighted by a systematic review of the current literature 
relating to neuropsychological correlates of bulimia nervosa (Van den Eynde et al., 
2011).  Design features addressing these limitations include use of a comparison 
group to address the issue of specificity and potentially confounding comorbidities, 
reporting of effect sizes within results and using measures already reported on within 
the literature in order to facilitate comparisons between studies.    
 
In addition, this project was designed within the context of the Tayside Eating 
Disorder Research Group to complement recent research relating to 
neuropsychological correlates of inpatients and outpatients with anorexia.   
5.2 Participants 
5.2.1 Inclusion/exclusion criteria 
The inclusion/exclusion criteria for each group; outpatients with Bulimia Nervosa or 
Eating Disorder Not Otherwise Specified with bulimic features (EDNOS-BN), and 
outpatients with anxiety and/or depression, are listed below. 
 
Group 1: Outpatients with Bulimia Nervosa or EDNOS-BN  
Inclusion Criteria: 
 Female  
 English speaking 




 Meet DSM-IV criteria for a diagnosis of Bulimia Nervosa or EDNOS-BN (or 




 Receiving treatment for Bulimia Nervosa or EDNOS-BN on an outpatient 
basis as part of NHS Tayside or NHS Grampian Eating Disorder Services 
 
Exclusion Criteria: 
 Medically unstable 
 Current diagnosis of Anorexia Nervosa 
 Psychosis 
 Previous inpatient treatment for their eating disorder 
 History of Learning Disability/Developmental Disorder 
 History of head injury involving loss of consciousness 
 History/current Neurological Disorder 
 Uncorrected significant visual or motor impairment  
 Past substance abuse/related disorder 
 Knowledge of Neuropsychological tests 
 
 
Group 2: Outpatients with Anxiety and/or Depression 
 
Inclusion Criteria: 
 Female  
 English speaking 
 Age 18-65 
 Meet DSM-IV criteria for Anxiety or Major Depression (any Anxiety 
disorder was acceptable as long as HADS scores were in the clinical range) 
 Score 11 or above on either the anxiety or depression scale of the HADS  
 Receiving treatment for anxiety and/or depression at primary care in Tayside   
 
                                                 
1





 History of Learning Disability/Developmental Disorder 
 Significant current Medical/Psychiatric Disorder. Significant psychiatric 
disorder is identified if the individual is receiving treatment from specialist 
mental health services for a disorder. 
 Any significant suicidal ideation or intent 
 History of head injury involving loss of consciousness 
 History/current Neurological Disorder 
 Uncorrected significant visual or motor impairment  
 Past substance abuse/related disorder 
 EDE score above 4 







5.2.2 The BN Group: Outpatients with Bulimia Nervosa or EDNOS-BN 
 
The BN group consisted of 21 female outpatients meeting the inclusion and 
exclusion criteria, as defined in Section 5.2.1, who were recruited from NHS Tayside 
and NHS Grampian Eating Disorder Services.  Demographic characteristics of the 
sample are primarily described in the journal article in Chapter 4 (Table 4.2 ).  
Additional information on descriptive categorical variables is provided in Table 5.1. 
 
5.2.2.1 Identification of Participants 
Potential participants were identified by their treating clinicians within the Eating 
Disorders Services, as those they felt were medically and psychiatrically fit to 
participate in the study.  Treating clinicians were Clinical Psychologists, Clinical 
Associates in Applied Psychology or Senior Nurse Specialists.    Clinicians offered 
these patients the Participant Information Sheet and briefly discussed the study with 
them.  For most participants, this information was provided during a therapy 
appointment.  A number of potentially suitable participants in Grampian were 
informed of the study by letter by their clinician, as there was a long time lapse 
between appointments within the service.  The letter text is reproduced in Appendix 
7. The Participant Information Sheet was enclosed (Appendix 8), along with a short 
description of the procedure.  Contact information was provided in the event that the 
patient wished to participate or to seek further information.   
 
Participation was voluntary and patients were informed that their choice to 
participate or not would have no affect on their treatment.  29 patients were offered 
study information by clinicians in Dundee and approximately the same number in 
Grampian, although exact numbers could not be obtained at the time of writing.  
Twenty nine patients agreed to be contacted by the researcher.  Of these, 2 dropped 
out before testing, 4 were unavailable, 1 was excluded for dyslexia and 1 for 





As described in the Introduction Chapter (Chapter 1), male patients were not 
included in this study, which allows the sample to be directly comparable to existing 
key papers that have used only female participants.   
 
5.2.3 The AD Group: Outpatients with Anxiety and/or Depression 
The AD group consisted of 23 female outpatients being treated for anxiety disorders 
and/or Major Depressive Disorder (MDD) within NHS Tayside Adult Psychological 
Therapies Services.  All participants met inclusion and exclusion criteria as set out in 
Section 5.2.1.  Demographic characteristics of the sample are primarily described in 
the journal article in Chapter 4 (Table 4.2).  Additional information on descriptive 
categorical variables is provided in Table 5.1. 
 
Although difficulties with set shifting and cognitive inhibition ability have been 
found in patient groups with symptoms of anxiety and depression, results have been 
mixed, as described in Chapter 4.  This group was included as a clinical comparison 
group to investigate if deficits which have been reported in BN are shared with other 
common psychological disorders.  
 
5.2.3.1 Identification of Participants 
Potential participants were identified by clinicians in the same way as patients with 
BN.  All Clinical Psychologists, Counselling Psychologists, CBT therapists and 
Clinical Associates in Applied Psychology working with the Angus, Dundee and 
Perth Adult psychological therapies services were informed of the study and asked to 
consider if patients on their caseload may be suitable.  As a large number of 
participants were sought and the time commitment was expected to discourage some 
potential participants, a large number of patients were invited to participate.  
 
Approximately 100 patients were offered study information by clinicians.  The 
Dundee Adult Psychological Therapies team reported 50 patients invited to 
participate, the Angus Adult Psychological Therapies team reported 29 patients 




to report an accurate number.  If an approximate number of 30 patients invited to 
participate is estimated for the Perth team, the total number of patients invited to 
participate in the AD group was approximately 109.  In total, 37 patients agreed to be 
contacted by the researcher.  Of these, 9 were ultimately unavailable to participate, 2 
were excluded for dyslexia, 1 for having poor quality spoken English, 1 did not meet 
inclusion criteria related to the HADS and 1 was unavailable for 2 consecutive hours. 
 
5.3 Additional Descriptive data for BN and AD groups 
The main participant characteristics are described in Chapter 4, Table 4.2.  Table 5.1 
below provides further information on descriptive data for both groups.  No 
significant differences were found between the groups on handedness, the amount of 
time since they had last eaten or the report of any birth related complications.  
Similar proportions of each group were current alcohol and medication users.  No 
one in either group was a current illegal drug user. 
Table 5.1: Demographic information for categorical data in Bulimic and 





Group  n=23 
Fisher’s exact 
test 
 N % n % p 
Handedness  
Right 19 90 17 74 .432 
Left 1 5 4 17  
Ambidextrous 1 5 2 9  
Time Last Eaten .369 
Within 3 hours 13 62 16 70  
3-6 hours ago 1 5 3 13  
6-24 hours 7 33 4 17  
Current Alcohol 
User 18 86 17 74 .462 
Current Drug User 0 0 0 0 .999 
Currently Taking 
Medication 11 52 15 65 .541 
Pre/Post Natal 







5.4.1 Psychological Measures 
Psychological Measures used are listed in Table 5.2. 
Table 5.2 Psychological Measures  
Psychological Measure Areas Assessed 
Hospital Anxiety and Depression Scale 
(HADS) 
Current anxiety and depressive 
symptoms 
Eating Disorders Examination (EDE) Eating psychopathology 
Symptom Check List−90 Revised 
(SCL−90R) 
General psychopathology 
Self Liking/Self Competence Scale Self esteem 
Yale−Brown Obsessive-compulsive 
Scale (Y−BOCS) 
Obsessive and compulsive symptoms 
Social Problem Solving Inventory 
Revised (SPSI−R) 
Social problem solving ability 
 
 
5.4.1.1 Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983) 
The HADS is a self-report measure of experienced anxiety and depression, which has 
been used extensively in clinical studies (Bjelland et al., 2002).  It contains an 
anxiety and a depression scale, each consisting of 7 questions with 4 possible 
responses relating to the severity of the symptom in question.  The response is 
translated into a score from 0 to 3 for each question.   The anxiety and depression 
scores are categorised individually as normal (0-7), mild (8-10), moderate (11-14) 
and severe (15-21). The HADS was administered to adult outpatients as part of 
routine clinical practice and ongoing review.   
The HADS depression subscale has 90% sensitivity and 86% specificity for 
depression compared to the gold standard of a structured diagnostic interview 
(Zigmond & Snaith, 1983).  Crawford, Henry et al. (2001) reported the reliability of 




review by Bjelland et al. (2002) reported the reliability of the Anxiety subscale to 
vary from 0.68 to 0.93 (mean 0.83) and for the Depression subscale from 0.67 to 
0.90 (mean 0.82).   
 
5.4.1.2 Eating Disorders Examination (EDE) Version 12 (Fairburn & Cooper, 
1993) 
The EDE is a semi-structured, investigator based clinical interview that is generally 
regarded as the ‘gold standard’ instrument for measuring eating disordered attitudes 
and behaviours.  It contains 23 items rated in regards to the past 28 days on a 7-point 
Likert scale, ranging from ‘0’ (‘not at all’) to ‘6’ (‘markedly’ or ‘every day’), with 
higher scores indicating more severe eating pathology.  Responses are used to 
calculate four subscales (Dietary Restraint, Eating Concern and Weight Concern, 
each ranging from 0-30, and Shape Concern, ranging from 0-48),  and a global score 
(mean of the 4 subscales).   All subscale mean scores and the global score range from 
0-6. The EDE can also be used as a diagnostic tool for DSM-IV, containing 
frequency measures of binge eating and compensatory behaviours.   
Good internal consistency, (Beumont et al., 1993; Cooper et al., 1989) concurrent 
(Rosen et al., 1990) and discriminant (Cooper et al., 1989; Rosen et al., 1990; 
Wilson & Smith, 1989) validity, and inter-rater reliability (Black & Wilson, 1996; 
Cooper & Fairburn, 1987; Rosen et al., 1990; Wilson & Smith, 1989) have been 
demonstrated for the EDE in adults.   It also discriminates well between different 
types of eating disorder (Beumont et al., 1995; Fairburn & Cooper, 1993) . 
 
5.4.1.3 Symptom Check List−90 Revised (SCL−90R) (Derogatis, 1994; Derogatis 
et al., 1973) 
The SCL−90R is a 90−item self−report instrument for measuring general 
psychopathology for use with community, medical and psychiatric respondents. It 
contains 90 problem items rated in regards to the past 7 days on a 5-point Likert 
scale of distress from 0 ‘Not at All’ to 4 ‘Extremely’.  It comprises nine primary 




Sensitivity, Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation and 
Psychoticism – for which mean scores (range 0-4) are calculated. An ‘Additional’ 
scale is also included in the measure which contains a collection of symptom items 
relating to disturbed sleep, feelings of guilt, overeating, thoughts of death and poor 
appetite.   
 
Responses to these subscales are used to calculate three global indices: the Global 
Severity Index (GSI), the Positive Syndrome Distress Index (PSDI) and the Positive 
Symptom Total (PST).  The GSI is the mean value of all the items (total divided by 
90).  GSI thus ranges from 0-4.  The PST is the number of items which have been 
scored higher than zero.  PST thus ranges from 0-90.  The PSDI is the total sum of 
all ratings divided by the PST, and ranges from 0-4.   
 
Good internal consistency of the primary symptom dimensions and global indices 
has been demonstrated across a number of populations including control groups 
(Derogatis, 1983), psychiatric inpatients (Rauter et al., 1996), and substance abuse 
inpatients (Zack et al., 1998) as well as cancer patients (Fitch et al., 1995).  Alpha 
coefficients have ranged from 0.77 to 0.90 in one study of 209 symptomatic 
volunteers (Derogatis et al., 1976) and from 0.79 to 0.90 with a sample of psychiatric 
outpatients (Horowitz et al., 1988). More recently, similar results have been found 
with Cronbach’s alpha coefficient ranging from 0.77 for the Hostility subscale to 
0.90 for the Somatisation and Depression subscales among psychiatric outpatients in 
Finland (Holi, 2003; Holi et al., 2003).  The SCL-90-R has been found to have good 
test-retest reliabilities across a range of patient groups and test-retest intervals 
(Derogatis, 2000).  Therefore, previous completion of the SCL-90-R was acceptable 
among participants.  Good convergent-discriminant validity for the SCL-90R has 
also been demonstrated in patients and healthy controls (Boleloucky & Horvath, 
1974; Derogatis et al., 1976; Peveler & Fairburn, 1990); however examination of the 
convergent and discriminant validity of the subscales has produced mixed results.  
The Depression and Anxiety subscales have the most evidence of convergent and 
discriminant validity (Bech et al., 1992; Derogatis, 2000; Koeter, 1992).  The 
Obsession-Compulsion subscale has been shown to be internally consistent (Woody 




1992; Woody et al., 1995).  The SCL-90 has been used in BN patient groups to 
assess general psychopathology (Brand et al., 2007; Fairburn et al., 2007; Krug et 
al., 2008), and found to have good concurrent validity within a BN patient group 
using comparison with an investigator based interview, the Present State 
Examination (Peveler & Fairburn, 1990). 
 
Scores for all scales were recorded for the purpose of comparison between the two 
groups on psychological distress.  The symptoms dimensions of Depression, 
Obsession-Compulsion and Anxiety were used in the investigation of the relationship 
between psychopathology and performance on neuropsychological tasks of set 
shifting and inhibition.   
 
5.4.1.4 Self−Liking/Competence Scale (Revised) (SLCS−R) (Tafarodi & Swann, 
2001) 
The SLSC−R is a 16 item measure of two-dimensional self-esteem composed of two 
interdependent subscales of self liking and self competence. It contains 8 items 
relating to self worth and self competence and 8 items relating to sense of self-
efficacy. Participants rate the items on a 5-point Likert scale ranging from 1 (strongly 
disagree) to 5 (strongly agree).  The item scores are then summed and combined into 
an overall subscale score. These can range from 8 to 40, with higher scores 
indicating higher self-competence or higher self-liking. It has been tested for 
discriminant and convergent validity and found to constitute best fit on all indices, 
when compared to other self esteem measures.  Reliability and validity of a 
translated version of the questionnaire were found to be appropriate in a Dutch 
sample (Vandromme et al., 2007). Internal consistency was found to be good in an 
American sample, with alpha coefficients of 0.90 for Self-Liking and 0.82 for Self-
Competence (Mar et al., 2006).  Self competence has also been found to correlate 





5.4.1.5 Yale−Brown Obsessive Compulsive Scale−Symptom Check List 
(Y−BOCS−SC) (Goodman, Price, Rasmussen, & Mazure, 1989). 
Regarded as the 'gold standard' for the assessment of obsessive compulsive 
symptoms, (Deacon & Abramowitz, 2005; Frost et al., 1995; Moritz et al., 2002), the 
YBOCS consists of a 58 item symptom checklist and a 10 item severity scale.  The 
symptom checklist covers a range of obsessions and compulsions, clustered by 
behavioural expression (e.g. checking compulsions) and thematic content (e.g. 
contamination obsessions).  Obsessions and compulsions are assessed over the 5 
dimensions of time spent, interference in functioning, distress, efforts to resist and 
perceived control, creating a 10-item severity measure.   
 
Respondents used the symptom checklist to identify their main symptoms and then 
completed the YBOCS severity scale with these in mind, in relation to the past 7 
days. Items are rated on a 5-point scale from 0 (no symptoms) to 4 (extreme 
symptoms.) The symptom checklist is not scored.  Scores on the YBOCS thus range 
from 0-40 with higher scores indicating more severe OCD symptoms. 
 
The YBOCS can be administered in the form of interview or self-report.  There are 
small differences between the two versions, such as the inclusion of plain-language 
explanations of the concepts and the removal of an ‘other’ option in the symptom 
checklist.  A number of studies have demonstrated the validity and reliability of the 
interview version (Goodman, Price, Rasmussen, & Mazure, 1989; Goodman, Price, 
Rasmussen, Mazure, et al., 1989; Kim et al., 1990; Woody et al., 1995). Comparison 
of interview and self-report administration showed moderate to good agreement 
between both the symptom checklist and severity ratings, with Federici et al. (2010) 
noting that the compulsions scales were more highly correlated between versions 
than were the obsessions scales (Steketee et al., 1995). The current study uses a self-
report version of the YBOCS (Baer, 1991) which was also used by Federici et al. 
(2010). The YBOCS has been used to measure obsessive and compulsive symptoms 
in bulimic patients in a number of studies (Kaye, 2005; Matsunaga et al., 1999; 





5.4.1.6 Social Problem Solving Inventory Revised (SPSI−R) (D'Zurilla et al., 1998) 
(D’Zurilla & Maydeu-Oliveres, 1995) 
The SPSI−R is a 52−item, multidimensional, self-report measure of social problem 
solving ability. Each item is rated on a five-point scale from 0 ‘not at all true of me’ 
to 4 ‘extremely true of me’.  The SPSI-R comprises two problem orientation 
measures (positive problem orientation, negative problem orientation) and three 
actual problem-solving measures (rational problem-solving, impulsivity/carelessness 
style, avoidance style), as described in Table 5.3. 
 
Table 5.3 Subscales of the SPSI-R 
Subscale  Attitudes and Behaviours 
Measured 
Problem Orientation  
Positive Problem Orientation (PPO)  Positive appraisal, self-efficacy and 
outcome expectancies. 
Negative Problem Orientation (NPO)  Dysfunctional cognitive processes, 
threat perception and frustration 
tolerance. 
Problem Solving  
Rational Problem Solving (RPS)  Systematic problem solving, realistic 
goal setting and evaluating outcomes 
Impulsivity/Carelessness Style (ICS)  Impulsive, incomplete or careless 
problem solving strategies 
Avoidance Style (AS)  Procrastination, passivity and inaction  
 
 
The problem solving subscales of the SPSI-R have been shown to accurately predict 
academic success after controlling for aptitude, indicating ecological validity of the 
subscales (D'Zurilla & Sheedy, 1992). Acceptable convergent, construct and 
discriminant validity have been reported among psychiatric inpatients and healthy 
adults (Chang & D'Zurilla, 1996; D'Zurilla et al., 1998; D’Zurilla & Maydeu-
Oliveres, 1995). Test-retest reliabilities range from 0.72 for positive problem 





The negative problem orientation and avoidance subscales have been linked to eating 
pathology in anorexia (Paterson et al., 2007).  These scales have also been linked to 
depressive symptoms (Klein et al., 2011; Londahl et al., 2005).  Negative problem 
orientation has also been found to be a significant predictor of worry after controlling 
for trait anxiety (Belzer et al., 2002). 
 
5.4.2 Neuropsychological Measures 
As executive function describes a broad spectrum of cognitive abilities, and tests of 
executive function have been shown to require the use of a number of cognitive 
functions simultaneously, it is difficult to isolate an ability such as set shifting or 
inhibition in any one task (Burgess, 2003).  Many studies have consistently reported 
varying performance among their subjects on neuropsychological tests which 
measure similar constructs (for example in BN samples; Alvarez-Moya et al., 2009; 
Brand et al., 2007; Tchanturia, Morris, et al., 2004).  For these reasons the test 
battery contained a number of measures designed to access set shifting and cognitive 
inhibition ability but which necessarily also overlap with other executive functions. 
 
Table 5.4 Neuropsychological Measures and Primary Areas Assessed 
Neuropsychological Measures Primary Areas Assessed 
National Adult Reading Test (NART) Pre-morbid intellectual ability 
Delis−Kaplan Executive Function System 
(DKEFS) Trail Making Task 
Attention, Set shifting, cognitive 
flexibility 
Delis−Kaplan Executive Function System 
(DKEFS) Verbal Fluency 
verbal fluency Cognitive flexibility, 
set shifting (condition 3),  
Delis−Kaplan Executive Function System 
(DKEFS) Colour-Word Interference 
Response inhibition, (also set shifting 
in condition 4) 
Hayling Test Response inhibition 
Brixton Test Set shifting 






5.4.2.1 National Adult Reading Test (NART) (Nelson, 1982; Nelson & Willison, 
1991) 
The NART is a measure of premorbid intellectual ability. The participant is asked to 
read aloud 50 irregularly spelt words (e.g. cough).  The number of pronunciation 
errors is recorded and used to estimate the Wechsler Adult Intelligence Scale 
(WAIS-R; Wechsler, 1981) score from standardised norms.  The NART’s validity as 
a measure of premorbid intelligence has been well documented (e.g. Crawford, 
Deary, et al., 2001).  Recently Bright et al. (2002) demonstrated that neither the use 
of demographic variables or a combination of NART score and demographic 
variables was significantly better than NART scores at estimating premorbid IQ.  
NART performance remains preserved despite a number of cognitive impairments, 
however its preservation in some disorders, such as Alzheimer’s and Huntington’s 
disease has been questioned.  The NART has demonstrated good internal consistency 
(Crawford et al., 1988; Nelson & Willison, 1991), test-retest reliability, and inter-
rater reliability (Crawford et al., 1989).  The NART has been used as a measure of 
premorbid IQ in eating disordered patients in a number of neuropsychological studies 
(Guillaume et al., 2010; Lopez et al., 2008; Tchanturia, Morris, et al., 2004; Van den 
Eynde et al., 2012). 
 
5.4.2.2 Delis−Kaplan Executive Function System (D-KEFS) (Delis et al., 2001) 
Three tests from the D-KEFS were used: 
 
Verbal Fluency Test − This is a measure of spontaneous production of words in 
conditions of  letter fluency (FAS, condition 1), category fluency (Animals and Boys 
names, condition 2) and a category switching condition where a participant must 
switch between naming items from each of 2 categories (Fruits and Furniture, 
condition 3).  In each condition, the score is the total number of correct responses 
generated in 60 seconds.   
 
FAS test-retest reliability and inter-rater reliability were found to be good by Vlaar 




et al., 2001).  The inter-rater reliability for general category fluency tasks is very 
good (Spreen & Strauss, 1998).  Good internal consistency has been reported for the 
verbal fluency component and category switching component in the D-KEFS manual 
(Delis et al., 2001).  Performance of BN patients on the FAS task is not different to 
controls according to the current literature (Brand et al., 2007; Tchanturia, Anderluh, 
et al., 2004).  However, the switching element of condition 3 in the D-KEFS is not a 
component of the standard verbal fluency task, which usually only includes a letter 
and category fluency task (Lezak et al., 2004).  This switching task may highlight 
difficulties in set shifting in individuals with BN. 
 
Colour Word Inference Test − This is a measure of selective attention and response 
inhibition.  The Stroop test, which is a longstanding test of cognitive flexibility and 
inhibition, has been modified in the D-KEFS battery to include a baseline colour 
naming condition (condition 1) and a set shifting condition (Colour Word Inhibition 
Switch, condition 4) in addition to the traditional colour word reading (condition 2) 
and colour word interference tasks (condition 3).  In each condition, the outcome 
measures are the time taken to read 50 items and the number of errors made.  Good 
internal consistency and test-retest reliability has been reported (Delis et al., 2001).  
Colour word interference 3 has been identified as an a priori key variable as 
significant differences have been found on this measure between samples of people 
with BN and healthy controls (Kemps & Wilsdon, 2010). 
 
Trail Making Test (TMT) − This test assesses planning and cognitive flexibility.  
There are 5 conditions in the D-KEFS TMT in contrast to the 2 conditions in the 
traditional TMT.  The five conditions are visual scanning (condition 1), number 
sequencing (condition 2), letter sequencing (condition 3), number-letter switching 
(condition 4), and motor speed (condition 5).  The procedure for the first condition 
involves a timed visual search.  The remaining conditions involve drawing a line 
connecting the target items (numbers, letters or empty circles) as quickly as possible 
while ignoring distracter items.  The switching task involves switching back and 
forth between connecting numbers and letters, completing the task as quickly as 




number of errors.  Good internal consistency and moderate test-retest reliability are 
described in the technical manual (Delis et al., 2001).  TMT4 completion time and 
TMT4 number of errors were identified as key variables, due to significant 
differences between BN patients and healthy controls found on these subscales in 
recent studies (Brand et al., 2007; Konstantakopoulos et al., 2011; Roberts et al., 
2010; Tchanturia, Morris, et al., 2004). 
 
5.4.2.3 Hayling & Brixton (Burgess & Shallice, 1997) 
The Hayling and Brixton tests measure behavioural regulation, including response 
inhibition and set shifting.  
 
The Hayling test evaluates initiation speed, by first requiring participants to logically 
complete 15 sentences as quickly as possible.  The second part of the task requires 
them to complete 15 sentences with unrelated words as quickly as possible, which is 
a measure of response suppression.  The sum of time to respond and total number of 
errors are the outcome measures. The number of errors in the Hayling test part 2 was 
chosen as an a priori key measure as a composite value using this measure described 




The Brixton test is a concept formation and set shifting task. The test consists of 56 
pages, each consisting of the same array of ten circles numbered 1–10 (one circle 
coloured blue). Participants are asked to predict the movement of the blue circle from 
page to page by detecting a logical pattern from previous pages. The pattern changes 
8 times during the task and the participant has to determine the new pattern.  The 
outcome measure is the total number of incorrect predictions made. No differences 
have been found to date between patients with BN and healthy controls on this task 






The technical manual reports the test-retest reliabilities for both tasks as adequate 
(Burgess & Shallice, 1997).  Adequate inter-rater reliability was reported for the 
Hayling test by Andres and Van der Linden (2000) .  
 
 
5.4.2.4 Wisconsin Card Sort Test (WCST) (Heaton et al., 1993) 
The WCST is one of the most widely used tasks in the assessment of cognitive 
function. It measures the aspects of executive function thought to be related to the 
frontal lobes, such as concept formation, set-shifting, and set maintenance. The 
WCST was administered in the standardized format (Heaton et al., 1993).  Four 
stimulus ‘key cards’ with symbols differing in colour, shape and number are placed 
in front of the participant, who is given a pack of 128 response cards and instructed 
to match each response card to one of the key cards by placing it on the table under 
that key card.  The researcher informs the participant whether each pairing is correct 
or incorrect.  The participant’s aim is to match cards according to the current 
criterion.  After coupling 10 cards with the first criterion (colour), the subject is 
required to shift to the second one (shape) and then to the third one (number).  The 
procedure is repeated twice or until all 128 cards have been used. The official 
computerised scoring package was used to compute scores. 
 
Test-retest reliabilities for the WCST have been examined by Heaton et al. (1993) 
and reported as ranging from 0.39 to 0.72. Bowden et al. (1998) reviewed these data 
and investigated reliability in an alcoholic and student population leading them to 
report a lower test-retest reliability of 0.22 to 0.55.  Although previous literature had 
expected large practice effects to be seen in the WCST, these were not present in 
Bowden et al.’s (1998) data (Franzen, 1989).  Ingram et al. (1999) also reported 
similar test-retest reliability 0.34 to 0.83 (mean=0.64) among sleep apnoea patients.  
Participants in the current study are unlikely to have encountered the WCST before 
and re-testing is not part of the procedure.  Variable values for inter-rater reliability 
have been reported, ranging from excellent (Axelrod et al., 1992) to quite low 





Number of Perseverative errors, categories completed and non-perseverative errors 
were identified as a priori key measures based on significant findings related to these 
variables found in BN patient groups in studies by Roberts et al. (2010) and Alvarez-
Moya et al. (2009).  A perseverative error is one where the participant continues to 
sort the cards in the same way, after the examiner says the card is wrong or changes 
criteria. Number of categories completed is the number of runs of 10 correct 
responses in a row (max. 6).  A non-perseverative error is any error not categorised 
as a Perseverative error.  Non-perseverative errors have been hypothesised to contain 
both efficient errors, which are used to test out and establish the new criterion, and 
inefficient errors, which have been linked to disinhibition and distraction in 
responding (Alvarez-Moya et al., 2009; Barceló & Knight, 2002).    
 
5.5 Procedure 
A diagram representing the participant journey from being approached by clinical 





Figure 5.1 Participant Journey 
 
5.5.1 The BN Group: Patients with Bulimia/EDNOS-BN 
Study Sites: NHS Tayside Eating Disorder Service and Grampian Eating Disorder 
Service 
 
Any outpatients attending NHS Tayside Eating Disorders Service, NHS Grampian 
Eating Disorders Service or NHS Tayside Adult Psychological Therapies Services 
Groups 1 &2: Both Clinical Groups 
 
Group 1: Bulimia/Atypical Bulimia 
Patient identified as 
suitable for study by 




as part of routine 
clinical practice 
Patient identified as 
suitable for study by 
clinician and offered 
study information. 
 
Contact details taken by clinicians from interested 
patients. Details passed to researcher electronically 
or on paper 
At least 24 hours later, patient contacted by phone 
or email to confirm their interest in participation, if 
they wished to proceed, time and place arranged for 
participation 
Met with researcher at NHS premises convenient to 
the participant.  Screened for inclusion/exclusion 
criteria, consent form completed if appropriate 
Completed semi-structured interview, 
neuropsychological tests and questionnaires 
General discussion and feedback following 
participation 




for treatment of an Eating Disorder and meeting inclusion criteria for the BN group 
were considered for participation in the study.  The Adult Psychological Therapies 
pathway was ultimately not used for the BN group as the department was 
transitioning to a model where all eating disordered patients were transferred to the 
Eating Disorder Service.  
 
Participants were recruited to the study through their treating clinician, as described 
in section 5.2.2.1.  Patients with a possible interest in participation were given verbal 
and written information about the study by their clinician (Appendix 8).  This 
information included details of the researcher’s clinical supervisor within NHS 
Tayside Department of Clinical Neuropsychology, who could be contacted for 
further information.  Patients who expressed a wish to participate and gave consent 
for their contact details to be passed on to the researcher, were given 24 hours to 
consider the information provided.  When contacted by the researcher, participants 
were asked if they still had an interest in taking part.  Most participants chose to give 
telephone contact details but email contact details were also used.  Previous research 
has used similar methodology to contact potential participants and has demonstrated 
a high response rate (Crombie et al., 2008; Kiezebrink et al., 2009).   
 
Patients wishing to participate met with the researcher in a clinic room at NHS 
premises convenient to their location within Tayside or Grampian.  At the meeting, 
patients were given the opportunity to ask any further questions, screened for 
inclusion/exclusion criteria and if these were met, completed consent forms. They 
were informed that their participation was confidential and that they could withdraw 
from the study at any time without giving a reason. 
 
The research procedure consisted of a semi-structured interview, to collect 
demographic information, and administration of the Eating Disorder Examination 
(EDE), which took 20 to 30 minutes. This was followed by formal 
neuropsychological testing in the order indicated in Table 5.2.  Following this, a 




Neuropsychological tests lasted on average 45 to 60 minutes and the 4 questionnaires 
took approximately 20-30 minutes to complete. 
  
Following completion of the measures, the researcher discussed with the participant 
her feelings about the experience of participation and any concerns or questions she 
had.  In addition, items of the YBOCS and SCL-90-R relating to thoughts of death 
and self harm were checked by the researcher.  If such items were endorsed, the 
researcher discussed with the participant their current levels of risk and support.  If 
the researcher identified an unmet need for support, a protocol was in place to 
contact a clinical supervisor for further advice (see section 5.6.4). 
 
5.5.2 The AD Group: Patients being treated for anxiety or depressive 
disorders in the Adult Psychological Therapies Service 
Any outpatients attending NHS Tayside Adult Psychological Therapies Services for 
treatment of anxiety or depressive symptoms and meeting inclusion criteria for the 
comparison group were considered for participation in the study.  Participants were 
recruited and testing administered as described in section 5.5.1.     
 
5.5.3 Recruitment activity at the level of clinicians 
Recruitment procedure was designed using recommendations from current literature, 
involving close collaboration with recruiting colleagues, regular feedback to them 
and using these discussions to consider the impact of study design on recruitment 
(Patel et al., 2003). The researcher met with clinical teams before recruitment began, 
presenting information about the background, rationale and procedure for the study 
at team meetings.  Meetings were attended periodically during the study and the 
researcher was in regular contact with the teams by email, including through 
reminder emails and recruitment updates to clinical leads.  Clinical teams were also 
provided with updated feedback at intervals on the numbers of participants recruited.  
In addition, various methods were used to encourage recruitment within the teams, 




clinic rooms or placing study information in patient files with coloured reminders 
pinned to the exterior of files.  
 
Clinician workload in recruiting was minimised to identification of suitable 
participants and provision of study information for the BN group and additionally, 
the use of the HADS questionnaire to establish inclusion criteria for the AD group.  
Low clinician workload related to a study has been found to be associated with 
increased referral to Randomised Controlled Trials (B. Fletcher et al., 2012).  
Clinicians were told that telephone numbers were the preferred method of contact, as 
previous experience and Cochrane reviews of literature on recruitment have 
indicated that telephone follow up can significantly increase recruitment levels 
(Treweek et al., 2010; Watson & Torgerson, 2006) as have individual studies 
(Zaslavsky et al., 2002).   
 
5.6 Ethical Issues 
 
5.6.1 Approval 
Ethical approval was granted from the NHS Tayside Research Ethics Committee.  
Management approval was granted from NHS Tayside Research and Development 




The confidentiality of all information collected during the study was communicated 
to the participants in the Participant Information Sheet, the consent form and during 
discussion (Appendices 8 & 10). The limits to confidentiality in the event of a 
disclosed risk and the procedure to be followed were also highlighted in the 
Participant Information Sheet (see Appendix 8).  
Personally identifiable data (name and date of birth) were recorded on consent forms 




encoded with a unique identifier for each participant. Only the researcher and her 
clinical supervisor at the NHS Tayside Eating Disorder Service (EDS) had access to 
personally identifiable data. 
 
5.6.3 Data Storage 
Consent forms were stored in a locked filing cabinet in a locked office within a 
locked department on NHS Tayside property. Only the researcher and her clinical 
supervisor at NHS Tayside Eating Disorder Service had access to this cabinet. A key 
to anonymised data was stored on a password protected NHS secured memory stick 
which is designed to erase all data if an incorrect password is used or if it is 
damaged. Only the researcher had access to this password.  No personally 
identifiable information was stored on a computer.  Study related documents, such as 
consent forms, were transferred using personal transport. 
 
Non identifiable data was stored in a locked filing cabinet in the same way as consent 
forms, but within a different NHS office.  All data stored on computer was 
anonymised and all computers used were password protected, including a home 
laptop which also had anti-virus software.   One NHS memory stick, as described 
above, was used to transfer data between sites.  Data was stored in line with the Data 
Protection Act (Department of Health, 1998), NHS Tayside Information Governance 
Policy (2010) and NHS Code of Practice on Protecting Patient Confidentiality 
(Scottish Executive, 2003).  
 
Following study completion, personally identifiable data will be stored for 6-12 
months and then destroyed, as recommended by NHS Tayside Research and 
Development Office. Non-identifiable data will be stored for 5 years from the date of 
publication in accordance with NHS Tayside Research and Development guidance 





5.6.4 Potential Distress to Participants/Disclosure of risk issues 
There was a risk that participants may have found the questionnaires and 
neuropsychological testing upsetting.  A number of measures were taken to address 
this possibility.  Referring clinicians were asked to use their judgement as to the 
current emotional state of the patient and their ability to undergo neuropsychological 
testing.  Then, at the beginning of the session, participants were reminded that they 
were free to withdraw at any time.  In addition, following participation, the 
investigator had a general discussion with the participant about how they found the 
testing, providing general feedback on neuropsychological test performance and 
explanation of the normal range of test performance. Written feedback was available 
on request.  
 
As self harm and suicidality can be a risk factor in BN, as well as a potential risk 
factor for patients with severe anxiety or depression, items 15 and 59 of the SCL-90-
R, relating to distress caused by ‘thoughts of ending your life’ and ‘thoughts of death 
or dying’, were routinely checked after administration of the questionnaire and 
discussed with the participant if any issues of risk were highlighted.  Similarly, the 
first two items on the YBOCS symptom checklist, ‘I fear I might harm myself’ and ‘I 
fear I might harm other people’ were also checked and discussed with the participant 
if endorsed. 
 
In the event of the procedure causing distress or an issue of risk being disclosed, 
participants were able to speak to the researcher in the first instance and, if further 
assistance was needed, the researcher’s clinical supervisor, a Consultant Clinical 
Neuropsychologist, was contactable to advise on immediate and longer term care for 
the patient including discussing the issue with their treating clinician and/or referral 
to other appropriate areas of the service.  
 
As participation in the study required approximately 1.5 to 2 hours, there was 
potential for the participant to become fatigued.  For this reason, participants were 





There were potential benefits for participants.  Participants may have enjoyed the 
experience of participation in neuropsychological testing, as neuropsychological 
research indicates many participants do (Bennett-Levy et al., 1994).  They may also 
have felt positive about contributing to research that will increase the understanding 
of their condition and potentially help future patients. 
 
5.7 Data analysis 
Data were analysed using SPSS version 15. 
 
5.7.1 Investigating assumptions for parametric statistical testing 
The data was first explored using graphing, tests of normality and homogeneity of 
variance to confirm that it met the assumptions for appropriate use of parametric 
statistics.   
 
5.7.2 Main analysis 
The main aim of the study was to explore potential differences between the two 
groups on measures of set shifting, inhibition, psychopathology and eating 
pathology.  A priori key measures were identified in order to reduce the number of 
comparisons within the data.  Key measures chosen were TMT4 completion time and 
TMT4 number of errors, WCST Perseverative errors, WCST categories completed, 
WCST non-perseverative errors, Stroop Interference 3 and Hayling number of errors.  
 
Comparisons were made using independent samples t-tests and Mann-Whitney U 
tests with Bonferroni corrections for multiple comparisons.  When a number of 
comparisons are being performed on a dataset, Bonferroni’s correction dictates that 
the alpha level should be divided by the number of comparisons.  The alpha level 
used for this study was 0.05, however where Bonferroni’s correction is applied a 
smaller value will be required to reach significance. 
 
The relationship of general psychopathology and eating pathology to set shifting and 




correlations were conducted between the identified a priori set shifting and inhibition 
variables and the relevant psychological measures.  Anxiety symptoms were 
described by the anxiety scale of SCL-90 and by the YBOCS score.  Depressive 
symptoms were described by the SCL-90 depression subscale (as described in 
Chapter 4). 
 
As differences between the groups on neuropsychological measures were non-
significant, a post-hoc regression analysis was conducted to investigate the predictive 
ability of measures of anxiety, depression and obsessive-compulsive symptoms on 
neuropsychological performance (Chapter 4). 
5.7.3 Additional Analysis 
Further analysis of the data presented in Chapter 4, and analysis of measures not 
chosen as a priori key measures, but included in the research, are also described.   
Following that, analysis related to the secondary aims of the thesis, and the measures 
of Social Problem Solving and Self Esteem are described.   
 
5.7.3.1 Clinical significance of impaired performance 
Clinically significant impairment in set shifting and inhibition was determined on a 
case by case basis by using standardised test norms. 
 
In order to investigate clinically significant impairment, two comparisons were 
conducted.  Each participant’s performance on key measures was compared to their 
estimated premorbid IQ and to normative data.  Z scores were calculated for the 
NART estimated IQ and each a priori key measure using standard scores.  
Underperforming was defined as the Z score of neuropsychological test performance 
falling one standard deviation (SD) or more below the Z score of the individual’s 
estimated premorbid ability, indicated by NART IQ.  Participants underperforming 
on 3 or more measures were highlighted as potentially impaired relative to past 
ability.  Each participant’s performance was also compared to the normative data for 




5.7.3.2 Secondary Variables 
Further exploratory analysis of set shifting and inhibition were conducted comparing 
the performance of the two groups on other variables not identified as key variables 
but commonly reported in the literature. Secondary variables were DKEFS Letter 
Fluency, DKEFS Category Fluency, DKEFS Category Shift and Brixton total errors. 
 
 Self reported self esteem as measured by the SLSC and self reported social problem 
solving style as measured by the SPSI were also compared between groups.  The 
relationship between social problem solving and self esteem, set shifting and 
inhibition was also investigated using correlational analysis in the Additional Results 
Chapter (Chapter 6). 
 
5.7.4 Missing Data 
Missing data were treated as follows:  
Missing values were found in the items of both the SCL-90 and SPSI-R for two 
participants.  These missing items were replaced by the participant’s average value 
for the existing items on that subscale assuming that no more than 2 items were 
missing from a subscale.  Neither questionnaire had more than 1 missing value per 
participant in the collected data.  One BN participant failed to complete the SPSI, 
YBOCS or SLSC.  This participant was excluded from analyses of these variables. 
 
5.8 Statistical Power and Sample Size 
The issue of limited power due to small sample sizes has been highlighted in many 
recent reviews of neuropsychological impairment in BN, as a major limitation 
present in most of the current research (Roberts et al., 2007; Van den Eynde et al., 
2011).  Only 13 of 37 studies included in a recent systematic review of 
neuropsychological impairment in BN patients, had sample sizes of 26 or greater, 
which is a necessary sample size to detect large effect sizes between two groups 
using t-tests with 80% power and a 0.05 two-tailed significance level (Van den 
Eynde et al., 2011).  Effect sizes found in comparisons between BN groups and 





No studies were found that compared bulimic and anxious or depressed groups on 
similar measures of cognitive abilities, from which to estimate an expected effect 
size for the comparisons in this study.  An appropriate sample size was determined 
by first estimating an expected effect size from the literature. Means and standard 
deviations for samples of people diagnosed with bulimia, anxiety and depressive 
disorders were obtained from existing literature, relating to the a priori key subscales 
of the WCST.  Effect sizes were estimated using these data and subsequently 
appropriate sample sizes were determined using the parameters of a power of 80% 
and a 0.05 two-tailed significance level (using GPower 3.1.2).  Difficulties related to 
these comparisons are reported in section 5.8.1. 
 
Effect sizes estimated for  the variable ‘categories completed’ were calculated using 
data from Alvarez-Moya et al. (2009) and Roberts et al. (2010) in samples of 
patients with BN, and from Stordal et al. (2004) and Merriam et al. (1999) in 
samples of patients with depressive symptoms.  Effect sizes estimated from this data 
ranged from 0.78 to 1.2 and group size determined ranged from 12 participants per 
group to 27 participants per group. 
 
Effect sizes estimated for the variable ‘perseverative errors’ were calculated using 
data from Galderisi et al. (2011) for a BN sample, from Merriam et al. (1999) and 
Stordal et al. (2004) for samples of patients with depressive symptoms and from 
Boldrini et al. (2005) and Abbruzzese et al. (1995) for samples of patients with 
anxiety disorders. Effect sizes estimated from this data ranged from 0.14 to 0.76 
comparing samples of patients with BN to those with anxiety disorders, and from 
0.806 to 1.06 comparing samples of patients with BN and  depression.  These effect 
sizes lead to proposed sample sizes of 14, 15, 21, 28, 123 and 781 participants per 
group.  
 
In light of the varied sample sizes determined from the data, a maximum sample size 
of 40 participants was chosen for each group.  A sample size of 26 was determined to 





5.8.1 Difficulties identifying appropriate data for use in determining sample 
size 
Unfortunately, as has been pointed out in many review papers (Van den Eynde et al., 
2011; Zakzanis et al., 2010), it is a limitation of the available research that tests have 
been chosen and results reported in such a way that direct comparisons between 
papers are difficult.  In reviewing recent studies, it was found that even when the 
same test measures are used, some studies may report medians, while some report 
means; some report a combined or composite scores such as TMT B-A, while others 
report B and A separately.  As such, comparison of means and standard deviations 
across the areas of eating disorders, anxiety disorders and depression, was only 
possible for some of the a priori key measures and for some patient samples in order 







Chapter 6:  Additional Results 
Analyses of data relating to Aims 1 and 2 of the Thesis project are described in 
Chapter 4. Further analysis of these data, including the assessment of normality, is 
described below.  Analysis of measures not chosen as a priori key measures, but 
included in the research are also described here.  Following this, analysis related to 
Aim 3 of the thesis, exploring social problem solving and self esteem in the BN and 
AD groups is reported.    
6.1 Further analysis of data presented in Chapter 4 
6.1.1 Assessing Normality of the Data 
The a priori variables were assessed for the assumptions of normality by examining 
the Z scores of skewness and kurtosis, the Shapiro-Wilkes test of normality and 
Levene’s test of equal variance between the BN group and the AD group (see Table 
6.1).  Results indicated that only the variable Stroop interference, met the 
assumptions of normality in both groups.  The variable TMT condition 4 also met the 
assumptions of normality but only in the BN group.  All other variables analysed 
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(.94) 10.8† 0.595 .001*  
ns = non-significant, Z = value/SE,  






6.1.2 Further details on analysis of Age normed scaled scores for a priori 
variables 
As described in Chapter 4, the BN group was significantly younger than the AD 
group.  Therefore, differences between the groups on age normed scaled scores were 
investigated on neuropsychological measures, where such scaled scores were 
available.  These data were non-normal for all but CWIT inhibition, therefore Mann 
Whitney U tests were used in the majority of comparisons.  Further detail of these 
comparisons is provided here. 
WCST perseverative errors scaled scores (SS) did not differ significantly between 
the BN group (Mdn=97) and the AD group (Mdn=96), U=202.5, Z=-.918, ns, r =-
0.14.  The BN group (Mdn=10) also did not differ significantly from the AD group 
(Mdn=11) on TMT condition 4 scaled scores, U=205.5, Z=-.857, ns, r = -.13.  
Differences between the BN group (M=11.24, SD=2.68) and the AD group 
(M=10.74, SD=3.25) were non-significant on CWIT inhibition, t(42)=0.552, p=.584, 
r=.007, and on CWIT inhibition switch (BN median =12, AD median = 11), U=173, 
Z=-1.62, ns, r=-25. These results still indicate the non-significant effects seen when 
using non age corrected variables.  
 
6.1.3 Relationship of general and eating psychopathology 
A number of associations between general psychopathology and eating disorder 
psychopathology were seen in the BN group.  A significance level of p < .01 was 
chosen, as a Bonferroni correction was considered too conservative for this analysis.  
Increased Eating Restraint was associated with increased depression among BN 
participants.  Increased Restraint was also associated with increased distress on the 
‘Additional’ subscale of the SCL-90-R, which contains items related to sleep and 
appetite disturbance.  Increased Eating Concern was significantly associated with 
obsessive-compulsive symptoms as measured by the SCL-90-R but not by the 
YBOCS, and with higher distress on the ‘Additional’ scale.  Weight concern was 
significantly associated with increased scores on the ‘Additional’ scale and the 
Positive Syndrome Distress Index.  Only Shape Concern was not significantly 




Table 6.2  Correlation of general and eating psychopathology in BN group 
 YBOCS EDE 
 Restraint Eating Shape Weight 
SCL-90      
O-C .114 .272 .459** .332* .403* 
Depression -.011 .426** .390* .254 .364* 
Anxiety .255 .301 .355* .365* .294 
Phobia .158 .230 .156 .212 .412* 
Somatisation .216 .252 .297 .350* .284 
Hostility .001 -.106 .139 .095 .075 
I-S .124 .103 .189 .005 .137 
Paranoia -.033 -.025 .168 .069 -.030 
Psychoticism .361* .139 .284 .275 .257 
Additional .102 .457** .475** .295 .537** 
GSI .208 .307 .388* .360* .377* 
PSDI .117 .272 .373* .402* .419** 
Y-BOCS 1.000 .038 .160 .096 -.043 
O-C = obsessive-compulsive scale, I-S = interpersonal sensitivity 
*p<.05, ** p<.01, PSDI=Positive Syndrome distress index, GSI = Global Severity Index  
 
In the AD group, there was only one significant relationship between eating 
pathology and general pathology.  Increased Eating Restraint was associated with 
lower Phobic anxiety as measured by the SCL-90-R, however this did not appear to 





Table 6.3  Correlation of general and eating psychopathology in AD group 
 YBOCS EDE 
 Restraint Eating Shape Weight 
SCL-90      
O-C .213 -.089 .270 .242 -.033 
Depression .202 -.249 .168 .231 -.041 
Anxiety .225 -.355* .099 .065 -.221 
Phobia .118 -.538** -.110 .095 -.156 
Somatisation -.021 -.265 -.113 .004 -.195 
Hostility .258 -.037 .156 .267 .026 
I-S .212 -.222 .137 .270 -.013 
Paranoia .181 -.101 .142 .212 .199 
Psychoticism .358* -.189 .311 .348* .001 
Additional .256 -.185 .197 .228 -.083 
GSI .290 -.288 .185 .237 -.082 
PSDI .274 -.244 .204 .261 -.057 
Y-BOCS 1 .045 .125 .207 -.106 
O-C = obsessive-compulsive scale, I-S = interpersonal sensitivity 
*p<.05, ** p<.01, PSDI=Positive Syndrome distress index, GSI = Global Severity Index  
 
6.1.4 Clinically Significant Impairment 
17 patients (81%) from the BN group and 18 (78%) from the AD group performed at 
least 1 standard deviation (SD) below their estimated premorbid ability on one or 
more a priori measure.  Underperformance relative to estimated premorbid ability on 
3 or more measures was defined as impaired, relative to estimated premorbid ability.  
Seven from the BN group and 12 from the AD group demonstrated 
underperformance on 3 or more measures (Table 6.4).  
Impaired performance relative to normative data was defined as performance at 2 
SDs or more below the normative mean on one or more measures.  Five people from 
the AD group and 3 from the BN group were impaired relative to normative data.  
These participants were also impaired relative to past ability. 
The measures on which the underperformance and impaired performance occurred 





Table 6.4: Number of participants demonstrating underperformance and 
impairment 
 Underperformance on 
at least 1 measure 
(%) 
Underperformance on 
3 or more measures 
(%) 
Impaired relative to 
normative group on 1 
or more measure (%) 
BN Anx/Dep BN Anx/Dep BN Anx/Dep 
Set Shifting       
WCST  
   Perseverative errors 9 (43) 14  (61) 7 (33) 11 (48) 0 1 (4) 
   Categories completed 10 (48) 13 (57) 7 (33) 12 (52) 2 (10) 1 (4) 
DKEFS       
  Trail Making test 
  Number/letter switch 6 (29) 3 (13) 3 (14) 2 (9) 0 1 (4) 
  Trail Making test 
  Number of errors 2 (10) 4  (17) 2 (10) 4 (17) 0 1 (4) 
Inhibition       
WCST   
   Non-perseverative 
errors 11 (52) 14 (61) 7 (33) 12 (52) 3 (14) 2 (9) 
  Colour Word  
  Inhibition  4 (19) 6  (26) 2 (10) 4 (17) 0 1 (4) 
Hayling 
Errors 1 (5) 2 (9) 1 (5) 2 (9) 0 1 (4) 
Total Number of 
individuals  17 (81) 18  (78) 7 (33) 12 (52) 3 (14) 5 (22) 
 
Those defined as impaired relative to past ability were significantly younger than 
unimpaired participants (U=119.5, Z=-2.799, p < .05), scored lower on EDE restraint 
(U= 126, Z = -2.657, p < .05), had higher estimated premorbid IQ (t(42) = 3.82, p 
<.05) and scored lower on the YBOCS (t(442) = 2.42, p < .05).  There was no 
difference in BMI, years of education or SCL-90-R subscales anxiety, depression or 
obsessive compulsive symptoms.  
Individuals from either group with a deficit relative to normative data were not 
significantly different to the rest of the participants (all p>.05) on age, BMI, 
premorbid IQ, years of education, EDE restraint, SCL-90-R subscales of anxiety, 
depression, obsessive compulsive symptoms or the YBOCS. 
The proportions of each group who were impaired relative to normative data (p = 





6.1.5 Relationships between performance on different neuropsychological 
measures 
In the BN group, there were no significant correlations of set shifting measures with 
each other after a correction for multiple comparisons of p < .01 was applied, 
although increased perseverative errors were associated with fewer categories 
completed, at the level of p < .05.  However, non-perseverative errors were 
significantly correlated with categories completed, indicating that increased non 
perseverative errors was strongly related to fewer categories being completed by BN 
participants.  No significant correlations were found between the inhibition 
measures, suggesting that participants in the BN group did not perform in a similar 
way on all the inhibition measures (Table 6.5).   
 
Table 6.5 Relationship between performance on set shifting and inhibition 
measures in the BN group 
 WCST DKEFS TMT WCST CWIT Hayling 
PE CC N/L switch Errors NPE Inhibition Errors 
Set Shifting        
WCST 
   Perseverative errors (PE) 
 -.467* .138 .255 .632* 
-.128 -.101 
  Categories completed (CC) -.467*  .037 -.084 -.646** .373* .195 
DKEFS        
  Trail Making test 
  Number/letter switch 
.138 .037  .247 .170 
.329* .093 
  Trail Making test   No. of 
errors 
.255 -.084 .247  .132 
-.041 -.414* 




.632* -.646** .170 .132  
-.077 -.076 
DKEFS   
   Colour Word   Inhibition  
-.128 .373* .329* -.041 -.077 
 .237 
Hayling Errors -.101 .195 .093 -.414* -.076 .237  
*p<.05, ** p<.01 
 
In the AD group, there were no significant correlations between measures of 
inhibition.  However, a trend was seen relating increased WCST non-perseverative 
errors with longer times to complete the CWIT inhibition condition.  Measures of set 




indicating that participants who performed poorly on one set shifting task also 
showed impairment across the others.  However, the number of errors on TMT 
number/letter switch was not correlated with other set shifting measures, which 
suggests that it may not reflect the same difficulties as the other set shifting 
measures.  
There were also significant correlations between inhibition and set shifting measures, 
as increased non-perseverative errors were associated with increased time to 
complete the TMT number/letter switch task and increased perseverative errors.  
This indicates that participants who performed poorly on set shifting tasks also 
committed more non-perseverative errors, suggesting that their cognitive inhibition 
was also impaired. 
Unlike the BN group, correlations within the AD group indicate that both 
perseverative and non-perseverative errors contributed approximately the same 
amount to impaired category completion among AD participants (Table 6.6). 
 
Table 6.6 Relationship between performance on set shifting and inhibition 
measures in the anxious and/or depressed group 
 WCST DKEFS TMT WCST CWIT Hayling 
PE CC N/L switch Errors NPE Inhibition Errors 
Set Shifting        
WCST 
   Perseverative errors (PE) 
 -.666** .490** .208 .717** 
.288 .163 
  Categories completed (CC) -.666**  -.447** -.147 -.691** -.312 -.215 
DKEFS        
  Trail Making test 
  Number/letter switch 
.490** -.447**  .286 .435** 
.217 .212 
  Trail Making test   No. of 
errors 
.208 -.147 .286  .151 
.314 .149 




.717** -.691** .435** .151  
.346* .168 
DKEFS   
   Colour Word   Inhibition  
.288 -.312 .217 .314 .346* 
 .071 
Hayling Errors .163 -.215 .212 .149 .168 .071  




6.2 Non-key Executive function measures and additional 
subscales of the SCL-90-R 
The groups were compared on the Brixton task and the three conditions of the 
DKEFS Verbal Fluency task, which formed part of the neuropsychological battery, 
but were not chosen as a priori measures.  No significant differences were observed 
between the groups on the Brixton task or the three tasks of Verbal Fluency.  Similar 
levels of psychopathology symptoms, on the paranoia, psychoticism and ‘additional’ 
subscales of the SCL-90-R were also seen in the two groups (Table 6.7).   
 
6.3 Analysis Relating to Aim 3 - Social Problem Solving and Self 
Esteem 
The self esteem and social problem solving styles of the BN and AD participants 
were investigated using the Self-Liking/Self Competence scale (SLSC) and the 
Social Problem Solving Inventory (SPSI).   
6.3.1 Social Problem Solving Style 
The dimensions identified by the Social Problem Solving Inventory are Positive 
Problem Orientation (PPO), Negative Problem Orientation (NPO), Rational Problem 
Solving (RPS), Impulsivity/Carelessness style (ICS) and Avoidance style (AS).  
Adaptive social problem solving is indicated by the subscales PPO and RPS.  
Maladaptive problem solving is indicated by subscales NPO, ICS, AS.  The SPSI 
provides standard scores for each dimension of social problem solving with a mean 
of 100 and a standard deviation of 15.   
Both groups obtained mean scores one standard deviation lower than the normative 
group on PPO and one standard deviation higher than the normative group in NPO, 





Figure 6.1 Social Problem Solving Styles of the BN group 
 
 
Figure 6.2 Social Problem Solving Styles of the AD group 
 
6.3.2 Group comparisons of self esteem and social problem solving 
As all the variables were found to be normally distributed, t-tests were used to 
compare groups.  The age standardised scores for the SPSI were used for the 

















































The BN group indicated significantly lower self liking and sense of self competence  
than the anxious/depressed group, illustrated on the total score of the Self Liking/Self 
Competence scale (t(41)=-2.824, p < .01) and on its individual scales, Self liking 
(t(41)=-2.674, p < .05) and Self competence (t(41)=-2.417, p <.05).  The two groups 








Table 6.7: Comparison of groups on additional psychological variables and non key executive function measures 
 
Bulimic group n=21 Anxiety/Depression group n=23    Cohen’s  
Mean SD Median (range) Mean SD Median (range) t U p d r 
Psychological Variables            
SCL-90-R (PSDI) 2.35 0.71  2.12 .60  1.16  .254 0.35  
Paranoia 6.81 6.87 5 (0-25) 4.91 3.82 5 (0-13)  212 .493  -0.11 
Psychoticism 6.52 5.87 5 (0-21) 6.39 5.65 5 (0-20)  234.5 .875  -0.02 
Additional 12.52 6.97  9.48 5.62  1.60  .117 0.48  
SPSI-R
a
            
PPO 79.35 18.93  75.96 15.59  0.645  .523 0.20  
NPO 115.95 18.20  119.09 19.41  0.544  .589 -0.17  
RPS 85.3 12.17  85.74 13.63  0.111  .912 -0.03  
I-CS 101.65 14.21  100.30 11.86  0.338  .737 0.10  
Avoidance style 106.20 15.28  112.22 13.58  1.367  .179 -0.42  
Global Score 87.55 17.62  81.74 13.41  1.226  .227 0.37  
SLSC
a
            
Self liking 15.25 4.89  19.30 5.01  2.674  .011* -0.82  
Self Competence 17.55 6.18  21.6 4.82  2.417  .020* -0.73  
Total Score 32.8 9.75  40.9 9.08  2.824  .007** -0.86  
Neuropsychological Variables            
DKEFS Verbal Fluency            
  Letter Fluency 42.71 10.12  39.48 12.51  0.94  .354 0.28  
 Category Fluency 45.19 7.96  41.65 8.94  1.38  .175 0.42  
 Category Shift, total switching acc 14.33 3.69  13.78 3.04  0.54  .591 0.16  
Brixton errors 12.62 3.35  21.57 34.90  1.17  .249 -0.36  
a one participant failed to complete the SPSI-R and the SLSC, therefore n=20 in the BN group on these measures 




6.3.3 Relationship between a priori variables and Social Problem Solving  
A significance level of p < .01 was chosen, as a Bonferroni correction was 
considered too conservative for the analysis.  Social problem solving was not 
significantly related to any of the neuropsychological measures in the BN group 
(Table 6.8).   
 
Table 6.8: Correlation of Social Problem Solving Patterns and a priori variables 
in the BN group 
 Adaptive Problem 
Solving 
Maladaptive Problem Solving 
PPO RPS NPO ICS AS 
Set Shifting      
WCST 
   Perseverative errors .134 -.066 -.060 -.245 -.045 
   Categories completed .057 .073 .136 .244 -.008 
DKEFS      
  Trail Making test 
  Number/letter switch .114 -.199 .001 -.157 -.098 
  Trail Making test   No. of 
errors .099 -.212 .270 -.183 -.122 
Inhibition      
WCST 
   Non-perseverative errors .077 .055 -.022 -.154 .083 
DKEFS   
   Colour Word   Inhibition  .097 .097 .059 .130 .070 
Hayling Errors -.026 .033 -.265 .131 .053 
*p<.05, ** p<.01 PPO = Positive Problem Orientation, RPS = Rational Problem Solving, NPO = 
Negative Problem Orientation, ICS = Impulsivity/Carelessness Style, AS = Avoidance Style 
 
Within the AD group, trends of association were seen that were not significant at the 
chosen p <.01 level.  There was a trend of association between NPO and WCST 
categories completed and between Impulsivity/Carelessness style and errors on the 
Hayling task.  Endorsement of rational problem solving strategies showed a trend of 
association with fewer errors on the TMT.  Upon visual inspection of graphs, there 





Table 6.9 Correlation of Social Problem Solving Patterns and a priori variables 
in the AD group 
 Adaptive Problem 
Solving 
Maladaptive Problem Solving 
PPO RPS NPO ICS AS 
Set Shifting      
WCST 
   Perseverative errors .137 -.176 -.099 -.107 .055 
   Categories completed -.134 .152 .364* -.058 -.108 
DKEFS      
  Trail Making test 
  Number/letter switch .238 -.171 -.144 -.069 .001 
  Trail Making test   No. of 
errors .303 -.401* .241 -.057 -.318 
Inhibition      
WCST 
   Non-perseverative errors .127 -.143 -.074 -.075 -.051 
DKEFS   
   Colour Word   Inhibition  -.040 -.020 .120 .012 -.065 
Hayling Errors .222 -.062 -.085 .320* -.005 
*p<.05, ** p<.01 PPO = Positive Problem Orientation, RPS = Rational Problem Solving, NPO = 
Negative Problem Orientation, ICS = Impulsivity/Carelessness Style, AS = Avoidance Style 
 
6.3.4 Relationship between a priori variables and Self-Liking and Self-
Competence 
No relationships were found between reported self liking or self competence and 





Table 6.10: Association between a priori variables and self liking/self 
competence  
 BN Group AD Group 
SL SC Tot SL SC Tot 
Set Shifting       
WCST 
   Perseverative errors .184 .172 .160 .185 .128 .188 
   Categories completed -.049 .049 .072 -.287 -.213 -.273 
DKEFS       
  Trail Making test 
  Number/letter switch .309 .292 .284 .279 .283 .295 
  Trail Making test   No. of 
errors .114 .303 .271 .182 .143 .219 
Inhibition       
WCST 
   Non-perseverative errors .176 .038 .033 .131 .046 .123 
DKEFS   
   Colour Word   Inhibition  .249 -.005 .086 .033 -.057 -.008 
Hayling Errors .171 .013 .071 -.014 .050 .001 






Chapter 7: Additional Discussion 
Further analysis was performed on the data presented in Chapter 4 and data relating 
to two additional measures of set shifting and measures of self esteem and social 
problem solving were analysed in Chapter 6.  The findings of these analyses will 
now be discussed in the order they were presented in Chapter 6.  
7.1 Age differences between groups 
Participants in the BN group were significantly younger than patients in the AD 
group.   This difference was most likely related to the fact that the average age of 
onset of bulimia (20yrs) is younger than average onset of depression (30yrs), GAD 
(31 yrs) or Panic Disorder (24yrs) although not of OCD (19yrs) (Hudson et al., 2007; 
Kessler et al., 2005).  As such, these age differences are likely to represent inherent 
characteristics of the two groups.  An analysis of key variables using age normed 
scaled scores revealed a similar pattern of results to those using raw scores, 
suggesting that age did not influence the pattern of results.    
7.2 Relationships of general and eating pathology 
In the BN group, there were a number of correlations indicating significant 
relationships between eating disorder symptoms and psychopathology.  This is 
consistent with the literature reporting a high level of comorbidity between BN and 
other disorders (Hudson et al., 2007) and associations found in the literature such as 
Herpertz-Dahlmann and Remschmidt’s (1993) report of a high correlation between 
depression and eating disorder symptoms.  
In the AD group, there was no significant relationship between eating pathology and 
general pathology.  This is to be expected, as the AD group were chosen to be 
without problematic levels of eating disorder symptoms (EDE < 4).   
7.3 Clinically significant impairment 
Clinical significance calculations indicated that very few participants in each group 
were impaired on any neuropsychological test compared to normative data.  Similar 
proportions of participants in each group underperformed and demonstrated 
impairments in relation to normative data.  Overall, the performance of each group 




participants were underperforming relative to their own estimated premorbid ability. 
This is consistent with many findings of no impairments relative to controls in 
studies of BN, anxiety and depression on executive function tasks (Brand et al., 
2007; Claes et al., 2006; McClintock et al., 2010).  Most participants in the AD 
group used here were diagnosed with GAD, specific phobia or panic disorder with or 
without comorbid depression. The literature would suggest that a group of this 
composition would not have specific deficits in set shifting or inhibition (Airaksinen 
et al., 2005; Chapter 2 of this thesis; O'Toole & Pedersen, 2011).  Findings of 
relatively few participants who were significantly impaired among a sample of eating 
disorder patients is consistent with the literature.  Approximate proportions of 65% 
unimpaired and 35% impaired were reported by Lauer et al. (1999) in relation to 
their own study of BN and AN and in their discussion of other eating disorder studies 
(Kingston et al., 1996). 
When considering performance among the impaired participants, different patterns 
were seen.  Participants in the AD group were impaired across all a priori measures, 
while BN participants were exclusively impaired on WCST non-perseverative errors 
(NPE) and number of categories completed (CC).  A pattern similar to this in BN 
participants was reported by Alvarez-Moya et al. (2009), where BN participants 
made significantly more non-perseverative errors than healthy controls.  Barceló and 
Knight (2002) have suggested that WCST NPE can reflect random errors relating to 
impairments in maintaining set, due to distractibility or impulsivity.  In their sample 
of patients with prefrontal lobe injuries, the CC score, which is often taken to relate 
to set shifting errors, was in fact more commonly lowered due to failure to continue 
with a correct responding pattern.  This implies that where NPE is impaired, 
impaired CC may not indicate set shifting difficulties but is rather a consequence of 
the high number of NPEs. There is a ‘failure to maintain set’ scale in the WCST, 
which measures a similar construct, but this only counts errors after five or more 
correct matches.  NPE may reflect shorter durations of set-consistent responding.  
Although these impairments suggest the presence of cognitive disinhibition, similar 
impairments relative to normative data were not seen on the other measures of 




7.4 Relationships between performance on neuropsychological 
measures 
Set shifting measures correlated with each other in the AD group but not in the BN 
group.  This analysis suggests (in addition to the clinical impairment analysis) that 
despite non-significant differences between groups, the style of performance was 
different in each group.   
In the BN group, there were no significant correlations of set shifting measures with 
each other, after a correction for multiple comparisons, nor were inhibition measures 
correlated with each other.  However, non-perseverative errors were significantly 
correlated with categories completed.  This indicates that increased non perseverative 
errors were strongly related to fewer categories being completed by BN participants, 
and supports the idea that a low number of categories completed is related to loss of 
set, rather than perseverative set maintenance, in this group.  
In the AD group, there were no significant correlations between measures of 
inhibition, suggesting that AD participants performed differently on each measure of 
inhibition.  Measures of set shifting tended to be significantly correlated with each 
other, suggesting that participants who performed poorly on one set shifting task also 
displayed impairment across other set shifting tasks.  However, the number of errors 
on TMT number/letter switch task was not correlated with the other set shifting 
measures, which suggests that participants in the AD group did not perform on it in 
the same way as they did on the other set shifting measures.  Many 
neuropsychological measures can be said to assess a number of cognitive functions 
(Burgess, 2003).  In this case, the number of errors on the TMT number/letter switch 
task may not have been primarily tapping into the same ability as the other set 
shifting tasks in the AD group.   
There were significant correlations between inhibition and set shifting measures in 
the AD group, as increased non-perseverative errors were associated with increased 
time to complete the TMT number/letter switch task.  This suggests that participants 
who performed poorly on set shifting tasks also committed more non-perseverative 
errors and indicates that patients with set shifting impairments in this group may also 




Unlike the BN group, where only NPE made a significant contribution to the 
categories completed variable in the WCST, in the AD group both perseverative and 
non-perseverative errors contributed approximately the same amount to impaired 
category completion. 
7.5 Non-key Executive Function Measures 
No group differences were found on the additional measures of verbal fluency and 
set shifting, which is consistent with the lack of group differences on set shifting 
measures reported in Chapter 4.  It is also consistent with literature that indicates that 
the performance of BN patients on the FAS task is not different to controls (Brand et 
al., 2007; Tchanturia, Anderluh, et al., 2004).   
7.6 Aim 3 – Social Problem Solving and Self Liking/Self 
Competence 
Both groups were found to have social problem solving styles characterised by low 
positive problem orientation and high negative problem orientation. This similarity is 
consistent with the literature which suggests that BN participants would display high 
negative problem orientation (NPO) (Paterson et al., 2011), and that high NPO has 
also been associated with depression (Klein et al., 2011) and high levels of worry 
(Belzer et al., 2002).  These findings suggest that maladaptive social problem solving 
is not specific to BN and may be related to other shared factors such as anxiety and 
depression symptoms. 
No significant differences were found in social problem solving style between the 
two groups. Social problem solving style was also not related to neuropsychological 
task performance among BN participants or AD participants.  
Self esteem, as measured by the Self Liking/Self Competence scale was significantly 
lower in the BN group than in the comparison group of females with anxiety and/or 
depressive disorders.  This is consistent with reports in the literature of low self-
liking and self competence in AN groups relative to healthy controls (Paterson et al., 
2011; Paterson et al., 2007).  It is not consistent with similar reports of low self 
esteem in anxiety and depression (Silverstone & Salsali, 2003).  However, neither 




performance on set shifting or inhibition tasks in either group.  At the time of 
writing, no literature could be found that explored this association.  However, the 
literature on self liking and self competence suggests that self competence is 
associated with perfectionism in AN (Gordon et al., 2005; Surgenor et al., 2007), and 
as perfectionism is associated with impaired set shifting (Egan et al., 2011; 
Tchanturia, Morris, et al., 2004), some relationship may have been expected between 
self-competence and set shifting performance.  However, as has been demonstrated 
in a number of studies, AN and BN do not perform in the same way on 
neuropsychological measures (Murphy et al., 2004; Roberts et al., 2010), so these 
findings for AN may not be applicable in a BN group. 
Fairburn et al.’s (2003) cognitive behavioural model of BN includes severe 
perfectionism, core low self esteem, mood intolerance and interpersonal difficulties 
as maintenance mechanisms for the disorder.  In relation to this model of BN,  these 
data demonstrate evidence for three of these maintaining factors.  Participants in the 
BN group demonstrated significantly lower self esteem than a comparison group 
suffering from psychological distress.  Perfectionism, in the form of obsessive 
compulsive traits, may be present at a higher level in the BN group as trends were 
seen (Chapter 4), however they were not found to be significant.  Interpersonal 
difficulties also showed a trend towards being increased in the BN group on the 
interpersonal sensitivity scale of the SCL-90-R and the BN group demonstrated 
higher negative problem orientation and lower positive problem orientation than the 
normative group on the SPSI.   
7.7 Limitations 
Limitations were described in the journal article in Chapter 4. 
7.8 Implications and future directions 
In AN, set shifting impairments have been found to impact on Cognitive Behavioural 
Therapy (CBT) treatment.  Cognitive remediation therapy has been used to improve 
cognitive flexibility and facilitate the implementation of CBT strategies with patients 
with anorexia (Tchanturia et al., 2008).  In light of the suggestion that BN 
participants’ impairment on WCST categories completed may not relate to set 




not support a need for cognitive remediation in most cases of BN.  The trends 
relating to deficits in WCST non-perseverative errors suggest cognitive impulsivity 
may be a significant problem for a proportion of people with BN and as such, this 
study supports the possible use of some form of cognitive control training in the 
treatment of BN, as proposed by Robinson et al. (2009). 
The finding of small proportions of a BN group demonstrating neuropsychological 
impairments has been seen in other studies (Lauer et al., 1999) and suggests that 
future research may best utilise large sample sizes to investigate this small proportion 
of the BN population and any characteristics that may define them.  Larger sample 
sizes would also facilitate investigation of small to medium differences that may 
exist between BN groups and groups representing disorders commonly comorbid 
with BN.   
7.9 Conclusion 
Eating pathology was be related to anxiety and depression symptoms in the BN 
group but not the AD group.  Further analysis indicated that few participants in either 
group were impaired in relation to normative data on neuropsychological measures. 
This evidence suggests that cognitive performance difficulties are not widespread in 
BN or related to anxiety, depression or obsessive compulsive symptoms. There was 
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Appendix 2 Systematic Review Database Search Terms 
Embase Search Terms 
1     cognition/ or attention/ or executive function/ or learning/ or memory/ or mental 
capacity/ or mental performance/ or orientation/ or social cognition/ or "theory of 
mind"/ or thinking/ 
2 neurocognition.mp. [mp=title, abstract, subject headings, heading word, drug 
trade name, original title, device manufacturer, drug manufacturer, device trade 
name, keyword] 
3 exp task performance/ or exp attention/ or exp learning/ or exp cognition/ 
4 "inhibition (psychology)"/co [Complication] 
5 inhibition.mp. [mp=title, abstract, subject headings, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, 
keyword] 
6 central coherence.mp. [mp=title, abstract, subject headings, heading word, drug 
trade name, original title, device manufacturer, drug manufacturer, device trade 
name, keyword] 
7 exp cognitive defect/ 
8 exp memory/ or exp short term memory/ or exp autobiographical memory/ or 
exp procedural memory/ or exp spatial memory/ or exp auditory memory/ or exp 
associative memory/ or exp tactile memory/ or exp working memory/ or exp 
visual memory/ or exp explicit memory/ or exp implicit memory/ or exp sensory 
memory/ or exp memory disorder/ or exp declarative memory/ or exp verbal 
memory/ or exp long term memory/ or exp semantic memory/ or exp episodic 
memory/ 
9 decision making.mp. or exp decision making/ 
10 exp motor control/ 
11 exp spatial discrimination/ or exp hemispheric dominance/ or exp task 
performance/ 
12 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 
13 Neuropsychological test.mp. or exp neuropsychological test/ 
14 12 or 13 
15 exp anxiety/ or exp anxiety neurosis/ or exp generalized anxiety disorder/ or exp 
anxiety disorder/ or exp "mixed anxiety and depression"/ 




17 exp agoraphobia/ 
18 exp social phobia/ or exp phobia/ 
19 exp posttraumatic stress disorder/ 
20 exp obsession/ or exp obsessive compulsive disorder/ or exp compulsion/ 
21 social anxiety.mp. 
22 15 or 16 or 17 or 18 or 19 or 20 or 21 
23 14 and 22 
24 limit 23 to (english language and yr="1980 -Current") 
25 13 and 24 






Medline Search Terms 
1 exp Cognition/ or exp Cognition Disorders/ or exp Neuropsychological Tests/ or 
neurocognition.mp. 
2 attention.mp. or exp Attention/  
3 exp Problem Solving/ or executive function.mp. or exp Executive Function/ or 
exp Mental Processes/ 
4 exp Association Learning/ or exp Learning/ or exp Paired-Associate Learning/ 
or learning.mp. or exp Discrimination Learning/ or exp Verbal Learning/  
5 memory.mp. or exp Memory/ or exp Memory, Long-Term/ or exp Memory, 
Episodic/ or exp Memory Disorders/ or exp Memory, Short-Term/  
6 exp Mental Competency/ or exp Decision Making/ or exp Mental Processes/ or 
mental capacity.mp. or exp Intelligence/  
7 exp Psychomotor Performance/ or mental performance.mp.  
8 orientation.mp. or exp Orientation/  
9 exp Social Perception/ or social cognition.mp.  
10 theory of mind.mp. or exp "Theory of Mind"/  
11 thinking.mp. or exp Thinking/  
12 task performance.mp. or exp "Task Performance and Analysis"/  
13 inhibition.mp. or exp "Inhibition (Psychology)"/  
14 central coherence.mp.  
15 decision making.mp. or exp Decision Making/  
16 exp Motor Skills/ or motor control.mp.  
17 exp Visual Perception/ or exp Pattern Recognition, Visual/ or visuospatial 
processing.mp.  
18 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 
or 17  
19 exp Anxiety/ or exp Anxiety Disorders/ or anxiety.mp.  
20 generalised anxiety disorder.mp.  
21 (mixed anxiety and depression).mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, protocol supplementary concept, rare 
disease supplementary concept, unique identifier]  
22 exp Panic Disorder/ or exp Panic/ or panic.mp.  
23 agoraphobia.mp. or exp Agoraphobia/  
24 phobia.mp. or exp Phobic Disorders/  
25 social anxiety.mp.  




27 obsessive compulsive disorder.mp. or exp Obsessive-Compulsive Disorder/  
28 ocd.mp.  
29 obsession.mp. or exp Obsessive Behavior/  
30 exp Compulsive Behavior/ or compulsion.mp.  
31 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30  
32 Neuropsychological test.mp. or exp Neuropsychological Tests/ 
33 18 and 31 and 32  
34 limit 33 to (english language and yr="1980 -Current" and "all adult (19 plus 
years)" and humans)  







PsycInfo Search terms 
1 exp Cognition/ or exp Cognition Disorders/ or exp Neuropsychological Tests/ or 
neurocognition.mp.  
2 attention.mp. or exp Attention/ 
3 exp Problem Solving/ or executive function.mp. or exp Executive Function/ or 
exp Mental Processes/ 
4 exp Association Learning/ or exp Learning/ or exp Paired-Associate Learning/ 
or learning.mp. or exp Discrimination Learning/ or exp Verbal Learning/  
5 memory.mp. or exp Memory/ or exp Memory, Long-Term/ or exp Memory, 
Episodic/ or exp Memory Disorders/ or exp Memory, Short-Term/  
6 exp Mental Competency/ or exp Decision Making/ or exp Mental Processes/ or 
mental capacity.mp. or exp Intelligence/  
7 exp Psychomotor Performance/ or mental performance.mp.  
8 orientation.mp. or exp Orientation/ 
9 exp Social Perception/ or social cognition.mp.  
10 theory of mind.mp. or exp "Theory of Mind"/ 
11 thinking.mp. or exp Thinking/  
12 task performance.mp. or exp "Task Performance and Analysis"/ 
13 inhibition.mp. or exp "Inhibition (Psychology)"/  
14 central coherence.mp.  
15 decision making.mp. or exp Decision Making/ 
16 exp Motor Skills/ or motor control.mp.  
17 exp Visual Perception/ or exp Pattern Recognition, Visual/ or visuospatial 
processing.mp.  
18 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 
or 17  
19 exp Anxiety/ or exp Anxiety Disorders/ or anxiety.mp.  
20 generalised anxiety disorder.mp.  
21 (mixed anxiety and depression).mp. [mp=title, abstract, heading word, table of 
contents, key concepts, original title, tests & measures]  
22 exp Panic Disorder/ or exp Panic/ or panic.mp.  
23 agoraphobia.mp. or exp Agoraphobia/ 
24 phobia.mp. or exp Phobic Disorders/ 
25 social anxiety.mp. 
26 post traumatic stress disorder.mp. or exp Stress Disorders, Post-Traumatic/  




28 ocd.mp.  
29 obsession.mp. or exp Obsessive Behavior/ 
30 exp Compulsive Behavior/ or compulsion.mp.  
31 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 
32 Neuropsychological test.mp. or exp Neuropsychological Tests/ 
33 18 and 31 and 32  







PsycArticles search terms 
1 neurocognition.mp. [mp=title, abstract, full text, caption text]  
2 cognition.mp. [mp=title, abstract, full text, caption text]  
3 attention.mp. [mp=title, abstract, full text, caption text]  
4 learning.mp. [mp=title, abstract, full text, caption text]  
5 memory.mp. [mp=title, abstract, full text, caption text]  
6 mental capacity.mp. [mp=title, abstract, full text, caption text]  
7 executive function.mp. [mp=title, abstract, full text, caption text]  
8 mental performance.mp. [mp=title, abstract, full text, caption text]  
9 orientation.mp. [mp=title, abstract, full text, caption text]  
10 social cognition.mp. [mp=title, abstract, full text, caption text]  
11 thinking.mp. [mp=title, abstract, full text, caption text]  
12 theory of mind.mp. [mp=title, abstract, full text, caption text]  
13 task performance.mp. [mp=title, abstract, full text, caption text]  
14 inhibition.mp. [mp=title, abstract, full text, caption text]  
15 central coherence.mp. [mp=title, abstract, full text, caption text]  
16 cognitive defect.mp. [mp=title, abstract, full text, caption text]  
17 cognitive deficit.mp. [mp=title, abstract, full text, caption text]  
18 decision making.mp. [mp=title, abstract, full text, caption text]  
19 motor control.mp. [mp=title, abstract, full text, caption text]  
20 visuospatial processing.mp. [mp=title, abstract, full text, caption text]  
21 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 
or 17 or 18 or 19 or 20  
22 Neuropsychological test.mp. [mp=title, abstract, full text, caption text]  
23 anxiety.mp. [mp=title, abstract, full text, caption text]  
24 anxiety disorder.mp. [mp=title, abstract, full text, caption text]  
25 GAD.mp. [mp=title, abstract, full text, caption text]  
26 (mixed anxiety and depression).mp. [mp=title, abstract, full text, caption text]  
27 panic.mp. [mp=title, abstract, full text, caption text]  
28 agoraphobia.mp. [mp=title, abstract, full text, caption text]  
29 phobia.mp. [mp=title, abstract, full text, caption text]  
30 social anxiety.mp. [mp=title, abstract, full text, caption text]  
31 post traumatic stress disorder.mp. [mp=title, abstract, full text, caption text]  
32 ptsd.mp. [mp=title, abstract, full text, caption text]  
33 ocd.mp. [mp=title, abstract, full text, caption text]  




35 obsession.mp. [mp=title, abstract, full text, caption text]  
36 compulsion.mp. [mp=title, abstract, full text, caption text]  
37 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36
  
38 21 and 22 and 37  























No anxiety disorder 
n=680 
No test of cognitive 
function n=42 
Participants over 65 
n=9 
Participants under 18 
n=6 




Study protocol only 
n=1 
Less than 15 per group 
n=22 
 
No anxiety disorder 
n=1663 
No test of cognitive 
function n=109 
Participants over 65 
n=8 
Participants under 18 
n=1 










under 18 n=1 






Total Number of articles found in search over 4 databases 
n=3431 














174 1 248 40 
References combined as described in Figure 2.1 













No panic group 
n=23 
 
No anxiety disorder as 
primary difficulty n=16 
No panic group n=203 
 
No panic group 
n=1 
 
No anxiety disorder as 
primary difficulty n=43 





Appendix 4 Details of Quality Criteria 
i. Eligibility criteria are specified 
Well-covered (2) Inclusion criteria clearly detailed and appropriate 
Adequately addressed (1) Inclusion criteria are not outlined clearly, though 
they can be ascertained from the details given. 
Poorly  addressed (0) Some information is given about eligibility for the 
trial, though it could not be confidently replicated. 
Not  addressed (0)  
ii. Comparison group is matched 
Well-covered (2) A suitable comparison group is matched on age, 
gender, education or IQ  
Adequately addressed (1) Group only matched on some of the above. 
Poorly addressed (0) Not matched/ no details given 
Not addressed (0)  
 
iii. Diagnosis using appropriate criteria and measure 
Well-covered (2) Diagnosis (or absence of diagnosis for HCs) 
ascertained by DSM/ICD criteria, structured 
interview by clinician 
Adequately addressed (1) Diagnosis by DSM/ICD criteria, using questionnaire 
based on DSM/ICD criteria 
Poorly addressed (0) Unspecified diagnosis procedure or questionnaire not 
specifically designed to reflect diagnostic criteria 
Not addressed (0)  
 
iv. Neuropsychological Measures are robust 
Well-covered (2) Outcome measures robust for this population (valid, 
reliable)  
reliability and validity specified in paper or easily 
obtainable using Lezak et al.’s (2004) reference text 
or reference provided in the paper. 
Adequately addressed (1) Tests well described but reliability and validity not 
found as described in under ‘well covered’. 
                 or 
Tests well described with reliability and validity 
given but not the most valid for this population  
Poorly addressed (0) Outcome measures poorly described and less robust. 






v. Sample size adequate for all groups 
Well-covered (2) Sample size 25 or more in each group because of 
minimum number needed to detect large sample size  
Adequately addressed (1) Sample size 15-25 in each group 
Poorly addressed (0) Sample size not adequate (less than 15)  
Not addressed (0)  
 
vi. Levels of uptake are reported 
Well-covered (2) Levels of uptake are reported and affects of uptake 
levels considered  
Adequately addressed (1) Levels of uptake described in detail 
Poorly addressed (0) Levels of uptake not described 
Not addressed (0)  
 
vii. Results – appropriate outputs provided 
Well-covered (2) Means, standard deviations and confidence intervals 
reported 
Adequately addressed (1) Enough reported to facilitate comparison, not all of 
the above 
Poorly addressed (0) Some of above reported but not enough to make a 
complete comparison, or Selective reporting of 
initial measures mentioned in methods. 
Not addressed (0)  
 
viii. Appropriate Statistical techniques  
Well-covered (2) Appropriate statistics used, compensations for 
multiple comparisons, new alpha level clearly stated. 
Adequately addressed (1) No corrections for multiple comparisons but 
otherwise adequate statistics used. 
 
Questionable statistics used - Post hoc tests used 
after a MANOVA or a variable used as a covariate 
where group differences exist on that variable 
Poorly addressed (0) Inappropriate statistics used 
Not addressed (0)  
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Method, Results, and Discussion. This should be followed by References, 
Appendixes, Acknowledgments, Tables, Figures, and Figure Legends. 
The use of abbreviations, except those that are widely used, is strongly discouraged. 
They should be used only if they contribute to better comprehension of the 
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Special Note Regarding Figures 
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have short titles and all figure legends should be on separate pages. 
If you plan to use figures or tables that have been redrawn or modified from other 
publications, and you are not the copyright holder, please obtain permission for this 
re-use. Authors should err on the side of caution and seek advice from the editorial 








Please provide details of the sources of financial support for all authors, including 
grant numbers. For example, “This work was supported by the National Institutes of 
Health (grant number XXXXXXX)”.  Multiple grant numbers should be separated 
by a comma and space, and where research was funded by more than one agency the 
different agencies should be separated by a semi-colon, with “and” before the final 
funder. Grants held by different authors should be identified as belonging to 
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ZZZZ); the Natural Environment Research Council (E.F., grant 
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research, please provide the following statement “This research received no specific 
grant from any funding agency, commercial or not-for-profit sectors.” 
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Appendix 7 Invitation letter to NHS Grampian Participants 
 
Dear    , 
I am writing to you as someone who is currently waiting for treatment for Bulimia 
with the NHS Grampian Eating Disorders Service.  The service is currently 
supporting a research project investigating how people think and solve problems, as 
well as their flexibility when they are suffering from bulimia or atypical bulimia.  
This is being run in conjunction with colleagues from NHS Tayside.   
Participation involves meeting with a researcher at the Eating Disorder Service at the 
Royal Cornhill Hospital and completing some brief neuropsychological pen-and-
paper tasks which assess this flexibility.  Some general feedback would be available 
on the outcome of these tasks.  Participation would also involve gathering 
information about your current psychological symptoms through interview and 
questionnaires.   
The project will run until the end of June.  I have enclosed a leaflet with further 
information.  If you have an interest in participating in the project or would like 
additional information please contact my colleagues Kate O’Sullivan or Jan 
Templeton whose details are listed below. 
Yours sincerely, 
 
Dr Phil Crockett 
For further information contact: 
Jan Templeton     Kate O’Sullivan  
Clinical Associate in Applied Psychology  Trainee Clinical Psychologist  
Eating Disorder Service    TSMS  
Royal Cornhill Hospital     Constitution House 
Tel: 01224 557 392 (main office)    Dundee 
           DD1 1LB 







Appendix 8 Participant Information Sheets 
 





                                                                               
Participant Information Sheet: NHS Grampian and NHS Tayside Eating 
Disorder Services 
Neuropsychological Correlates of Eating Disorders in Adult Females 
You are being invited to take part in a research study.  We believe it to be of 
potential importance.  Before you decide whether or not you wish to participate, we 
would like to explain why the study is being carried out, and what taking part will 
involve for you.  Please read the following information carefully.  If you have any 
questions please contact either of the people named at the bottom of this sheet, who 
will be happy to discuss the study and provide further information.   
 
Background to the Study 
Investigation of brain functioning in eating disorders is a relatively new field, 
however it is widely recognised as having potential to advance our understanding of 
eating disorders.  Many aspects of brain functioning have been investigated in 
eating disorder populations including general intelligence, attention, memory, 
learning, visuospatial processing, and executive functioning.  “Executive functioning” 
refers to a set of skills which include problem solving, planning, organisation, shifting 
attention, and decision making. There is evidence to suggest aspects of executive 
functioning may be impaired in this population.  However it is not known how these 
impairments may affect individuals and their relationship to psychological 
characteristics commonly seen in people with eating disorders.  
It is hoped this study will advance our understanding of eating disorders and 
help inform new interventions. 
 
Why have I been chosen? 
The study aims to compare individuals with bulimia nervosa, and other eating 
disorders to a clinical and a non-clinical comparison group.  You are being asked to 
participate as part of a clinical group, as you are receiving treatment for an eating 
disorder in NHS Tayside or NHS Grampian.  Everyone meeting certain criteria 
attending NHS Eating Disorder Services in Tayside or Grampian may be asked to 
consider taking part in the study.  
Do I have to take part? 
It is entirely your decision as to whether or not you take part in the study.  If you 
decide to take part, you may withdraw at any time, without giving a reason.  Equally, 
you may choose not to take part at all.  Your decision to take part or not, and the 
answers that you give will not influence any treatment that you are currently 
being given or may receive in the future.   




If you decide you would like to take part in the study, you should let your clinician 
know, and they will pass your details on to a member of the research team to 
arrange a meeting. During the meeting you will be given the opportunity to ask 
questions about the study and then if you wish to proceed to complete a consent 
form.  The investigator will interview you about your eating behaviour and collect 
some basic information.  The investigator will then administer a range of 
neuropsychological tests.  These are similar to tests seen on “brain training” games 
and involve problem solving and pen and paper tasks.  This will take approximately 
45-60 minutes.  You will then be given a short break before being asked to fill in 4 
questionnaires.  In total this will take about 1.5-2 hours.  After participation in the 
study you will have the opportunity for discussion with the investigator and get 
general feedback about your neuropsychological test performance.  The treatment 
you will receive if you do take part in the study will be no different from the treatment 
you would receive otherwise. 
What are the possible disadvantages and advantages of taking part? 
The study will take approximately 1.5-2 hours to complete, which you may find an 
inconvenience.  The questions and tests administered are the same for every 
participant, and are not intended to reflect any personal causes of eating disorders 
however some of the questions asked during interview or in the questionnaires may 
give rise to difficult feelings.  The investigator will be available to discuss any issues 
that may arise during participation, and can direct you to internal and external 
sources of support. After participation you will have a discussion with the 
investigator and get general feedback about your neuropsychological test 
performance, which may be of interest.  It is hoped that the information gathered will 
be of value in enhancing our understanding of eating disorders and in informing new 
interventions.   
Will my taking part in the study be confidential? 
Participation in the study is completely confidential. Confidentiality may be limited if 
there is an issue of risk to yourself or others, in which instance the investigator may 
contact her supervisor Dr Alison Livingston and clinical staff within the relevant 
Eating Disorder Service may be informed.  
Has this study been ethically reviewed? 
The study has been reviewed by The University of Edinburgh’s School of Health 
ethics committee and The University of Stirling Psychology Department ethics 
committee.  It has been approved through NHS Tayside Research Ethics Committee 
and NHS Tayside Research and Development Department. 
How can I make a complaint about this study? 
If you believe that you have been harmed in any way by taking part in the study you 
have the right to pursue a complaint and seek any resulting compensation through 
the usual NHS process.  To do so you can submit a written complaint to the Patient 
Liaison Manager, Complaints Office, Ninewells Hospital (Freephone 0800 027 




you are harmed and this is due to someone’s negligence, you may have grounds for 
a legal action against NHS Tayside but you may have to pay your legal costs.  
Contact Details  
If you would like more information on the study or have any questions, please 
contact:  
Kate O’Sullivan, Dr Alison Livingstone, 
Trainee Clinical Psychologist  Consultant Clinical Neuropsychologist & Lead  
Email: kate.osullivan@nhs.net;  Clinician,   
Tel: 01382 306150  Department of Clinical Neuropsychology,  
 Level 6, Ninewells Hospital, Dundee, DD1 9SY.   
 01382 740 406   
 Email: alison.livingstone@nhs.net 
 










                                                                            
        
Participant Information Sheet: NHS Tayside Psychological Therapies 
Service 
Neuropsychological Correlates of Eating Disorders in Adult Females 
 
You are being invited to take part in a research study.  We believe it to be of 
potential importance.  Before you decide whether or not you wish to participate, we 
would like to explain why the study is being carried out, and what taking part will 
involve for you.  Please read the following information carefully.  If you have any 
questions please contact either of the people named at the bottom of this sheet, who 
will be happy to discuss the study and provide further information.   
 
Background to the Study 
Anxiety and depression are often comorbid with eating disorders.  Investigation of 
brain functioning in eating disorders is a relatively new field, however it is widely 
recognised as having potential to advance our understanding of eating disorders.  
Since anxiety and depression can also affect brain functioning, they need to be taken 
into account when we investigate brain function in eating disorders.  Many aspects of 
brain functioning have been investigated in eating disorder populations including 
general intelligence, attention, memory, learning, visuospatial processing, and 
executive functioning.  “Executive functioning” refers to a set of skills which include 
problem solving, planning, organisation, shifting attention, and decision making. 
There is evidence to suggest aspects of executive functioning may be impaired in this 
population.  However it is not known how these impairments may affect individuals 
and their relationship to psychological characteristics commonly seen in people with 
eating disorders.  
This study aims to investigate executive function in eating disorders and 
account for comorbidity by also studying a clinical comparison group of age and 
gender matched individuals with anxiety and/or depression. It is hoped this study will 
advance our understanding of eating disorders and help inform new interventions. 
 
Why have I been chosen? 
The study aims to compare individuals with bulimia nervosa, and other eating 
disorders to a clinical and a non-clinical comparison group.  You are being asked to 
participate as part of a clinical comparison group, as you are receiving treatment in 
NHS Tayside Adult Psychological Therapies Service.  Everyone meeting certain 
criteria attending NHS Tayside Adult Psychological Therapies Service may be asked 





Do I have to take part? 
It is entirely your decision as to whether or not you take part in the study.  If you 
decide to take part, you may withdraw at any time, without giving a reason.  Equally, 
you may choose not to take part at all.  Your decision to take part or not, and the 
answers that you give will not influence any treatment that you are currently 
being given or may receive in the future.   
 
What does taking part involve? 
If you decide you would like to take part in the study, you should let your clinician 
know, and they will pass your details on to a member of the research team to arrange 
a meeting. During the meeting you will be given the opportunity to ask questions 
about the study and then if you wish to proceed to complete a consent form.  The 
investigator will interview you about your eating behaviour and collect some basic 
information.  The investigator will then administer a range of neuropsychological 
tests.  These are similar to tests seen on “brain training” games and involve problem 
solving and pen and paper tasks.  This will take approximately 45-60 minutes.  You 
will then be given a short break before being asked to fill in 4 questionnaires.  In 
total this will take about 1.5-2 hours.  After participation in the study you will have 
the opportunity for discussion with the investigator and get general feedback about 
your neuropsychological test performance.  The treatment you will receive if you do 
take part in the study will be no different from the treatment you would receive 
otherwise. 
 
What are the possible disadvantages and advantages of taking part? 
The study will take approximately 1.5-2 hours to complete, which you may find an 
inconvenience.  The questions and tests administered are the same for every 
participant, and are not intended to reflect any personal causes of eating disorders 
however some of the questions asked during interview or in the questionnaires may 
give rise to difficult feelings.  The investigator will be available to discuss any issues 
that may arise during participation, and can direct you to internal and external 
sources of support. After participation you will have a discussion with the 
investigator and get general feedback about your neuropsychological test 
performance, which may be of interest.  It is hoped that the information gathered will 
be of value in enhancing our understanding of eating disorders and in informing new 
interventions.   
 
Will my taking part in the study be confidential? 
Participation in the study is completely confidential. Confidentiality may be limited 
if there is an issue of risk to yourself or others, in which instance the investigator 
may contact her supervisor Dr Alison Livingston and clinical staff within NHS 





Has this study been ethically reviewed? 
The study has been reviewed by The University of Edinburgh’s School of Health 
ethics committee and The University of Stirling Psychology Department ethics 
committee.  It has been approved through NHS Tayside Research Ethics Committee 
and NHS Tayside Research and Development Department. 
  
How can I make a complaint about this study? 
If you believe that you have been harmed in any way by taking part in the study you 
have the right to pursue a complaint and seek any resulting compensation through the 
usual NHS process.  To do so you can submit a written complaint to the Patient 
Liaison Manager, Complaints Office, Ninewells Hospital (Freephone 0800 027 
5507).  Note that the NHS has no legal liability for non-negligent harm.  However if 
you are harmed and this is due to someone’s negligence, you may have grounds for a 
legal action against NHS Tayside but you may have to pay your legal costs.  
 
Contact Details  
If you would like more information on the study or have any questions, please 
contact:  
Kate O’Sullivan, Dr Alison Livingstone, 
Trainee Clinical Psychologist  Consultant Clinical Neuropsychologist & Lead  
Email: kate.osullivan@nhs.net;  Clinician,   
Tel: 01382 306150  Department of Clinical Neuropsychology,  
 Level 6, Ninewells Hospital, Dundee, DD1 9SY.   
 01382 740 406   
 Email: alison.livingstone@nhs.net 
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Participant Information Sheet: NHS Tayside Psychological Therapies 
Service 
Neuropsychological Correlates of Eating Disorders in Adult Females 
 
You are being invited to take part in a research study.  We believe it to be of 
potential importance.  Before you decide whether or not you wish to participate, we 
would like to explain why the study is being carried out, and what taking part will 
involve for you.  Please read the following information carefully.  If you have any 
questions please contact either of the people named at the bottom of this sheet, who 
will be happy to discuss the study and provide further information.   
 
Background to the Study 
Investigation of brain functioning in eating disorders is a relatively new field, 
however it is widely recognised as having potential to advance our understanding of 
eating disorders.  Many aspects of brain functioning have been investigated in eating 
disorder populations including general intelligence, attention, memory, learning, 
visuospatial processing, and executive functioning.  “Executive functioning” refers to 
a set of skills which include problem solving, planning, organisation, shifting 
attention, and decision making. There is evidence to suggest aspects of executive 
functioning may be impaired in this population.  However it is not known how these 
impairments may affect individuals and their relationship to psychological 
characteristics commonly seen in people with eating disorders.  
It is hoped this study will advance our understanding of eating disorders and 
help inform new interventions. 
 
Why have I been chosen? 
The study aims to compare individuals with bulimia nervosa, and other eating 
disorders to a clinical and a non-clinical comparison group.  You are being asked to 
participate as part of a clinical group, as you are receiving treatment for an eating 
disorder in NHS Tayside.  Everyone meeting certain criteria attending NHS Tayside 
Adult Psychological Therapies Service may be asked to consider taking part in the 
study.  
 
Do I have to take part? 
It is entirely your decision as to whether or not you take part in the study.  If you 
decide to take part, you may withdraw at any time, without giving a reason.  Equally, 




answers that you give will not influence any treatment that you are currently 
being given or may receive in the future.   
 
What does taking part involve? 
If you decide you would like to take part in the study, you should let your clinician 
know, and they will pass your details on to a member of the research team to arrange 
a meeting. During the meeting you will be given the opportunity to ask questions 
about the study and then if you wish to proceed to complete a consent form.  The 
investigator will interview you about your eating behaviour and collect some basic 
information.  The investigator will then administer a range of neuropsychological 
tests.  These are similar to tests seen on “brain training” games and involve problem 
solving and pen and paper tasks.  This will take approximately 45-60 minutes.  You 
will then be given a short break before being asked to fill in 4 questionnaires.  In 
total this will take about 1.5-2 hours.  After participation in the study you will have 
the opportunity for discussion with the investigator and get general feedback about 
your neuropsychological test performance.  The treatment you will receive if you do 
take part in the study will be no different from the treatment you would receive 
otherwise. 
 
What are the possible disadvantages and advantages of taking part? 
The study will take approximately 1.5-2 hours to complete, which you may find an 
inconvenience.  The questions and tests administered are the same for every 
participant, and are not intended to reflect any personal causes of eating disorders 
however some of the questions asked during interview or in the questionnaires may 
give rise to difficult feelings.  The investigator will be available to discuss any issues 
that may arise during participation, and can direct you to internal and external 
sources of support. After participation you will have a discussion with the 
investigator and get general feedback about your neuropsychological test 
performance, which may be of interest.  It is hoped that the information gathered will 
be of value in enhancing our understanding of eating disorders and in informing new 
interventions.   
 
Will my taking part in the study be confidential? 
Participation in the study is completely confidential. Confidentiality may be limited 
if there is an issue of risk to yourself or others, in which instance the investigator 
may contact her supervisor Dr Alison Livingston and clinical staff within NHS 
Tayside Adult Psychological Therapies Services may be informed. 
 
Has this study been ethically reviewed? 
The study has been reviewed by The University of Edinburgh’s School of Health 




committee.  It has been approved through NHS Tayside Research Ethics Committee 
and NHS Tayside Research and Development Department. 
  
How can I make a complaint about this study? 
If you believe that you have been harmed in any way by taking part in the study you 
have the right to pursue a complaint and seek any resulting compensation through the 
usual NHS process.  To do so you can submit a written complaint to the Patient 
Liaison Manager, Complaints Office, Ninewells Hospital (Freephone 0800 027 
5507).  Note that the NHS has no legal liability for non-negligent harm.  However if 
you are harmed and this is due to someone’s negligence, you may have grounds for a 
legal action against NHS Tayside but you may have to pay your legal costs.  
 
Contact Details  
If you would like more information on the study or have any questions, please 
contact:  
Kate O’Sullivan, Dr Alison Livingstone, 
Trainee Clinical Psychologist  Consultant Clinical Neuropsychologist & Lead  
Email: kate.osullivan@nhs.net;  Clinician,   
Tel: 01382 306150  Department of Clinical Neuropsychology,  
 Level 6, Ninewells Hospital, Dundee, DD1 9SY.   
 01382 740 406   
 Email: alison.livingstone@nhs.net 
 





Appendix 9 Letters of Ethical Approval 
Approval of Substantial amendment to Tayside Eating Disorder Research 























Dr Philip Crockett 
Consultant Psychiatrist 
in Eating Disorders 
Eating Disorder Service 
Royal Cornhill Hospital 
Aberdeen 
AB25 2ZH 
Date 29 February 2012 
Our Ref 2009PC006 
Enquiries to Anne-Marie Sinclair 
Extension 53846 
Direct Line 01224 553846 
Email grampian.randdpermissions@nhs.net 
 
Dear Dr Crockett 
 
Project Title: Neuropsychological correlates of Anorexia Nervosa in Adult Females 
Amendment no: AM06 
Amendment date: 24/09/2011 
Ethics ref: 08/S1401/133  
 
Thank you for sending a copy of the amendment to the above project relating to changes to 
the Electronic Form: Patient Contact Details (v1, 24/09/2011), Description of new sites: 
Group 4 & 5 (v1, 24/09/2011), Group 5 Inclusion/Exclusion Criteria (v1, 24/09/2011), 
Questionnaire: Group 5 Anxious/Depressed Patients (v1, 24/09/2011), Questionnaire: Group 
4 Bulimia (v2, 24/09/2011), Participant Information Sheet: Group 5 Comparison Group (v1, 
24/09/2011), Participant Information Sheet: Group 4 Bulimic Group (v2, 24/09/2011), 
Participant Information Sheet: Group 5 Anxious and/or Depressed Patients (v1, 
24/09/2011), Participant Information Sheet: Group 4 Bulimic Patients for Adult Services 
(v2, 24/09/2011), Participant Information Sheet: Group 4 Bulimic Patients from Eating 
Disorder Services (v2, 24/09/2011), Protocol (v5, 24/09/2011) and Details of Local 
Collaborator.  
 
This letter is confirmation that this amendment does not alter local NHS Grampian R & D 











Non Commercial Manager 
 
 
Cc Dr Alison Livingstone, Consultant Clinical Neuropsychologist/ Lead Clinician, 
NHS Tayside 






Ethical Approval for Original Study submission not including the groups 



















Appendix 10 Consent form 
                                                                                 
Consent Form   
 
Title of Project: Neuropsychological Correlates of Eating Disorders in Adult Females 
 
This form must be completed and signed by the subject in the presence of someone 
with knowledge of the research designated by the Principal Investigator.  This may 
be a doctor, nurse, clinical psychologist or other member of the research team who 
must countersign the form as witness to the subject’s signature. 
 
1. I confirm that I have read and understood the subject information sheet for 
the above study.  
 
2. I have had an opportunity to ask questions and further discuss the study; and 
have received satisfactory answers to all my questions.  I feel I have now 
received enough information about the study. 
 
3. I understand that my participation is entirely voluntary and that I have the 
right to withdraw from the study at any stage without giving a reason. I 
understand this will have no impact on my present or future medical care.  If I 
decide to withdraw from the study the data already collected with consent 
will be retained and included in the study analysis. 
 
4. I understand that all information collected during study participation will be 
confidential. Confidentiality may be limited if there is an issue of risk to 
myself or others, in which instance the Clinical/University staff will be 
informed. 
 
5. I agree to participate in this study. 
 
 
_______________________        ____________________ ______________ 
Name of Subject                            Signature                                  Date 
 
_______________________         ____________________ ______________                  
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